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Abstract  
 
BOLD fMRI is widely used for neuroimaging in rodent models and typically requires 
anaesthesia. Here, the literature investigating the influence of different anaesthesia 
regimes and changes in physiological parameters as confounders of BOLD fMRI in 
rats and mice was systematically reviewed, following a published protocol for 
systematic reviews of animal studies. Four databases were searched. 122 
publications met predefined inclusion criteria. Dose rates of anaesthetics and timing 
of image acquisition relative to induction of anaesthesia commonly influenced 
readouts under otherwise identical conditions. The heterogeneity of included studies 
prevented strong conclusions for pairwise comparison of anaesthetics. Differences 
between awake and anaesthetized imaging were however consistently reported. 
Arterial blood pressure, arterial partial pressure of oxygen and carbon dioxide 
affected BOLD signal across various experimental paradigms and should therefore 
be maintained at stable physiological levels throughout experiments. Despite high 
risk of bias in all included studies, this review demonstrates that BOLD fMRI studies 
risk to be confounded by anaesthetic protocols and management. Establishing 
evidence-based optimal dose ranges and imaging timepoints for a selection of 
anaesthetic protocols, as well as standards of anaesthetic monitoring should 
therefore be a priority for improving the validity of BOLD fMRI in anaesthetised rodent 
models. 
 
Keywords: BOLD fMRI, anaesthesia, monitoring, rat, mouse 
Zusammenfassung  
 
Neurologische Bildgebung mittels BOLD fMRI erfolgt bei Nager-Modellen 
üblicherweise unter Anästhesie. In der vorliegenden Arbeit wurde die Literatur, 
welche den Einfluss verschiedener Anästhesieprotokolle und Veränderungen 
physiologischer Parameter als Störfaktoren auf BOLD fMRI bei Ratten und Mäusen 
untersucht, in einem systematischen Review zusammengefasst. 122 Publikationen 
aus vier Datenbanken erfüllten die zuvor definierten Einschlusskriterien. In den 
meisten Fällen beeinflussten die Dosisraten der Anästhetika sowie der Zeitpunkt der 
Bildgebung bei sonst gleichen Bedingungen die Ergebnisse. Die Heterogenität der 
eingeschlossenen Studien erlaubte keine aussagekräftigen Schlussfolgerungen für 
Vergleiche zwischen Anästhetika. Unterschiede zwischen Messungen bei wachen 
und anästhesierten Tieren wurden jedoch übereinstimmend beschrieben. Arterieller 
Blutdruck, arterieller Sauerstoff- und Kohlenstoffdioxidpartialdruck beeinflussten das 
BOLD Signal und sollten während des Experiments auf physiologischem Niveau 
stabilisiert werden. Trotz des hohen Risikos für Bias in allen Studien zeigt diese 
Arbeit, dass BOLD fMRI Studien für verzerrende Einflüsse von Anästhesieprotokollen 
anfällig sind. Evidenzbasierte optimale Dosisbereiche und Bildgebungs-Zeitfenster 
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für eine Auswahl von Protokollen sowie Standards für die Anästhesieüberwachung 
sollten etabliert werden, um die Validität von BOLD fMRI Studien bei anästhesierten 
Nager-Modellen zu verbessern.  
 
Stichworte: BOLD fMRI, Anästhesie, Monitoring, Ratte, Maus 
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1 Introduction  
1.1 BOLD fMRI for functional neuroimaging  
Blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) 
is the most commonly used functional neuroimaging modality in humans and widely 
used in preclinical and basic research rodent models (Martin, 2014; Jonckers et al., 
2015; Pan et al., 2015). Changes in blood oxygenation levels are interpreted as a 
surrogate for neuronal activation, based on the mechanism of neurovascular coupling 
(Logothetis and Pfeuffer, 2004). Upon neuronal activation, a feedforward mechanism 
dilates arterioles and potentially also capillaries to allow more fully oxygenated blood 
to flow in (Attwell et al., 2010). As the increased supply of oxygen (O2) exceeds the 
increase of O2 consumption associated with neuronal activation, venous oxygenation 
increases in those areas. The BOLD signal arises from changes of 
deoxyhaemoglobin content per unit of brain volume. Deoxyhaemoglobin content is a 
function of cerebral metabolic rate of oxygen (CMRO2), cerebral blood flow (CBF) 
and cerebral blood volume (CBV) (Kim and Ogawa, 2012).  
 
1.2 BOLD fMRI and anaesthesia  
As fMRI is susceptible to movement artefacts, animals need to be immobilised for 
image acquisition. Traditionally, this has been achieved by general anaesthesia and 
while imaging of conscious animals is gaining popularity (Gao et al., 2017), it is still 
common practice to image rats and mice under general anaesthesia or sedation. In 
terms of animal welfare, scanning under anaesthesia is preferable to awake scanning 
under rigorous fixation (Low et al., 2016). 
However, anaesthesia drug- and dose-dependently modulates aspects of 
neurovascular coupling: first, neuronal baseline metabolism and thus CMRO2 is 
markedly reduced compared to the awake state (Gao et al., 2017). Second, 
anaesthetics may modulate the signal cascades responsible for neurovascular 
coupling on the molecular level (Nakao et al., 2001; Petzold and Murthy, 2011). 
Third, haemodynamic baseline conditions and vascular reactivity are typically altered, 
either as a result of direct drug effects on cerebral vasculature or as a result of 
systemic cardiovascular and respiratory depression. CBV and CBF responses to 
stimulation are typically slower and have a lower amplitude in anaesthetised animals 
compared to conscious animals (Gao et al., 2017). For example, hypotension below 
autoregulatory limits reduces cerebral perfusion pressure (if intracranial pressure 
remains constant) and may thus reduce the CBF response. Similarly, hypoventilation 
in spontaneously breathing animals typically results in elevated partial pressure of 
carbon dioxide (pCO2), which induces vasodilation and thus limits maximal 
vasodilation in response to stimuli.  
Beyond the impact of anaesthetics on neurovascular coupling and the resulting 
potential for bias in signal detection (false positives and negatives), anaesthetics alter 
neuronal activation and information processing so that measurements may reflect 
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activation or spontaneous activity under a distinct state of anaesthesia rather than 
universal patterns.  
While it is very likely that the choice of a specific anaesthetic protocol will have an 
impact on the observed BOLD signal, predicting the overall effect of all potentially 
involved mechanisms is almost impossible. A systematic review of anaesthetic 
protocols used for phMRI found a wide variety of agents, combinations, dosages and 
respiratory gases used (73 different protocols in 126 studies) (Haensel et al., 2015). 
Knowing the “profile” of effects of different drugs and drug combinations on the BOLD 
signal is vital for the integration of findings across studies as well as for planning 
further investigations. Although studies have measured how different anaesthetics, 
dosages or timepoints of imaging affect the BOLD signal acquired under otherwise 
identical imaging paradigms, a systematic review of those findings has not been 
published yet. Similarly, alterations in systemic physiological parameters are common 
under general anaesthesia and sedation and can induce bias in BOLD fMRI 
experiments if they are not monitored, but a consensus on minimal monitoring for 
rodent BOLD fMRI experiments has not been established.  
 
1.3 Aim of the review  
One part of this review therefore focuses on studies which directly compare different 
anaesthetic protocols with each other or with awake scanning. We want to analyse 
how different states of anaesthesia affect the BOLD outcome measures specified in 
the respective studies in adult rats and mice. The other part of this review focuses on 
the specific effects of alterations in systemic physiological parameters on different 
BOLD outcome measures.  
Our aim is to demonstrate the extent of anaesthetic protocol-related differences in 
BOLD fMRI outcomes, to formulate evidence-based minimal standards for monitoring 
during BOLD fMRI experiments, and ultimately to elaborate recommendations on 
how to choose an appropriate anaesthetic protocol. To our knowledge, this is the first 
systematic review about the impact of anaesthetic protocols on BOLD fMRI validity in 
laboratory rodents. 
The concept of systematic reviews was originally developed for clinical studies 
(Moher et al., 2000) and recently extended and adapted to pre-clinical studies (de 
Vries et al., 2015). The question we are addressing is however from the field of basic 
research. While narrative reviews are commonly encountered in basic research, 
systematic reviews are not established yet. This systematic review therefore also 
serves as a case-study for the application of systematic reviews in basic research. 
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2 Materials and Methods  
This review was designed as a systematic review. The „Systematic review protocol 
for animal intervention studies” (de Vries et al., 2015) was used for preparation and 
validation. The protocol as on the day when the systematic literature search was 
performed is provided in appendix 2.  
2.1 Systematic literature search  
A systematic search was conducted in Embase, Medline, Scopus and Web of 
Science in august 2017. Search terms are listed in table 1. Each reference had to 
contain at least one term of each building block. Terms were searched in titles and 
abstracts (Medline, Embase) or the closest option available (title, abstract, keywords 
for Scopus and Web of Science). Emtree vocabulary and MeSH were additionally 
used for the search in Embase and Medline, respectively, if a correspondent entry 
existed. Language was restricted to English, German and French. As the first article 
describing BOLD contrast in MRI was published in 1990, filters for publication year 
1990 or later were used. 
 
Table 1. Structure of systematic literature search. Search terms within one building 
block were linked with “OR”, building blocks with “AND”. Database-specific syntax, 
truncation options and proximity operators (“NEAR” for Embase and Web of Science, 
“adj” for Medline, “W” for Scopus) were used. 
Rodents 
rat OR rats OR mouse OR mice OR rodent OR rodents 
MRI 
((MRI OR MRT OR NMR OR “magnetic resonance imaging”) proximity operator5 
functional) OR fMRI OR BOLD OR “Blood oxygen level dependent” 
Anaesthesia OR physiology 
anesthe* OR anaesthe* OR hypercapnia OR hyperoxia OR hypoxia OR apnoea OR 
“blood pressure” OR hypotension OR hypertension OR autoregulation OR 
thermoregulation OR “physiological noise” OR “functional connectivity” OR 
somatosensory OR stimulation OR isoflurane OR sevoflurane OR halothane OR 
medetomidine OR dexmedetomidine OR alpha-chloralose OR chloralose OR α-
chloralose OR urethane OR propofol OR ketamine OR xylazine 
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2.2 Screening and study selection  
Systematic review software, DistillerSR (Evidence Partners, Ottawa, Canada), was 
used for screening, study selection and later data extraction. References were 
automatically checked for duplicates before entering the screening process. For the 
screening process, a refined version of the eligibility criteria formulated in the study 
protocol was used (appendix 3). 
Studies were eligible if they reported BOLD fMRI results of the brain of adult rats or 
mice under different anaesthetic or physiologic conditions. Differences in 
physiological parameters could be intentionally induced (interventional studies) or 
naturally occurring, but explicitly analysed for their effect on BOLD signal 
(observational studies; intention to analyse effects of physiological parameter 
fluctuations on BOLD signal had to be expressed in abstract). The publication had to 
describe original research. Reviews, book chapters and opinion pieces were 
excluded. Re-analysis of previously acquired data, however, was eligible as a 
strategy to reduce the number of animal experiments. Full articles were included as 
well as short forms (conference papers/abstracts/posters). No restrictions regarding 
sex, strain or health status of the animals were imposed. Adult was defined as at 
least 8 weeks of age or 18 g for mice and at least 8 weeks or 200 g for rats and up to 
12 months of age for both species. If age or weight ranges at the lower end of the 
scale “overlapped” with the definition of adult, so that it was to be expected that the 
majority of animals met the inclusion criteria (e.g. rats of 180 to 240 g), the study was 
included. Studies which did not report age or weight of the animals were included if 
they not explicitly stated that younger (e.g. pups, neonatal, juvenile, adolescent) or 
older (geriatric, aged) animals were investigated. 
BOLD fMRI had to be applied to the brain. Studies imaging other regions of the body 
(e.g. spine, heart, kidneys) or brain tumours were excluded. Other fMRI modalities 
such as arterial spin labelling (for CBF measurement) or contrast enhanced CBV 
measurements and structural MRI studies were not eligible. Whether imaging was 
performed under stimulation (peripheral/central), as a pharmacological MRI (phMRI) 
or in the resting state, was irrelevant for inclusion. Similarly, no restrictions were 
made regarding outcome measures except that they had to be directly derived from 
the BOLD signal. Correlations of the BOLD signal with signals from other functional 
neuroimaging methods, with measurements of neural activity or cerebral 
haemodynamics were however excluded. In the special case of studies determining 
CMRO2 with multimodal fMRI, the decision was based on whether the BOLD signal 
was separately reported or not. If a study used multiple methods (e.g. EEG and 
BOLD fMRI), only data from those experiments meeting the inclusion criteria were 
analysed. 
Other reasons of exclusion were duplicates which were not recognised by the 
automatic screening, short forms for which a corresponding full article was available 
and publications with a strong suspicion of multiple reporting (criteria: same authors, 
same number of animals in same experimental design, similar methods of 
analysis/same outcome measure and no declaration that data from a previous study 
was re-analysed). 
For included short forms, Embase and Google Scholar were searched for 
publications of the same authors within 3 years of publication of the short form in 
order to identify corresponding full articles.  
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Any reference fulfilling inclusion criteria, but not identified by the systematic search, 
was included if found in the literature. 
Study selection was performed by a single reviewer. Currently there is not enough 
evidence to claim independent screening by two reviewers (Shamseer et al., 2015). 
The screening process consisted of two stages. In the first stage (title abstract 
screening), title and abstract were screened for obvious exclusion reasons such as 
other species, imaging of other body regions, absence of fMRI, or reviews and 
opinion pieces. Any publication using BOLD fMRI was included at this stage. If it was 
not clear from the abstract which (f)MRI modality was used or with which method 
functional connectivity (fc) was measured, the reference was included. Similarly, 
references for which no abstract was displayed were taken to the next level unless 
the title clearly indicated that they investigated other species or body regions. For the 
second screening stage (full text screening), full text versions of all references were 
acquired. Based on the full text it was decided whether a publication was in- or 
excluded. References for which this decision was not straightforward are listed in 
appendix 4 together with a rationale. 
2.3 Data extraction  
In a quarter of included studies, data were extracted in double by a second reviewer 
(Frédérik Rousseau-Blass) to ensure consistency of data extraction. For each 
included study, animal characteristics (species, sex, strain, age, weight, numbers per 
experimental group), the exact anaesthetic protocol (drugs, doses, route of 
administration, time point of administration, gas mixture, gas flow, concentration of 
inhalant anaesthetic) and presence or absence of monitoring of specific parameters 
(temperature, heart rate, arterial oxygen saturation (SpO2), respiratory rate/ventilator 
setting, end-tidal gas concentrations, blood gas parameters and timing, arterial blood 
pressure, reflexes) were extracted. Additionally, surgical preparations for the 
experiment, study design, type and timing of stimulations during BOLD fMRI, duration 
of image acquisition and total experiment, magnetic field strength, regions of interest 
and the data analysis approach were extracted. For records investigating the effect of 
physiological parameters on BOLD fMRI outcome, details of the interventions to alter 
the physiological parameter(s) and the observed changes in physiological 
parameters were additionally extracted. 
Forms for data extraction were implemented in DistillerSR and are available in 
appendix 7. 
To account for the variety of outcome measures used in individual studies, the 
outcome to be extracted from each study was defined as whether a – qualitative or 
quantitative – difference in the individual outcome measure was observed between 
different states of anaesthesia or physiologic conditions. If a difference was 
observed, it was specified.  
2.4 Data analysis  
Data was analysed in a structured (narrative) synthesis. Data was analysed for rats 
and mice separately but following the same structure algorithm.  
14 
 
For the comparison of physiological conditions, references were grouped by 
experimental paradigm (e.g. resting state fMRI (rsfMRI), fMRI measuring response to 
a certain type of stimulation). If a reference reported results for multiple experimental 
paradigms, it was allocated to all paradigms for which inclusion criteria were fulfilled. 
Within each experimental paradigm we analysed whether in- and/or decreases of 
specific physiological parameters were consistently reported to affect BOLD outcome 
measures, and whether the reported effects were consistent, complementary or 
inconsistent.  
For the comparison of states of anaesthesia, analysis followed an analogous 
structure. References were grouped by experimental paradigm (e.g. rsfMRI, fMRI 
measuring response to a certain type of stimulation). If a reference reported results 
for multiple experimental paradigms, it was allocated to all paradigms for which 
inclusion criteria were fulfilled. Within each experimental paradigm we analysed 
whether studies comparing the same anaesthetics, different doses of the same 
anaesthetic or different timepoints of imaging for the same anaesthetic, consistently 
reported differences, and whether the observed differences were consistent, 
complementary or inconsistent.  
The order in which comparisons would be addressed per paradigm as well as to 
which level stimulation paradigms would be differentiated was not a priori defined in 
order to allow clustering based on the included publications. 
2.5 Risk of bias assessment  
Risk of bias was assessed for individual studies using an adapted version of the 
SYRCLE risk of bias tool (Hooijmans et al., 2014), to our knowledge the only 
standardised tool for the assessment of risk of bias in animal intervention studies. 
Signalling questions and examples provided for each item were adapted to the 
settings of the studies under investigation. Item number 4 of the original tool, 
randomised housing, was excluded because preliminary literature search suggested 
that many BOLD experiments are performed in one session without prior 
interventions whose effects could vary due to different housing conditions. Moreover, 
while it is plausible that differences in individual experiences (social status, cage 
position in the room) have an impact on the brain’s fc and reactivity to specific stimuli, 
such variance first adds to external validity of a study and it is second not known, 
whether and how such interindividual differences are transmitted to the 
anaesthetised or sedated state. 
The adapted version of the tool can be found in appendix 6. To ensure consistent 
assessment of studies, rules derived from specific examples were defined and 
continuously updated. Individual studies were assessed as having a low, unclear or 
high risk of bias according to the Cochrane Collaboration’s tool for assessing risk of 
bias in randomised trials (Higgins et al., 2011).  
High risk of bias was not an exclusion criterion. Instead, risk of bias across studies 
was indicated for each subgroup of analysis and resulted together with the 
consistency of the presence and direction of effects in an assessment of the strength 
of evidence for that particular subgroup (Berkman et al., 2015). 
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3 Results  
3.1 Systematic literature search  
A total of 9984 references was retrieved by the systematic literature search and 6284 
remained after duplicate removal. Of those, 4875 references were excluded at the 
first screening level and 1289 at the second screening level. Finally, 122 references 
were included, two of which were not found with the systematic search but forwarded 
by a colleague.  
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Figure 1: Number of references found via systematic literature search, grouped by 
database. 
 
The predefined inclusion and exclusion criteria did not cover all constellations 
encountered. During study selection, additional exclusion criteria were defined: 
Interventions tested on one animal only were excluded. References investigating the 
effects of physiological parameters were excluded if the anaesthetic agent was not 
reported. The results section had to contain at least one sentence about the 
comparison of interest. In selected cases, which are justified in appendix 4, 
references were excluded for insufficient detail of the reported results. As a rule of 
thumb, studies presenting only quantitative findings such as percent signal changes 
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without a statement on significance were excluded. Descriptive reporting of 
qualitative aspects was accepted unless generalised to the point that almost no 
information could be extracted (e.g. one sentence about “widespread activation” 
without further characterisation of the location, extent or reproducibility of that 
activation compared to the second experimental condition).  
Some studies used known effects of hypercapnia or hyperoxia to study differences in 
response to hyperoxic or hypercapnic challenges between experimental groups, 
without further characterising those responses, and were excluded. Two studies were 
excluded because animals were imaged in a vertical position. As orthostatic arterial 
blood pressure regulation is blunted during anaesthesia (Duke-Novakovski et al., 
2016), the haemodynamic status of vertically positioned animals was not considered 
comparable to the haemodynamic status of animals in horizontal position. 
Additional specific cases are described in appendix 4. The search also retrieved a 
few abstract collections or conference proceedings, typically containing several 
hundred abstracts. Those were excluded with the reasoning that individual potentially 
relevant abstracts could have been identified by the systematic search and are also 
listed in appendix 4. 
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Records identified 
through database 
searchings  
N = 9984 
 
  
Additional records  
identified through other 
sources  
N = 2 
 
 
 
  
Records after duplicates removed N = 6286 
   
Records screened  
N = 6286 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records excluded N = 4875 
-------------------------------------------------------- 
no MRI (N = 2488) 
other species (N = 796) 
other region of body (N = 688) 
other fMRI modality (N = 389) 
in vitro (N = 49) 
out of age range (N = 63) 
review (N = 343) 
commentary/opinion article (N = 26) 
book chapter (N = 14) 
data processing (N = 6) 
model description (N = 10) 
planned or ongoing study (N = 3) 
no reason of exclusion given (N = 0) 
 
   
Full-text articles assessed 
for eligibility 
N = 1411 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Full-text articles excluded, with reasons N = 1289 
------------------------------------------------------------------------ 
no MRI (N = 140) 
other MRI (N = 174) 
brain tumor only (e.g. glioma) (N = 16) 
other body region (N = 4) 
other (N = 72) 
younger (N = 74) 
older (N = 4) 
review/opinion piece/talk (N = 24) 
duplicate (N = 14) 
multiple reporting (N = 2) 
full article available (N = 8) 
one animal per condition (N = 2) 
anesthetic(s) not reported (N = 3) 
no results reported for the comparison of inter... (N = 11) 
insufficient detail of results (N = 7) 
other (N = 37) 
Neither AP nor PP comparison (N = 697) 
 
 
 
   
Studies included in 
quantitative synthesis 
(meta-analysis)  
N = 122 
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Figure 2. Prisma flow chart representing workflow from reference identification to 
definitive inclusion. The category “other” at the full-text screening level contains all 
reasons of exclusion that were not previously mentioned, such as quantitative fMRI 
not reporting BOLD signal changes, application of hypercapnia or hyperoxia, 
correlation of the BOLD signal with other parameters as the sole outcome measure, 
and less common reasons specified in appendix 4.  Flow chart generated with 
DistillerSR (Evidence Partners, Ottawa, Canada), based on (Moher et al., 2009). 
 
 
3.2 Data structure  
Of the 122 included references, 117 were full articles and 5 short forms of 
publications such as conference abstracts or posters. Those 122 publications were 
based on minimally 112 datasets. The exact number of datasets is difficult to identify 
because a cluster of five publications (Liang et al., 2012a, b; Liang et al., 2013; Liang 
et al., 2015a; Smith et al., 2017) appeared to re-analyse the same core dataset (16 
rats imaged awake and under isoflurane), adding however data from variable 
numbers of awake animals acquired in one of those five studies (Liang et al., 2012a) 
or in a previous study (Zhang et al., 2010). The reference cited for the core dataset 
(Liang et al., 2011) is not included in this review because findings from anaesthetised 
animals are not reported in that publication. Due to the intransparency of data 
provenance, those five references were considered as based on one dataset for 
further analyses. 
Unless indicated otherwise, the number of references corresponds to an equal 
number of datasets in the following section. In chapters 3.3 and 3.4, results are first 
reported for individual references and then summarised per dataset for the 
conclusions. 
Rats were studied in 107 references based on 99 datasets and mice in 15 references 
based on 13 datasets; no publication reported results for both species.  
The effect of changes in physiological parameters on the BOLD signal was 
addressed in 45 rat references (45 datasets) and 4 mouse references (4 datasets). 
Differences in BOLD fMRI measurements between anaesthetic protocols and/or 
awake and anaesthetised animals were addressed in 70 rat references (62 datasets) 
and 14 mouse references (12 datasets). Eight and three references in rats and mice, 
respectively, covered the effects of physiological parameters as well as anaesthetic 
protocol comparisons.  
Risk of bias was assessed as high in all included references. Lack of blinding, both 
during the experiment (121/122 references clearly not blinded, 1 reference unclear) 
and during data analysis (119/122 studies clearly not blinded, 4 studies unclear), was 
the primary reason for this classification, followed by concerns associated with study 
design (29/122 references, including the cluster of 5 references discussed earlier and 
4 references based on 2 datasets; i.e. 22/112 datasets). 
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Figure 3. Numbers of included references and underlying datasets per species and 
category. AP = comparison of states of anaesthesia, PP = investigation of effects of 
physiological parameters, AP and PP = comparison of states of anaesthesia as well 
as investigation of effects of physiological parameters. 
 
Included studies were heterogeneous in terms of animal characteristics, study 
design, experimental procedures and image acquisition.  
Sprague-Dawley rats were the most commonly used rat strain (57 references/55 
datasets, of which 1 also used Wistar rats), followed by Wistar (31 references/30 
datasets, of which 1 also used Sprague-Dawley rats) and Long-Evans rats (17 
references/12 datasets). In three studies the rat strain was not specified. All mouse 
studies used C57BL/6 mice, and two studies additionally investigated other strains 
(BALB/c and I/LnJ in one study, transgenic animals expressing channel rhodopsin 2 
in the other study). While primarily male rats were studied, both sexes were 
represented in mouse studies (figure 4).  
Animal numbers for fMRI ranged from 2 to 55 rats and from 8 to 63 mice per 
publication. Most studies either exposed different groups of animals to different 
conditions or successively exposed the same animals to multiple conditions in a 
single experimental session. Combinations of the previously mentioned designs and 
exposition of the same animals to different conditions in different experimental 
sessions were also represented (figure 5).  
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Figure 4. Sex distribution in studies investigating rats (left diagram) and mice (right 
diagram). Numbers of references and underlying datasets are shown. Male = study 
used only male animals, female = study used only female animals, both = study used 
animals of both sexes, na = sex of animals not reported  
 
Experimental procedures, for example whether animals were intubated and/or 
mechanically ventilated, or whether the same anaesthetic was used for induction and 
maintenance of anaesthesia, varied between studies, as did anaesthetic monitoring 
and total experimental times. A few studies performed surgical procedures on the 
head directly before fMRI acquisition (intracerebral or epidural electrode placement in 
nine references, skull exposure in two references, middle cerebral artery occlusion in 
one reference, implantation of a head bar plus a gastric tube in one reference). 
Tracheotomy was reported in roughly a quarter of included references (32, including 
4 that also did surgery on the head).   
 
 
 
 
Figure 5. Study designs used in included references. Reference counts are 
presented, because some references re-analysed only parts of the original dataset. 
Not clear = the study design was not clear from the provided information; multiple 
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sessions = animals underwent several experimental sessions on different days; 
single session nested = elements of simple study design are combined; single 
session simple = study design can be described by one of the following categories: 
between group = one group of animals per condition, one condition per animal; 
multiple conditions – not specified = multiple conditions per animal in not specified or 
fixed order; multiple conditions – crossover =  multiple conditions per animal in a 
crossover design; timepoints = one condition per animal, multiple measurements at 
different timepoints; observational = studies measuring and analysing the effect of 
naturally occurring signal fluctuations on BOLD signal.  
 
Heterogeneity between studies may further arise from image acquisition, processing 
and analysis. Magnetic field strength of scanners used in the included studies varied 
from 1.5 T to 11.7 T and was most commonly between 4.7 and 9.4 T (figure 6). 
Assessing additional technical specifications, the methods used for image processing 
and approaches to data analysis was however beyond the scope of this review. 
 
 
Figure 6. Magnetic field strength in tesla of MRI scanners used in the included 
studies. 
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3.3 Effects of physiological parameters on BOLD signals  
3.3.1 Rats  
3.3.1.1 Effects of changes in physiological parameters on the baseline BOLD signal  
The impact of alterations in systemic physiological parameters on the baseline BOLD 
signal was investigated in 31 interventional and 1 observational references. 27 did so 
under one anaesthetic condition, 5 (interventional) compared different conditions. 
Whether findings depended on anaesthetic protocols will be covered in chapter 3.4.  
The majority of references changed the concentrations of inspiratory gases and/or 
induced apnoea.  
 
3.3.1.1.1 Hypoxaemia and concomitant hypoxia  
Eleven studies investigated the effect of hypoxic gas mixtures on BOLD signal and 
consistently report a decrease of baseline BOLD signal intensity or an increase of 
effective relaxation rate (R2*), which translates into lower signal intensity, under 
varying degrees of hypoxia and hypoxaemia. This effect was found across a range of 
anaesthetic protocols (halothane, isoflurane, pentobarbital, α-chloralose, urethane, 
ketamine/xylazine, awake) and under spontaneous (Prielmeier et al., 1993; Dunn et 
al., 1999; Sicard and Duong, 2005; Duong, 2007) as well as controlled ventilation  
(Prielmeier et al., 1994; Kida et al., 1996; Lin et al., 1998b; Lin et al., 1998c; Houston 
et al., 2000). Sicard and Duong (2005) observed lower baseline BOLD signals with 
more pronounced hypoxia. A linear relation between the change in R2* (ΔR2*) and 
venous or weighted arterial plus venous O2 saturation was commonly observed 
(Prielmeier et al., 1994; Kida et al., 1996; Lin et al., 1998b; Lin et al., 1998c). One 
study found that the slope of this linear relationship differs significantly between 
normal and reduced haematocrit, with steeper slopes in anaemic animals (Lin et al., 
1998b). Signal intensity was typically reduced in vessels (e.g. sagittal sinus) and 
brain parenchyma, but some studies did not differentiate (e.g. Lowry et al. (2010). 
While studies consistently reported stronger (Prielmeier et al., 1993; Prielmeier et al., 
1994) or earlier (Kida et al., 1996) reductions of signal intensity or increases of R2* 
close to vessels in comparison to brain parenchyma, regional differences within brain 
parenchyma were more controversial. Houston et al. (2000) mention regional 
differences in signal decrease without further specifying them. Prielmeier et al. (1993) 
report higher signal changes in cortex than in caudate putamen (CPu) under 
halothane, whereas Dunn and Swartz (1997) observed a higher R2* in the CPu than 
cortex (i.e. opposite trend) under ketamine/xylazine. However, it is not clear whether 
those differences were statistically significant. Dunn et al. (1999) found significantly 
lower ΔR2* in hippocampus than in cortex and thalamic nuclei, while corpus callosum 
values were in between and not significantly different from other regions. Finally, Kida 
et al. (1996) noted that the decrease in signal intensity became evident in cortex prior 
to basal ganglia when the fraction of inspired oxygen (FiO2) was reduced stepwise , 
but  Prielmeier et al. (1994) did not find a significant difference in ΔR2* between 
cortical and basal ganglia region of interest (ROI) .  
Taken together, there is robust evidence that BOLD signal intensity decreases under 
hypoxic conditions. Some degree of regional heterogeneity in BOLD signal decrease 
is likely to occur, but whether it reaches statistical significance and where the 
23 
 
strongest and weakest changes have to be expected cannot be concluded from the 
current evidence.  
 
3.3.1.1.2 Hyperoxaemia and hyperoxia  
Three studies consistently report an increase in BOLD signal intensity during 
hyperoxia in healthy animals under controlled as well as spontaneous ventilation 
(Sicard and Duong, 2005; Lu et al., 2009; Lowry et al., 2010). Lu et al. (2009) 
observed strong signal changes primarily “in the outer layer of the cortex and several 
subcortical areas” including CPu and thalamus, the other two studies did not 
investigate regional differences. A fourth study used hyperoxia as a challenge in a 
stroke model and found that both 40 and 100% inspiratory O2 significantly increased 
effective transverse relaxation time (T2*), i.e. BOLD signal intensity, in the penumbra 
of an ischemic lesion compared to the ischemic core as well as the contralateral 
unaffected cortex (Baskerville et al., 2011). While in the latter two, changes in signal 
intensity did not significantly differ between 40 and 100% O2, in penumbra, signal 
increase under 100% O2 was significantly higher.  
In contrast, a fifth study briefly reports that no significant difference was found in 
baseline BOLD signal between animals ventilated with room air and 100% O2 under 
pentobarbital anaesthesia (Kannurpatti et al., 2003a).  
In summary, an increase in BOLD signal intensity due to hyperoxia was reported in 
some references (Sicard and Duong, 2005; Lu et al., 2009; Lowry et al., 2010; 
Baskerville et al., 2011) but not in earlier work (Kannurpatti et al., 2003a). 
 
3.3.1.1.3 Hypercapnia  
Six studies consistently report an increase in BOLD signal intensity during 
hypercapnia in awake as well as isoflurane-, nitrous oxide (N2O)- or pentobarbital-
anaesthetised animals and under both spontaneous and controlled ventilation 
(Graham et al., 1994; Brevard et al., 2003; Kannurpatti et al., 2003a; Sicard et al., 
2003; Sicard and Duong, 2005; Lu et al., 2009). A trend for higher signal increases 
under higher carbon dioxide (CO2) concentrations (2 versus 5% and 5 versus 10%) 
was consistently observed (Brevard et al., 2003; Kannurpatti et al., 2003a; Sicard et 
al., 2003; Sicard and Duong, 2005), but only in one study the difference reached 
statistical significance (Kannurpatti et al., 2003a). Most studies investigated whole 
brain ROI, only Lu et al. (2009) differentiated between different ROI and reports 
significant signal increases in cortex, thalamus, and depending on whether gradient 
echo or spin echo was used also in CPu, but not in hippocampus. Within the cortex 
signal changes were primarily found in the middle layer (2 mm below surface). An 
additional study repeatedly acquired scans 5 min after termination of 5 min of 
hypercapnia and did not find a significant increase of baseline BOLD signals, which 
was in line with a return of arterial partial pressure of CO2 (paCO2) to pre-hypercapnia 
levels (Dutka et al., 2002). 
Taken together, there is robust evidence that hypercapnia transiently increases 
BOLD signal intensity across a range of conditions.  
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3.3.1.1.4 Hyperoxia/hypercapnia  
One single report of combined hyperoxia and hypercapnia observed higher baseline 
BOLD signal intensity under carbogen, i.e. 95% O2 plus 5% CO2, than under room air 
(Kannurpatti et al., 2003a). 
 
3.3.1.1.5 Apnoea  
Three studies imposed apnoea on animals ventilated with room air, hyperoxic, 
hypercapnic or combined hyperoxic/hypercapnic gas mixtures under pentobarbital or 
urethane anaesthesia.  
In animals ventilated with room air, BOLD signal consistently decreased across all 
brain regions during apnoea (Kannurpatti et al., 2003a, b; Kannurpatti and Biswal, 
2004). When the duration of apnoea was increased from 20 to 30 s, a significant 
signal decrease was observed in more voxels and the magnitude of signal decrease 
tended to be higher. Regardless of the duration of apnoea, signal decrease was 
significantly larger in cortex than thalamus and hippocampus (Kannurpatti et al., 
2003b).  
When animals were ventilated with 100% O2, BOLD signal increased during apnoea 
(Kannurpatti and Biswal, 2004; Kannurpatti et al., 2003a). Distribution of the signal 
change was similar as for the room air condition, but reportedly fewer voxels were 
affected (no information on significance provided).  
Ventilation with 2 or 5% CO2 added to room air resulted in a significantly higher 
signal decrease than in the room air condition (Kannurpatti et al., 2003a; Kannurpatti 
and Biswal, 2004). 
The combined effects of hyperoxic and hypercapnic inspiratory gases appeared to 
level out when animals were ventilated with carbogen, i.e. a mixture of 95% O2 and 
5% CO2: no significant change in BOLD signal was detected during apnoea 
(Kannurpatti et al., 2003a).  
Taken together, a global change of BOLD signal intensity during apnoea can be 
expected for most inspiratory gas compositions, although the direction and 
magnitude of the signal change will depend on the inspiratory gas composition. 
 
3.3.1.1.6 Hypotension or decrease in arterial blood pressure  
Four studies investigated the effect of arterial blood pressure decreases on the 
baseline BOLD signal. Arterial blood pressure decreases were induced by blood 
withdrawal (Zaharchuk et al. (1999) halothane, Kalisch et al. (2001) halothane, 
isoflurane, propofol) or pharmacologically (Wang et al. (2006) α-chloralose) in three 
studies. The fourth study analysed potential correlations between blood pressure and 
BOLD signal intensity under different isoflurane concentrations (Tsurugizawa et al., 
2016).  
Zaharchuk et al. (1999) did not find significant changes in R2*, neither in a whole 
brain slice ROI, nor when separately analysing striatum, cortex and cortical rim. In 
contrast, Kalisch et al. (2001) observed significant positive correlations between 
arterial blood pressure and BOLD signal intensity in an entire brain slice, however, 
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correlations were region-specific with larger positive and negative (> 0.5 / < -0.5) 
correlations in the proximity of large vessels, positive correlations in cortex and some 
subcortical clusters, and negative correlations in other clusters. Contrary to the mixed 
positive and negative correlations of Kalisch et al. (2001), Wang et al. (2006) 
uniformly found a decrease in BOLD signal when arterial blood pressure decreased. 
The number of arterial blood pressure-correlated voxels depended linearly and 
significantly on the magnitude of arterial blood pressure change and became 
substantial for changes exceeding 30 mmHg. Those voxels were distributed across 
cortical and subcortical areas.  
Tsurugizawa et al. (2016) et al. investigated the effect of different isoflurane 
concentrations (1.5, 2.0, 2.5, 3.0%) on mean arterial blood pressure (MAP) and 
BOLD signal in somatosensory cortex. While MAP was significantly lower at all 
higher concentrations than 1.5% isoflurane, BOLD signal was significantly higher at 
2.0 and 2.5% isoflurane and decreased again at 3.0%, resulting in an inversed U-
shape. Arterial blood pressure and basal BOLD signal were thus not correlated in this 
study. 
Taken together, results are contradictory as to whether blood pressure decreases are 
correlated with BOLD signal changes: two studies each did or did not find 
correlations. Additionally, those two studies that did observe some positive 
correlations reported concurrent negative correlations.  
 
3.3.1.1.7 Hypertension or increase in arterial blood pressure  
In contrast to arterial blood pressure decreases, arterial blood pressure increases 
caused by pharmacological agents consistently caused BOLD signal increases, at 
least in some voxels, in five studies.  
Most studies administered noradrenaline as a bolus or short infusion of maximum 1 
min (Tuor et al., 2002; Wang et al., 2006; Qiao et al., 2007; Tuor et al., 2007). Voxels 
correlated to the arterial blood pressure time course or classified as “activated” by the 
noradrenaline stimulus (based on a cluster analysis) were identified in the 
sensorimotor cortex as well as in other brain regions. Tuor et al. (2002) noted that 
correlated voxels were more localised when arterial blood pressure changes were 
below 60 mmHg than when they exceeded 60 mmHg. The number of 
correlated/activated voxels typically significantly increased when a certain threshold 
of arterial blood pressure change, varying from 10 to 60 mmHg, depending on the 
region, was crossed (Wang et al., 2006; Tuor et al., 2007). In sensorimotor cortex, 
Wang et al. (2006) found a linear correlation between arterial blood pressure 
increase and the number of correlated voxels. BOLD signal increases within the 
correlated/activated voxels were reported to significantly correlate with the arterial 
blood pressure time course (Tuor et al., 2002) or to reach statistical significance 
(compared to baseline) at thresholds of 30 to 60 mmHg, depending on the region and 
condition (Qiao et al., 2007; Tuor et al., 2007). Notably, Tuor et al. (2007) 
investigated a stroke model 1 week after transient middle cerebral artery occlusion 
and observed that stroke animals showed significantly higher voxel number and 
signal intensity increases in the infarct and peri-infarct region for 31-45 mmHg arterial 
blood pressure increase than sham operated animals in the corresponding 
hemisphere. However, the increase in signal intensity and voxel numbers in the 
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contralateral, non-affected hemisphere, was significantly lower in stroke than sham 
animals.  
Finally, one study characterised the BOLD activation pattern of an only peripherally 
acting cocaine derivate (cocaine methiodide) which, like cocaine, increased MAP and 
heart rate. Positive as well as negative BOLD signal responses were observed in 
some “scattered” voxels (Luo et al., 2003).  
Taken together, voxels correlated to arterial blood pressure time courses and 
showing positive signal changes upon arterial blood pressure increases were 
consistently found, whereas concurrent negative signal changes were only 
sporadically mentioned. Typically, the number of correlated voxels and/or the signal 
intensity of correlated voxels were higher with higher arterial blood pressure 
increases. Arterial blood pressure increases of at least 30 mmHg were a common 
threshold for those changes to reach statistical significance.  
 
3.3.1.1.8 Single reports  
Vanhoutte et al. (2006) report a decrease of whole brain BOLD signal intensity when 
body temperature was increased over 38° C.  
Another study observed an increase in signal intensity (ROI brain parenchyma) 
during normovolemic haemodilution, i.e. anaemia (Lin et al., 1998a). Signal intensity 
significantly decreased once the procedure was completed but did not reach baseline 
values during the observation period. Significantly stronger reductions of R2* 
(translating into stronger signal intensity increase) were found when the double 
amount of blood was replaced (6 instead of 3 ml).  
Those reports suggest that body temperature as well as haematocrit may influence 
BOLD signal intensity, however, further studies would be required to characterise the 
effects.  
 
3.3.1.1.9 Summary  
Most studies found a modulatory effect of inspiratory gas concentrations, apnoea, 
blood pressure variations, body temperature and haematocrit on baseline BOLD 
signal. Hypoxia and apnoea under room air or room air plus CO2 consistently 
decreased the BOLD signal, whereas hypercapnia, apnoea under 100% O2 and 
increases in blood pressure consistently increased the BOLD signal. Hyperoxia and 
arterial blood pressure decreases were inconsistently reported to result in BOLD 
signal in- and decreases, respectively.  
 
3.3.1.2 Effects of changes in physiological parameters on BOLD signal responses to 
peripheral stimulation  
Fifteen references investigating the effect of physiological parameters on activations 
in response to peripheral stimulation were found. Thirteen of those applied electrical 
stimulation to the paws or in one case the cheeks, and one each used chemical 
somatosensory and mechanical visceral stimulation.  
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Eleven studies, all using electrical stimulation, deliberately modulated physiological 
parameters. The remaining four studies analysed the influence of naturally occurring 
physiological changes on BOLD responses.  
 
3.3.1.2.1 Electrical stimulation – changes in inspiratory gas compositions  
Modulations of inspiratory gas compositions had variable effects on the response to 
stimulation. Two studies report effects of hypoxia on response to forepaw stimulation 
in a way that the results cannot be directly compared (Sicard and Duong, 2005; 
Huang et al., 2013). On one hand Huang et al. (2013) report significantly higher 
BOLD signal intensity responses under 15 than under 21% O2. On the other hand, 
Sicard and Duong (2005) found significantly smaller absolute BOLD signal increases 
(BOLD signal normalised to baseline signal under room air) under 9 than 21% O2 and 
similar absolute signal increases under 12 and 21% O2. However, relative signal 
increases (i.e. relative to respective baseline signal) “varied” and were described as 
“markedly smaller” under 9% O2, however, the directions of these variations and 
whether any differences were significant is not reported. 
Conflicting results were also found regarding hyperoxia. Sicard and Duong (2005) 
report “similar” absolute signal increases during forepaw stimulation under 21 and 
100% O2. In contrast, significantly higher numbers of activated voxels and 
significantly higher signal increase under 100% O2 than under the baseline gas 
mixture (O2 enriched air, 47% O2) were found by Nasrallah et al. (2015), and arterial 
partial pressure of O2 (paO2) and BOLD signal change was positively correlated in 
both groups with similar paCO2 (Nasrallah et al., 2015).   
Hypercapnia, however, appears to have more consistent effects on response to 
forepaw stimulation. Nasrallah et al. (2015) report a significantly lower increase in 
signal intensity under 1 and 5% CO2 admixture and a significantly reduced number of 
activated pixels under 5% CO2 than under the baseline gas mixture (O2 enriched air, 
47% O2). Significantly lower signal intensity and number of activated pixels were also 
observed under combined hyperoxia and hypercapnia (95% O2 plus 5% CO2). A 
negative correlation between pCO2 and BOLD signal change was however only 
found for groups with similar paO2 in this study (Nasrallah et al., 2015). Although 
Sicard and Duong (2005) did not find a significant difference between 5% CO2 and 
room air, absolute signal changes were significantly smaller under 10% CO2. Taken 
together, the two studies agree that hypercapnia reduces response to electrical 
forepaw stimulation. 
The effect of hypercapnia as well as combined hypercapnia/hyperoxia on response 
to electrical forepaw and cheek stimulation was transient; no significant differences in 
response to stimulation were observed once paCO2 returned to baseline levels after 
the respective gas challenges (Bock et al., 1998; Dutka et al., 2002).  
Finally, one reference observed significantly higher numbers of activated pixels and 
signal increase in somatosensory cortex during forepaw stimulation when animals 
were hypocapnic (Hsu et al., 1998).  
In summary, inconsistent results were often reported for the effects of specific 
inspiratory gas conditions on response to electrical somatosensory stimulation, and 
only for hypercapnia reduced responses were consistently reported. 
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3.3.1.2.1 Electrical stimulation – changes in arterial blood pressure 
A second cluster of references investigated the effect of arterial blood pressure 
modulations on responses to electrical stimulation. Increases of arterial blood 
pressure by noradrenaline administration consistently increased the positive signal 
change and/or the number of voxels correlated to the forepaw stimulation time course 
(Wang et al., 2006; Qiao et al., 2007; Tuor et al., 2007). The threshold of blood 
pressure at which significance was reached varied between studies, regions and 
outcome measures, but was commonly in the range of 30-45 mmHg. Voxels 
correlated to the stimulation time course were also detected in other regions than 
somatosensory cortex. Notably, significant “activation” was even detected in stroke 
model animals when arterial blood pressure increases exceeded 15 mmHg, in which 
the somatosensory cortex was within the infarct region and did not display any 
response to stimulation under normotensive conditions (Tuor et al., 2007).  
Decreases of arterial blood pressure however either enhanced (Herman et al., 2007), 
decreased (Hempel et al., 1999) or did not significantly change the response to 
stimulation (Wang et al., 2006). Low arterial blood pressures were induced in those 
studies via blood withdrawal, negative lower body pressure or trimetaphan camsilate, 
respectively. 
Taken together, increases in blood pressure can be expected to increase response 
to forepaw stimulation, but reported results for blood pressure decreases are 
inconclusive.  
 
3.3.1.2.2 Electrical stimulation – naturally occurring changes in physiological 
parameters  
fMRI signal evoked by forepaw stimulation did not depend on the five investigated 
parameters paO2, paCO2, pH, MAP and heart rate in one study (Sumiyoshi et al., 
2012).  
Another study measured pCO2 over up to 4 h and found that response to forepaw 
stimulation could be detected only if transcutaneous pCO2 was less than 20% higher 
than baseline in spontaneously breathing animals under medetomidine or 
medetomidine/ketamine, or if arterial pCO2 (measured with blood gas analysis) was 
below 35 mmHg (Ramos-Cabrer et al., 2005). The observation that CO2 levels above 
a critical threshold reduce responses to forepaw stimulation is consistent with reports 
of experimentally induced hypercapnia (Sicard and Duong, 2005; Nasrallah et al., 
2015). 
 
3.3.1.2.3 Chemical somatosensory stimulation – naturally occurring changes in 
arterial blood pressure  
A significant linear correlation between arterial blood pressure increases and BOLD 
signal intensity increases was observed in the first 4 minutes after formalin injection 
into the paw (Tuor et al., 2002). This observation is consistent with reports from 
noradrenaline- induced arterial blood pressure increases. 
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3.3.1.2.4 Mechanical visceral stimulation – naturally occurring changes in arterial 
blood pressure  
Min et al. (2011) investigated arterial blood pressure and BOLD signal changes in 
response to inflation of a gastric balloon and found that arterial blood pressure 
changes were significantly associated with BOLD signal changes in several of the 
regions for which a significant number of activated voxels was detected. A quadratic 
model described the relationship between arterial blood pressure and BOLD signal 
changes most accurately (Min et al., 2011). This observation is consistent with 
reports from noradrenaline- induced arterial blood pressure increases. 
 
3.3.1.2.5 Summary  
In summary, hypercapnia and increases in arterial blood pressure were both in 
interventional and observational studies and across different stimulation modalities 
consistently reported to decrease and increase, respectively, the BOLD response to 
peripheral stimulation. Concerning arterial blood pressure decreases, the available 
evidence was inconclusive.  
 
3.3.1.3 Effects of changes in physiological parameters on BOLD signal responses to 
central stimulation  
Four references investigated the influence of arterial blood pressure changes or 
ventilation modes on BOLD signals detected in phMRI. 
One study analysed the contribution of the change of physiological parameters on 
fMRI activation by investigating the time course after cocaine administration (Schmidt 
et al., 2006). As the fMRI signal changes persisted after heart rate, arterial blood 
pressure and respiratory rate returned to baseline, the authors concluded that the 
influence of physiologic parameter changes was negligible in this case. 
A similar study compared BOLD responses to centrally acting cocaine with those to 
peripherally acting cocaine methiodide, which both significantly and dose-
dependently increased MAP (Luo et al., 2003). While cocaine methiodide produced 
activations in some “scattered” voxels (see chapter 3.3.1.1.7), which were not dose-
dependent, responses to cocaine (definition: (percent of activated voxels per ROI) x 
(AUC of signal intensity change in activated voxels)) were significantly larger and 
dose-dependent for positive as well as negative signal changes. Based on these 
observations, the authors concluded that MAP changes have not significantly 
contributed to the response to cocaine. 
On the other hand, Kalisch et al. (2005) used phenylephrine CRI during phMRI to 
counteract apomorphine-induced hypotension in animals with unilateral 6-OHDA 
lesions of the nigrostriatal dopaminergic tract. Averaged over the 55 min imaging 
period, arterial blood pressure did not significantly decrease when phenylephrine was 
administered, as opposed to the control group without phenylephrine. Significant 
positive signal changes were observed with phenylephrine, but significant negative 
signal changes without phenylephrine. Arterial blood pressure and BOLD signal time 
course were significantly correlated in the control, but not the phenylephrine group. 
Interhemispheric differences in response to apomorphine were detected in both 
groups. Supported by the additional finding of significant negative signal change 
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without, but no significant change with phenylephrine in the control region of visual 
cortex, the authors conclude that arterial blood pressure decreases caused by 
apomorphine introduced negative signal changes which masked activations in CPu 
(Kalisch et al., 2005).  
Xu et al. (2000) compared spontaneous and controlled ventilation for phMRI of heroin 
and found a significant difference: while BOLD signal globally decreased in 
spontaneously breathing animals, positive signal changes in specific brain regions 
were found in ventilated animals. The authors interpret the global signal reduction in 
spontaneously breathing animals as a consequence of hypoxaemia detected in 
arterial blood gas analysis in this (paO2 significantly lower than at baseline), but not 
the ventilated group (Xu et al., 2000). 
Taken together, arterial blood pressure changes in both directions were consistently 
reported to modulate BOLD responses in phMRI, however, the magnitude of effect 
and accordingly the authors’ judgement of the relevance of these changes varied. 
The single report of BOLD signal decrease in supposedly hypoventilating animals is 
in line with reports on the effect of apnoea on baseline BOLD signal. 
 
3.3.1.4 Effects of changes in physiological parameters on resting state BOLD 
measurements  
One study each analysed the effect of different inspiratory gas compositions 
(Nasrallah et al., 2015), blood withdrawal to decrease arterial blood pressure 
(Kannurpatti et al., 2008), and naturally occurring fluctuations in several physiological 
parameters (Kalthoff et al., 2011) on rsfMRI measurements. 
Nasrallah et al. (2015) report spatially more extended correlation maps for a seed in 
the frontlimb area of the primary somatosensory cortex (S1FL) under 100% O2 than 
under baseline condition, whereas 1-5% CO2 admixture to the baseline gas mixture 
(O2 enriched air, 47% O2) produced similar results as the baseline gas mixture. The 
combination of 95% O2 and 5% CO2 (carbogen) however reduced the spatial extent 
of correlation maps. Correlation strength between bilateral S1FL was significantly 
higher under 100% O2 and 5% CO2 than under the baseline condition. Depending on 
how the fluctuation of signal amplitude was assessed, a significant increase was 
observed only under 100% O2 or also under 5% CO2. Frequency distribution of the 
interhemispheric correlation was similar under baseline and 100% O2, but the fraction 
of correlations in the 0.04-0.07 Hz was significantly higher in all hypercapnic 
conditions compared to baseline conditions. When arterial blood gas measurements 
were analysed instead of inspiratory gas composition, bilateral S1FL connectivity 
strength was not correlated with paCO2. For paO2, significant correlations were only 
found for subgroups of conditions: a negative correlation when 100% O2 was 
excluded and a positive correlation when carbogen was excluded. Amplitude 
fluctuations were positively correlated with paO2, but not paCO2. 
Kannurpatti et al. (2008) observed that after blood withdrawal, BOLD signal 
fluctuation amplitudes were enhanced and accordingly the magnitude of the power 
spectrum was also enhanced. The power of frequencies around 0.02, 0.03, 0.07, 
0.10 and 0.125 Hz was significantly higher in the hypovolemic state. As a 
consequence of enhanced signal fluctuations, more voxels showed significant 
correlation with seed voxels placed in sensorimotor cortex, hippocampus or 
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thalamus, so that correlation maps appeared spatially more extended in the 
hypovolemic state.  
In a complex linear regression, Kalthoff et al. (2011) found that in spontaneously 
breathing animals respiratory regressors (respiratory waveform and its derivative) 
explained 5% of variance after previous motion correction; when cardiac regressors 
(cardiac waves and its derivative) were afterwards added, variance decreased again 
by 1%. Respiratory rate, heart rate, SpO2 and body temperature however were only 
rarely correlated to the BOLD signal and therefore not considered as regressors. In 
the authors’ judgment, fc maps and matrices were more specific after applying their 
correction algorithm.  
Taken together, those three reports suggest that inspiratory gas concentrations as 
well as arterial blood pressure decreases and respiration related physiologic noise 
(primarily motion) affect rsfMRI measurements, however, evidence for each 
parameter is only based on a single report. 
 
3.3.1.5 Conclusion  
Across experimental paradigms, results for each parameter were more consistent 
when the effect on baseline BOLD signal was investigated than when the effect on 
response to peripheral stimulation was investigated. The number of studies was too 
low to assess consistency of the results for central stimulation and resting state 
paradigms. Findings from all paradigms will be integrated per parameter in the 
following section.  
While variable levels of hypoxia unequivocally decreased baseline BOLD signal 
intensity, effects on electrical paw stimulation depended on the studies and levels of 
hypoxia. No data was available for the effect of hypoxia on central stimulation and 
rsfMRI. 
For hyperoxia, increased baseline BOLD signal was inconsistently reported, and 
results were contradictory regarding effect on response to peripheral stimulation. In a 
single resting state study, fc maps, interhemispheric connectivity strength and 
fluctuation of the signal amplitude were larger or higher under hypoxia. No data was 
available for central stimulation paradigms. 
Hypercapnia consistently increased baseline BOLD signal and decreased response 
to peripheral stimulation. In a single resting state study, fc maps were not affected by 
hypercapnia, but interhemispheric connectivity strength increased, and the frequency 
distribution of the interhemispheric correlation shifted. 
Combined hyperoxia and hypercapnia was reported by a single study to increase 
baseline BOLD signal, decrease the spatial extent of fc maps and shift the frequency 
distribution of interhemispheric correlations. No data was available for its effect on 
peripheral and central stimulation paradigms.  
Apnoea under room air and supposed hypoventilation in spontaneously breathing 
animals reduced the baseline BOLD signal and response to central stimulation, 
respectively, in one study each.  
Interestingly, findings for increases in blood pressure were consistent across 
experimental paradigms, whereas those for decreases were controversial within each 
paradigm. Increases in blood pressure increased both the baseline BOLD signal and 
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responses to different modalities of peripheral stimulation, including chemical 
somatosensory and visceral stimulation. Only two observational studies addressed 
phMRI and interpreted eventual contributions from arterial blood pressure increases 
as negligible. On the other hand, reported effects of blood pressure decreases varied 
from no effect on to decreased baseline BOLD signal and from reduced over 
unchanged to enhanced responses to peripheral stimulation. One study each found a 
positive correlation of arterial blood pressure time course and BOLD signal time 
course in an phMRI where the test substance induced hypotension, and increased 
signal amplitude fluctuation and spatially more extended fc maps under lower blood 
pressure in rsfMRI.  
In summary, the majority of studies found that modulations of physiological 
parameters, notably by changing inspiratory gas concentrations or manipulating 
arterial blood pressure, affected BOLD signal measurements across experimental 
paradigms. There was a clear trend that interventional studies more commonly 
identified an effect than observational studies (no difference in 3 out of 39 
interventional versus 3 out of 6 observational studies).  
 
 
 
 
 
 
Figure 7. Effects of experimentally induced hypoxia, compared to respective baseline 
condition, on baseline BOLD signal and responses to stimulation in rats (no data 
available for effects on fc). stronger = higher BOLD signal or lower R2*, or higher 
signal intensity and/or spatial extent of activated area upon stimulation under 
hypoxia; (stronger) = BOLD signal or response to stimulation stronger in some, but 
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not all aspects under hypoxia; no sign. diff. = no significant difference between 
respective baseline condition and hypoxia. “weaker” and “(weaker)” analogous to 
“stronger” and “(stronger)”. One data point per experimental paradigm per dataset 
and anaesthetic. If no statement on the significance of reported changes was 
available, “(stronger)” or “(weaker)” were selected. 
 
 
 
 
 
Figure 8. Effects of experimentally induced hypoxia, compared to respective baseline 
condition, on baseline BOLD signal, responses to stimulation and fc in rats. stronger 
= higher BOLD signal or lower R2*, higher fc strength and/or spatial extent of 
connectivities or higher signal intensity and/or spatial extent of activated area upon 
stimulation under hyperoxia; (stronger) = BOLD signal or response to stimulation 
stronger in some, but not all aspects under hyperoxia; no sign. diff. = no significant 
difference between respective baseline condition and hyperoxia. “weaker” and 
“(weaker)” analogous to “stronger” and “(stronger)”. One data point per experimental 
paradigm per dataset and anaesthetic. If no statement on the significance of reported 
changes was available, “(stronger)” or “(weaker)” were selected. 
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Figure 9. Effects of experimentally induced hypercapnia (intervention) or of naturally 
occurring increases of paCO2 (observation), compared to respective baseline 
condition, on baseline BOLD signal, responses to stimulation and fc in rats. stronger 
= higher baseline BOLD signal, higher fc strength and/or spatial extent of 
connectivities or higher signal intensity upon stimulation and/or spatial extent of 
activated area under hypercapnia/higher paCO2; (stronger) = baseline signal, fc or 
response to stimulation stronger in some, but not all aspects under 
hypercapnia/higher paCO2; no sign. diff. = no significant difference between awake 
and anaesthetised. “weaker” and “(weaker)” analogous to “stronger” and “(stronger)”. 
One data point per experimental paradigm per dataset and anaesthetic.  
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Figure 10. Effects of experimentally induced (= intervention) or naturally occurring (= 
observation) blood pressure increases on baseline BOLD signal and responses to 
stimulation in rats (no data available for effects on fc). stronger = higher baseline 
BOLD signal or higher signal intensity upon stimulation and/or spatial extent of 
activated area when blood pressure increased; (stronger) = baseline signal or 
response to stimulation stronger in some, but not all aspects when blood pressure 
increased; no sign. diff. = no significant difference associated with blood pressure 
increases. “weaker” and “(weaker)” analogous to “stronger” and “(stronger)”. One 
data point per experimental paradigm per dataset and anaesthetic. If positive and 
negative correlations of the BOLD signal with blood pressure were observed, 
“(stronger)” was selected in one case to indicate that a relevant difference was 
observed and “no significant difference” in another case where changes were limited 
to a few voxels and considered irrelevant by the authors.  
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Figure 11. Effects of experimentally induced (= intervention) or naturally occurring (= 
observation) blood pressure decreases on baseline BOLD signal, responses to 
stimulation and fc in rats. stronger = higher baseline BOLD signal, higher fc strength 
and/or spatial extent of connectivities or higher signal intensity and/or spatial extent 
of activated area upon stimulation when blood pressure decreased; (stronger) = 
baseline signal, fc or response to stimulation stronger in some, but not all aspects 
when blood pressure decreased; no sign. diff. = no significant difference associated 
with blood pressure decreases. “weaker” and “(weaker)” analogous to “stronger” and 
“(stronger)”. One data point per experimental paradigm per dataset and anaesthetic. 
In one case positive and negative correlations of the BOLD signal with blood 
pressure were observed and “(weaker)” was selected to indicate that a relevant 
difference was observed. 
 
 
3.3.2 Mice  
Four references addressed the effect of physiological parameter variations on 
baseline BOLD signal or response to electrical hind paw stimulation in mice. One 
study modulated inspiratory gas concentrations; three studies analysed naturally 
occurring changes in physiological parameters. 
Under 100% O2, R2* in the striatum was significantly lower than under air plus 10% 
CO2, and under air plus 10% CO2, R2* in the striatum was significantly lower than 
under room air, which translates to increasing baseline signal from air to air plus CO2 
to 100% O2 (Sedlacik et al., 2015).  
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Schroeter et al. (2014) observed that unilateral electrical hindpaw stimulation lead to 
widespread, bilateral activation including regions not involved in somatosensory 
processing under all four anaesthetic agents used in that study. As heart rate, pulse 
distension and SpO2 changed in response to stimulation, the authors concluded that 
an unspecific arousal response accounts for these signal increases. Except for SpO2, 
which was used together with CBV to calculate relative O2 delivery, which linearly 
correlated with the BOLD signal change, the relation between physiological 
parameters or their change during stimulation and the BOLD signal or its changes 
was however not quantitatively analysed. In a follow-up study (Schlegel et al., 2015), 
randomised single pulse stimuli were used instead of a block stimulation paradigm. 
With this paradigm, no changes in physiological parameters were observed, 
activation maps were spatially less extended, BOLD responses in visual cortex 
(serving as control region) were “strongly reduced”, and BOLD signal amplitudes in 
ipsilateral hindlimb area of the primary somatosensory cortex (S1HL) reached only 
approximately 60-80% of contralateral cortex responses, as opposed to equivalent 
responses to block stimulation. Again, the relation between physiological parameters 
and the BOLD signal was not quantitatively analysed. Another study by the same 
group showed that bilateral responses to unilateral hindpaw stimulation also occurred 
in acallosal mice (Schroeter et al., 2017) which the authors interpreted as a strong 
argument for the cardiovascular origin of the ipsilateral response. 
Taken together, single reports of experimentally altered inspired gas concentrations 
(hypercapnia, hyperoxia and hypoxia) suggest that the baseline BOLD signal in mice 
is modulated. Qualitative observational studies further suggest that cardiovascular 
responses elicited by somatosensory stimulation contribute to the measured BOLD 
signal changes. Overall, however, only limited evidence is available for influences of 
physiological parameter alterations on BOLD fMRI measurements in mice.  
 
 
3.4 BOLD responses and functional connectivity in awake animals 
and under different anaesthetic conditions 
3.4.1 Rats  
3.4.1.1 Effects of different states of anaesthesia on BOLD responses to experimental 
changes in physiological parameters  
Five articles specifically investigated whether and how BOLD responses to 
manipulation of physiological parameters differed under different states of 
anaesthesia. 
Duong (2007) studied three levels of hypoxia (9, 12, and 17% inspiratory O2 
concentration) in awake and isoflurane (2%)-anaesthetised, spontaneously breathing 
animals. A significant difference in responses was only observed when pa O2 was 
below 50 mmHg: the BOLD signal decrease was stronger under isoflurane.  
Brevard et al. (2003) and Sicard et al. (2003) both compared responses to 
hypercapnia in awake and isoflurane (2%)-anaesthetised, spontaneously breathing 
animals. Both observed a significantly higher signal increase in awake animals when 
38 
 
exposed to 5 or 10% CO2 in a normoxic gas mixture. Sicard et al. (2003) covered the 
entire brain and Brevard et al. (2003) a cortical and a subcortical ROI. In the cortical 
ROI, responses to CO2 were dose-dependent in both states of consciousness, 
whereas in subcortical ROI the signal change was only in awake animals dose-
dependent. Brevard et al. (2003) additionally noted significantly shorter rise times of 
the signal and Sicard et al. (2003) higher baseline MRI fluctuations in the awake 
condition.  
Kannurpatti and Biswal (2004) compared responses to apnoea starting from three 
different gas mixtures under urethane (1.2 g/kg intraperitoneal (ip)) and pentobarbital 
(60 mg/kg ip). Neither when starting from 100% O2 nor from 2 or 5% CO2 (probably 
added to room air, but not specified) any differences in the respective BOLD 
responses (amplitude, time to onset, time to peak) were observed between 
anaesthetics. Only when starting from room air, the time to maximal signal decrease 
was significantly longer under pentobarbital than under urethane. 
Kalisch et al. (2001) induced blood pressure decreases of variable degree by 
repeatedly withdrawing and re-infusing blood from isoflurane-, halothane- or propofol-
anaesthetised animals. In all three groups, significant correlations between blood 
pressure time courses and whole brain slice BOLD time courses were found. Due to 
small group sizes (3 animals per condition), the authors however explicitly refrained 
from characterising anaesthetic specific profiles of those correlations.  
Taken together, mainly single reports suggest that responses to hypoxia, 
hypercapnia, apnoea and decreases of blood pressure are qualitatively similar under 
different anaesthetics. Presence and direction of effects were consistent across 
groups. However, significant quantitative differences were found in responses to 
apnoea under room air, and alterations in inspiratory gas concentrations under 
urethane versus pentobarbital and isoflurane versus awake, respectively. 
Interestingly, the direction of the difference was opposite under hypoxia and 
hypercapnia: while upon hypercapnic stimulation stronger responses were observed 
in awake animals, hypoxic stimulation (if exceeding a certain level of severity) 
produced stronger responses in anaesthetised animals.   
 
3.4.1.2 Effects of different states of anaesthesia on resting state BOLD 
measurements  
34 articles investigated effects of different anaesthetic protocols and awake imaging 
on rsfMRI. Most information is available for the comparison of fc in the awake state 
versus under isoflurane, under varying levels of isoflurane, propofol or medetomidine 
and for the comparison of isoflurane with (dex)medetomidine or a combination of 
isoflurane and (dex)medetomidine. Isoflurane and propofol were only compared in 
one conference abstract with very limited detail of results and no comparisons of 
propofol with other anaesthetics were found.  
Some reports of ketamine, either administered on top of medetomidine, in 
combination with medetomidine or in combination with the α2-agonist xylazine (in the 
last case compared to isoflurane) were also found.  
Only single reports are available for fc under α-chloralose, urethane and 
thiobutabarbital, especially in comparison to other anaesthetics.  
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3.4.1.2.1 Isoflurane versus awake  
Seven articles based on three datasets compared fc in the awake state with fc under 
various concentrations of isoflurane. All articles found a reduction of overall fc 
strength (absolute and/or relative), fc between specific areas, or the temporal 
occurrence of specific fc patterns under isoflurane. 
One study reports “mainly […] localised connections” of the somatosensory cortices 
under isoflurane, while in awake animals, a seed placed in S1HL demonstrated fc 
with its contralateral counterpart, secondary somatosensory cortex (S2) and insular 
cortex (Chang et al., 2016). Similar findings were observed when random stimulation 
(air puffs) was delivered to a paw to simulate chronic pain conditions. Whole brain fc, 
assessed from pairwise correlation coefficients of 264 anatomically defined ROI, was 
stronger in awake animals (Chang et al., 2016). 
Another study found in thalamocortical and frontoparietal networks under isoflurane 
(0.5-3%) more commonly reduced than enhanced connectivity within the networks 
and a spatially homogenous reduction of averaged normalised fc (i.e. averaged value 
of its connections to all other voxels, normalised to the awake value, for each voxel) 
under isoflurane of 1.5% or higher (LORR at 1.5% under scanner conditions in this 
study due to delivery via nosecone) (Hamilton et al., 2017). For all doses of 
isoflurane, averaged normalised fc change was negative in all voxels compared to 
the awake state. Absolute fc changes (between 134 unilateral ROI as well as 
between each pair of voxels in the brain) were negatively correlated with the fc 
strength in the awake state. Entropy of the BOLD signal time course, a measure for 
the randomness of the signal, was significantly higher under isoflurane, while mutual 
information was significantly lower than in the awake state. Re-analysis of the same 
dataset revealed a significant decrease of fc strength between ROI pairs in static fc 
analysis, but similar spatial patterns between conditions, manifesting as high spatial 
correlation coefficients between RSFC matrices across conditions (Ma et al., 2017). 
Clustering of all pairwise correlation matrices obtained from sliding windows from all 
levels of isoflurane, including awake, into five recurring connectivity patterns revealed 
a pattern that most commonly occurred in the awake state and almost disappeared 
for isoflurane concentrations of 3% and higher. Nevertheless, all patterns occurred in 
all conditions. Interestingly, the first pattern was the least similar to the static 
connectivity patterns, whereas pattern number 5, the most similar to the static 
connectivity patterns, dominated at the highest isoflurane level. 
Three studies (Liang et al., 2013; Liang et al., 2015a; Smith et al., 2017) all re-
analysed (at least some) data from Liang et al. (2012a). The original article focuses 
on anti-correlation between the infralimbic cortex and the amygdala, which was 
absent in anaesthetised compared to awake rats (Liang et al., 2012a).  
Liang et al. (2013) report reduced thalamocortical connectivity “in all thalamocortical 
networks” (seed-based fc analysis for eight bilateral thalamic seeds) under isoflurane. 
Smith et al. (2017) report reduced fc of a seed placed in the claustrum with medial 
prefrontal cortex and mediodorsal thalamus, but not with cingulate and agranular 
cortex as well as with the contralateral claustrum. The same study also reports a 
decreased fc between a seed in prelimbic cortex (part of medial prefrontal cortex) 
and the claustrum as well as the mediodorsal thalamus. 
Liang et al. (2015a) investigated both static and dynamic fc in infralimbic and primary 
somatosensory networks. When seeds were placed bilaterally in infralimbic cortex, 
40 
 
both conventional correlation analysis and averaging of the co-activations observed 
in selected single frames (15% highest BOLD signal in seed) demonstrated 
“consistently weaker” and spatially more confined connectivity under anaesthesia. 
For a seed placed unilaterally in barrel field of the primary somatosensory cortex 
(S1BF), co-activation and correlation patterns were judged “similar” under both states 
of consciousness. Dynamic fc was analysed by clustering patterns from individual 
frames in the awake state into three co-activation patterns (CAP). For the infralimbic 
seed, the first CAP (CAP1) encompassed limbic and some prefrontal regions, the 
second CAP (CAP2) motor and somatosensory cortices, and the third CAP (CAP3) 
the hippocampus, with the first CAP observed most and the last least frequently. 
Under anaesthesia, the connectivity of the seed with limbic regions was reduced in 
CAP1, the strength of co-activation generally reduced in CAP2 (while the spatial 
pattern persisted) and the co-activation in CAP3 “virtually disappeared”. Emergence 
rate of CAP1, i.e. the percentage of selected frames displaying a certain CAP, 
decreased and of CAP3 increased significantly. For the somatosensory seed, the 
three CAP observed in the awake state were also observed in the anaesthetised 
state (higher within-cluster similarity between states than infralimbic network), with 
the exception of primary somatosensory cortex (S1)-hippocampus co-activation in 
CAP3 which was absent. Emergence rates did not significantly differ between states 
of consciousness. Overall, both static and dynamic fc were more affected for a seed 
placed in infralimbic cortex, i.e. in networks supposed to support cognitive and 
emotional functions, than in sensorimotor networks, and dynamic fc was more 
sensitive at revealing anaesthesia-related differences than static fc.  
The references presented here focused on different regions and networks, used 
variable methods of analysis and analysed the differences between awake and 
anaesthetised scans at variable level of detail. In conclusion, they consistently report 
reduced fc under isoflurane compared to the awake state and provide evidence that 
isoflurane anaesthesia affects different networks to different degrees. 
 
3.4.1.2.2 Isoflurane concentrations  
Nine articles based on eight datasets compared different concentrations of isoflurane.  
Hamilton et al. (2017) report a significant increase of entropy (a measure of 
randomness of the BOLD signal in individual regions) with increasing isoflurane 
concentrations (0.5-3.0%), reaching a plateau at 1.5%, whereas mutual information 
(a measure for the information exchanged between two brain regions) significantly 
decreased with increasing isoflurane, not reaching a plateau. Absolute fc changes 
(between 134 unilateral ROI as well as between each pair of voxels in the brain) were 
negatively correlated with the fc strength in the awake state, and the correlation was 
significantly more negative, the higher the isoflurane concentration was. Ma et al. 
(2017), based on the same dataset, report monotonic decrease of static fc with 
increasing isoflurane concentration in spatially similar (static) connectivity patterns, 
and dynamic fc patterns that are in contrast most common at low (pattern 1), high 
(pattern 5) or intermediate (pattern 3) isoflurane concentrations.  
As isoflurane concentrations were increased from 1 to 3%, Nasrallah et al. (2014a) 
observed a significant reduction of interhemispheric S1FL connectivity and a 
concurrent significant reduction of total power of the BOLD signal fluctuations. 
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Liu et al. (2011) also found a reduced magnitude of BOLD signal fluctuation at 2.0 
versus 1.8% isoflurane and a reduced coherence strength at 2.2 versus 1.8% 
isoflurane. Qualitatively, bilaterally synchronous “bumps” were observed in the S1FL 
reference regions under 1.8 and 2.0, but not 2.2% isoflurane. Correlation coefficients 
of voxels correlated with the seed region were generally weaker under 2.2% than 
under the lower concentrations and spatially less extended (for 1.8 and 2.0%, “strong 
correlation over the majority of cortical regions” is reported. Weaker correlations with 
CPu and thalamic nuclei are reported primarily for 1.8% isoflurane).  
In contrast, Pan et al. (2011) observed an increase of interhemispheric fc when 
isoflurane was increased from 1.0 to 1.8%.  
Similarly, Liu et al. (2013b) report spatially less specific correlation maps when 
isoflurane was increased from 1.0 to 1.8%. This range of isoflurane concentrations 
complements the range studied earlier study by the same group (Liu et al., 2011). 
Both studies report strong correlations in “most cortical and some subcortical regions” 
(Liu et al., 2013b) relative to a seed in S1FL at the shared concentration of 1.8% 
isoflurane; at 1.0%, correlations were mainly confined to interhemispheric correlation 
of the seed (in S1FL or S1BF) with its counterpart. At 1.8%, but not at lower 
concentrations, the 2013 study also observed the “bumps” in BOLD signal time 
courses described in the earlier study. Interestingly, signal fluctuations were smallest 
at 1.5%, i.e. at the intermediate concentration of those tested in the later study (Liu et 
al., 2013b). Power spectra analysis revealed a higher power in all frequencies at 
1.0% than at 1.5 and 1.8%, in line with the findings reported by Nasrallah et al. 
(2014a) for a broader range of isoflurane concentrations.  
In addition to spatial, Wang et al. (2011) also investigated temporal aspects of fc. ROI 
were defined in bilateral S1, S2, primary motor (M1) and secondary motor (M2) 
cortices plus CPu and ventral posterolateral thalamic nucleus (VPL). The relative 
amplitude of BOLD signal fluctuations was significantly reduced at 2.9% isoflurane 
compared to 0.5% isoflurane in all ROI. Within-ROI connectivity (i.e. mean correlation 
of all voxels within the ROI with the ROI’s reference signal time course) was 
significantly reduced at 2.9 versus 0.5% isoflurane in all cortical ROI and CPu. 
Interhemispheric correlation coefficients between homotopic regions was significantly 
decreased for M1, M2 and CPu at 2.9 versus 0.5% isoflurane, but not for S1FL, S2 
and VPL. Temporal characteristics were assessed by the Hurst exponent. While a 
Hurst exponent of 0.5 is equivalent to white noise, values above 0.5 indicate that the 
signal has a “positive autocorrelation over long time lags”. In contrast, values below 
0.5 represent an anticorrelated signal. H was over 0.5 in all ROI at 0.5 and 1.0% 
isoflurane, but significantly lower (in relation to 0.5%) at 2.9% isoflurane in all cortical 
ROI and CPu, approaching 0.5. This finding was interpreted by the authors as resting 
state signal fluctuations being driven by spontaneous neurophysiological events at 
lower isoflurane concentrations, but not containing meaningful information at higher 
concentrations anymore (abolition of spontaneous activity). 
One study did not address conventional fc measures, but instead calculated degrees 
of freedom (DOF) of the BOLD signal (Kundu et al., 2014). A high degree of freedom 
was interpreted as a higher amount of structured information within the signal and 
thus considered desirable. DOF were consistently reduced when isoflurane 
concentrations were increased from 1.0 to 1.5 and 2.0%. 
So far, all references investigated healthy animals. Gill et al. (2017) report the effect 
of different isoflurane levels on fc in a kainic acid model of temporal lobe epilepsy. 
42 
 
Connectivity matrices between 33 brain ROI were generated: those ROIs which 
connectivities’ differed significantly between kainite treated and control animals were 
defined as nodes, and significant correlations between nodes as (undirected) edges. 
At 2.0% isoflurane, the number of nodes and edges (7 and 6) was reported to be 
“greatly diminished” compared to 1.5% (23 and 78), although a minority of nodes 
were only observed at 2.0%. Differences in global network parameters as well as the 
regional network parameter betweenness centrality, between kainite treated and 
control animals, were consistent across isoflurane levels. Only for small worldness of 
the network, two parameters out of three (ω and γ, but not λ) differed significantly 
between groups at 1.5, but not 2.0% isoflurane.  
In conclusion, studies consistently report reduced amplitudes of signal fluctuation 
under higher isoflurane concentrations, but while some studies found reduced 
strength of fc and spatial extension of correlated regions, others report increased, 
unspecific correlations for higher isoflurane concentrations.  
 
3.4.1.2.3 Propofol doses  
Four articles based on three datasets investigated fc under different levels of 
propofol. Tu et al. (2011) report absent thalamocortical fc under 160 mg/kg propofol 
ip, whereas under 80 mg/kg ip connectivity between right thalamus, ipsilateral S1 and 
contralateral S2 were observed. Hudetz et al. (2015) compared the repertoire of 
dynamic “brain states” by calculating regional homogeneity (ReHo) and coincident 
threshold crossing from a sliding window approach under 20 versus 40 mg/kg/h of 
propofol intravenously (iv). ReHo is a measure for the similarity of a voxel’s time 
course with its 27 closest neighbours’ time courses. Voxels exceeding the mean 
ReHo by 2 standard deviations (SD) were selected and the temporal variance of 
ReHo values interpreted as representing the repertoire of brain states. Coincident 
threshold crossing selects per image all voxels which cross a threshold defined as a 
multiple of each voxel’s SD. The number of voxels crossing the threshold and their 
average BOLD signal were extracted, and the temporal variability of the average 
BOLD signal interpreted as representing the repertoire of brain states. Temporal 
variance of both measures was significantly reduced under the higher propofol dose. 
The number of unique brain states identified from coincident threshold crossing by 
clustering was reduced from 81 to 66 under the higher propofol dose. When 12 
anatomically defined ROI were analysed, visual cortex, parietal cortex and CPu 
contributed most to the global reduction of temporal variance, while changes in 
subcortical structures contributed relatively little. Interestingly, temporal variance of 
selected coincident threshold crossing voxels as well as the relative change under 
the higher propofol dose increased from lateral to medial, which was interpreted as 
potential activity and depression of default mode network under the lower and higher 
dose, respectively. Cross-correlation between significant ReHo areas was not 
different between doses, therefore the authors conclude that temporal dynamics 
rather than the degree of regional connectivity are a target of anaesthesia. 
Hudetz et al. (2016) re-analysed the data from Hudetz et al. (2015) and found a 
difference in the localization of selected voxels under the two doses (“visually 
evident”), but no difference in the average ReHo of selected voxels. Lempel-Ziv 
complexity, a proxy for “the amount of non-redundant information contained in a 
string”, which estimates “the minimal number of character sequences […] required to 
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describe the string”, was significantly higher under the lower propofol dose, i.e. lighter 
plane of anaesthesia. Finally, Liu et al. (2013a) found generally reduced whole brain 
and regional fc when propofol infusion rates were over 20 mg/kg/h iv (40/60/80/100 
mg/kg/h incrementally), however, effects were region-dependent and multiphasic 
patterns commonly observed (e.g. initial reduction with increasing dose followed by 
partial recovery of fc strength). Overall, cortical fc was reduced at lower doses than 
subcortical fc and while subcortical fc increased again at doses associated with burst-
suppression in EEG, this was not observed for cortical fc. A potential limitation of this 
study is that animals were hypoxic (SpO2 89-91%) throughout conditions. 
In conclusion, either a reduction of conventional static fc or a diminished repertoire of 
brain states was consistently observed with higher doses, however, decrease of 
regional fc was controversial: while Liu et al. (2013a) observed it, Hudetz et al. (2015) 
did not. A single study suggests that dose-dependent effects are non-monotonic and 
region-dependent. 
 
3.4.1.2.4 Isoflurane versus propofol  
Only one conference abstract briefly reports “generally higher” inter- and 
intrahemispheric fc in isoflurane-anaesthetised animals than in propofol-
anaesthetised animals (significant effect of anaesthetics in ANOVA) (Boonzaier et al., 
2017). A direct comparison of propofol with dexmedetomidine, which was also 
investigated in that study, is not reported. How the patterns of fc observed under 
propofol could be characterized in relation to other anaesthetics or the awake state 
remains therefore unknown. 
 
3.4.1.2.5 Medetomidine doses  
Three studies investigated different rates of medetomidine CRI and one investigated 
the impact of different duration of previous isoflurane exposition. 
Nasrallah et al. (2012; 2014a) compared 0.1, 0.2 and 0.3 mg/kg/h medetomidine 
infusion rates in two separate studies. Interhemispheric correlation between bilateral 
S1 and S2, but not CPu, was significantly reduced at 0.2 and 0.3 mg/kg/h compared 
to 0.1 mg/kg/h (Nasrallah et al., 2012). The amplitude of BOLD signal fluctuations 
was however not significantly different across infusion rates. Frequency analysis 
revealed that correlations in the 0.01-0.04 Hz range, the range of strongest 
correlations for S1 and S2, were significantly reduced at the higher two infusion rates. 
Additionally, correlations in the 0.04-0.07 Hz range and for S2 also in the 0.07-0.1 Hz 
range were significantly reduced at higher doses. No significant difference in any of 
the frequency bands was observed in CPu. The second study also reports 
significantly reduced interhemispheric connectivity between bilateral S1FL under 
higher doses, without any significant impact on the amplitude of signal fluctuations 
and the total power (Nasrallah et al., 2014a). 
Based on the observation that sedation from medetomidine-CRI is limited to a couple 
of hours, Pawela et al. (2009) evaluated the effect of medetomidine infusion rate 
changes after 120 min of constant 0.1 mg/kg/h on fc. While a secondary rate of 0.1 
mg/kg/h was generally associated with a decrease of pairwise correlation coefficients 
in the correlation matrix of 10 ROI (including S1, S2 and CPu), an increase of 
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correlation coefficients was observed with 0.3 mg/kg/h as the secondary rate in 
individual ROI pairs (changes significant for some pairs, not for others).  
As (dex)medetomidine CRI is often initiated after induction with isoflurane, Magnuson 
et al. (2014) investigated how the duration of previous isoflurane exposition affects fc 
observed under dexmedetomidine CRI (0.05 mg/kg/h subcutaneously (sc), 80 min 
after bolus increased to 0.15 mg/kg/h sc). 45 min after the initial dexmedetomidine 
bolus (0.025 mg/kg sc), connectivity between bilateral S1 was significantly higher in 
animals exposed to 30 min of isoflurane (short isoflurane group) than in animals 
exposed to 3 h of isoflurane (long isoflurane group). S1-S1 connectivity significantly 
increased over time in the long isoflurane group. Whole brain connectivity (i.e. 
correlation of each individual voxel’s signal time course with whole brain signal time 
course) was also significantly higher in the short isoflurane group at 45 min after the 
bolus and additionally at 105 min after the bolus. Maximum power was significantly 
higher in the short isoflurane group at some (75 min, 105 min, 135 min after bolus), 
but not all timepoints; the same applies for low- and highband (short isoflurane > long 
isoflurane at 75 min, 105 min and 165 min after bolus) and broadband (significant at 
135 min) frequencies. Qualitatively, the power in low band frequencies increased at 
1.25 h in the short isoflurane group but reached a similar level only at 3.25 h in the 
long isoflurane group. Accordingly, a significant increase of power in all three bands 
in the second half of the observation period (3.75-5.75 h after bolus) was found in the 
long isoflurane group, whereas a significant increase of power was observed in the 
short isoflurane group only in the broad- and high-band frequencies. 
In summary, Nasrallah et al. (2012) and Pawela et al. (2009) both suggest regional 
differences in the susceptibility of fc to medetomidine. The time frames covered by 
the studies are complementary, Nasrallah et al. (2012, 2014a) acquiring rs scans 
approximately 50 min after start of the medetomidine infusion over 10 min and 
Pawela et al. (2009) acquiring 10 rs scans of 3 min 40 s starting from 30 min after the 
rate change (150 min after start medetomidine infusion). Taken together, the 
presented studies suggest that while initially fc is lower under higher infusion rates, fc 
is not stable over prolonged periods of CRI and additionally affected by the duration 
of previous isoflurane exposition.  
 
3.4.1.2.6 Isoflurane versus (dex)medetomidine  
Five studies compared isoflurane with medetomidine or its active enantiomer 
dexmedetomidine. 
An abstract briefly reports “generally higher” inter- and intrahemispheric fc in 
isoflurane-anaesthetised than in dexmedetomidine-sedated animals (significant effect 
of anaesthetics in ANOVA) (Boonzaier et al., 2017).  
Kalthoff et al. (2013) used several different analytical approaches to compare fc 
under isoflurane (1.5%) and medetomidine (0.1 mg/kg/h sc). Seed-based fc maps 
under isoflurane displayed “widespread cortical or subcortical correlations”, 
regardless of the chosen seed, whereas connectivity between bilateral homotopic 
regions was dominant in maps acquired under medetomidine. Global signal 
regression reduced the widespread, supposedly non-specific correlations, but 
interhemispheric connectivity remained weak compared to medetomidine. Pairwise 
correlation of ROI resulted in higher, although less specific interhemispheric 
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correlations under isoflurane, which were stronger reduced by global signal 
regression than those observed under medetomidine. Notably, correlation strength 
between regions diminished with distance between regions under medetomidine 
(before global signal regression), but not under isoflurane. So far, it appears that fc 
was more specific and robust under medetomidine than under isoflurane. In line with 
this, independent component analysis (ICA) revealed a higher incidence of cortical 
and striatal networks under medetomidine than under isoflurane. Under 
medetomidine, networks consistently segregated into medial, lateral and intermediate 
components, and striatal components were observed at a high incidence, which was 
both not the case under isoflurane. 
Williams et al. (2010) administered animals first medetomidine (0.1 mg/kg/h), 
followed by 2% isoflurane. As described by Kalthoff et al. (2013), lower and more 
localized correlations were observed under medetomidine when correlation maps 
were created for seeds in S1, S2 and CPu. Average correlation values for voxels in 
contralateral S1 were higher under isoflurane. However, under isoflurane high 
correlation coefficients were observed in widespread cortical areas to the degree that 
fc maps for seeds in S1 and S2 did not show a clear difference. Meanwhile, high 
correlation coefficients in bilateral homotopic regions resulted in seed-specific maps 
under medetomidine. In pairwise ROI analysis, high correlations were observed in all 
pairs under isoflurane and for bilateral homotopic regions under medetomidine. 
Correlation between ipsilateral S1 and S2 and S2 and CPu were significantly lower 
under medetomidine than under isoflurane. Power spectra of the BOLD signal did not 
differ between anaesthetics.  
Paasonen et al. (2016a) compared among others isoflurane and medetomidine in a 
combined resting state and pharmacological fMRI. Fc was stable over time (1 h) 
under both protocols. Correlation between averaged connectivity with other regions in 
baseline rs scans and responses to nicotine stimulation for each ROI (14 total) 
yielded high values, especially in cortical regions, under isoflurane, whereas under 
medetomidine, consistent correlations were found primarily in subcortical regions. 
Regarding dose-dependence of the rs BOLD signal, Nasrallah et al. (2014a) found 
that under both isoflurane (1.0, 2.0 and 3.0%) and medetomidine (0.1, 0.2 and 0.3 
mg/kg/h ip after 0.05 mg/kg ip), interhemispheric connectivity between bilateral S1FL 
was significantly reduced under higher doses. However, while increasing the level of 
isoflurane reduced the amplitude of signal fluctuations and the total power, this was 
not the case when medetomidine rate was increased. 
Taken together, studies consistently report more localized and lower correlations 
under medetomidine, which are commonly interpreted as more specific than those 
observed under isoflurane. The single study which evaluated several doses of both 
drugs found for both a reduction of fc when higher doses were used. This is in line 
with the observations of Liu et al. (2011), Nasrallah et al. (2012) and Ma et al. (2017). 
 
3.4.1.2.7 (Dex)medetomidine combined with isoflurane  
Two articles investigated the temporal evolution of fc under a CRI of medetomidine 
(0.3 mg/kg/h, route and initial bolus not reported, on top of 1.3% isoflurane, 
(Nasrallah et al., 2014b)), or dexmedetomidine (0.015 mg/kg/h sc on top of 0.5-
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0.75% isoflurane; initial bolus of 0.015 mg/kg ip after isoflurane induction (Brynildsen 
et al., 2017)) in addition to isoflurane.  
Brynildsen et al. (2017) assessed connectivity to a seed in orbital frontal cortex 
during the first 30 min, 30-90 min and 90-150 min after start of the dexmedetomidine 
CRI. Spatially more extended connectivity was observed over time: while connectivity 
was primarily found around the seed in the first phase, significantly higher correlation 
with voxels in prelimbic and cingulate cortex was observed in the second phase. In 
the third phase, correlations were additionally significantly higher in bilateral orbital 
cortex, retrosplenial cortex, parietal association area, primary and secondary visual 
cortex and auditory cortex and temporal association area. No significant difference 
was found between the second and the third phase. Nasrallah et al. (2014b) 
observed during the first 40 min after start of the CRI a gradual, significant decrease 
of S1FL interhemispheric connectivity relative to that observed under isoflurane, 
reaching its peak 30-35 min after start of the CRI, and a significant decrease in 
thalamic interhemispheric connectivity, that peaked at 10-15 min after start of the 
CRI. In both areas, correlations in the 0.01-0.04 Hz range were significantly reduced 
after addition of medetomidine and for the thalamus, correlations in the 0.04-0.07 Hz 
range were also significantly reduced. 
An additional direct comparison of combined isoflurane and medetomidine (1.5% 
isoflurane plus 0.45 mg/kg medetomidine bolus sc, CRI 0.2 mg/kg/h iv) with 
isoflurane (1.0, 1.5 and 2.0%) did not address conventional fc measures, but instead 
calculated degrees of freedom (DOF) of the BOLD signal (Kundu et al., 2014). A high 
degree of freedom was interpreted as a higher amount of structured information 
within the signal and thus considered desirable. DOF of the isoflurane/medetomidine 
combination was in the same range as observed under 2% isoflurane. 
Taken together, Nasrallah et al. (2014b) report lower fc relative to previous isoflurane 
monoanaesthesia and Brynildsen et al. (2017) report lower fc relative to later phases 
of the infusion during the first 30-40 min of (dex)medetomidine infusion on top of 
isoflurane. Due to the different time and reference frames covered, no conclusive 
pattern of fc evolution can be derived. Additionally, the doses of isoflurane and 
(dex)medetomidine were both substantially higher in the study by Nasrallah et al. 
(2014b) than in the study by Brynildsen et al. (2017). The third study indicates that 
when combining (dex)medetomidine and isoflurane, a lower concentration of 
isoflurane is required to achieve a similar level of anaesthesia than when only 
isoflurane is used (Kundu et al., 2014). 
 
3.4.1.2.8 Isoflurane versus ketamine/xylazine  
Hutchison et al. (2010) compared 1% isoflurane to ketamine/xylazine 80/10 mg/kg ip 
and found no significant difference in the number of animals showing bilateral 
components identified by ICA per anatomic region. There was interindividual 
variability in component-specific power spectra, but no consistent peaks within a 
group and accordingly no between-group difference. Seed-based analysis was 
performed in a subset of both groups and bilateral connectivity between seeds and 
the contralateral homotopic region was observed in both groups, although again 
interindividual variability in fc maps and thresholds at which the interhemispheric 
connectivity was seen, was found.  
47 
 
This is the only article in this section which did not find any difference between 
anaesthetic protocols. The reported interindividual variability may have masked 
eventual between-group differences, however, without further evidence this remains 
speculation.  
 
3.4.1.2.9 Medetomidine and ketamine  
Two articles based on the same dataset report how a single dose of ketamine (5, 10 
or 25 mg/kg sc) on top of medetomidine (0.07 mg/kg sc bolus, 0.14 mg/kg/h CRI) 
affects fc. The original article used a seed-based approach as well as pairwise 
connectivity of ROIs (Gass et al., 2014). ROI-ROI connectivity of 3 prefrontal 
(infralimbic, prelimbic and orbitofrontal cortex), 2 cingulate, 1 retrosplenial and 4 
hippocampal ROIs was assessed by ANOVA. Significant dose effects are reported 
for connectivity between prefrontal and cingulate ROIs as well as some pairs on the 
anterior-posterior axis, with hippocampal and retrosplenial ROI on the posterior side 
and prefrontal and cingulate ROI on the anterior side. The time post-injection did 
however not have a significant effect on correlation values of any ROI pair. Seed-
based analysis revealed that ketamine most strongly increased correlations in 
prefrontal regions for the majority of seeds. For hippocampal seeds, changes were 
typically stronger at 30 than at 15 min post-injection. Of the prefrontal seeds, 
strongest changes were observed for the seed in infralimbic cortex, which displayed 
increased connectivity with orbital, cingulate and prelimbic cortex as well as the 
postsubiculum at one or both time points after injection. Overall, ketamine increased 
connectivity in hippocampal prefrontal circuits, and whether changes were time-
dependent depended on the method of analysis. The re-analysis confirms a 
significant increase of connectivity between left prelimbic cortex and both 
hippocampi, right prelimbic cortex and left hippocampus, but not right prelimbic cortex 
and ipsilateral hippocampus, after ketamine administration (Grimm et al., 2015).  
A third article reports the evolution of fc over time after a single bolus of 
ketamine/medetomidine (60/0.5 mg/kg ip) (Bettinardi et al., 2015). 15 sliding windows 
(10 min per window, slided in 1 min steps) starting from 60 min post induction were 
defined as deep anaesthesia period and the last 15 recorded windows (from 115 min 
post induction on) as light anaesthesia. A significant increase of mean BOLD signal 
variance (for each ROI between sliding windows), mean correlation values of ROI-
ROI pairs, SD of the correlation distribution, mean global synchronization (assessed 
by Kuramoto order parameter) and functional integration was observed in the light 
phase compared to the deep phase. Functional segregation (modularity) significantly 
decreased in the light phase. In the light, but not deep phase, five groups of robust 
connected nodes, i.e. pairs of areas that were consistently correlated across 
subjects, were identified. Over time, correlation of connected areas increased. This 
was not the case for unconnected areas. Overall, this study indicates more 
synchronized BOLD signal fluctuations at lighter levels of anaesthesia, however, 
trends were not for all measures monotonic. 
Taken together, a bolus of ketamine, either applied on top of or in combination with 
medetomidine, appears to affect aspects of fc in a dose- and time-dependent way, 
although time-dependence was inconsistently found when different methods of 
analysis were used. 
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3.4.1.2.10 Medetomidine versus α-chloralose  
Medetomidine was also compared with α-chloralose as a protocol for rsfMRI. Fc was 
stable over time under medetomidine (0.01 mg/kg iv bolus, 0.1 mg/kg/h iv), but 
increased under α-chloralose (60 mg/kg ip bolus, 30 mg/kg ip top-up every 60 min) 
(Paasonen et al., 2016a). Correlation between baseline fc and responses to nicotine 
stimulation in a phMRI was “mainly poor” under α-chloralose, and “more consistent” 
under medetomidine in subcortical regions.   
Another study modelled rs BOLD signal fluctuations as a “scale-free (fractal) 
distribution of amplitude power across a frequency range” (Herman et al., 2011). 
Scaling exponent (fractal index) β of that distribution was interpreted as “a variable 
responding to physiology” and in cortical, but not subcortical ROI higher under 
medetomidine than under α-chloralose. How this relates to other measures of fc 
remains elusive. 
 
3.4.1.2.11 Urethane  
Urethane is known to produce alternating fast and slow wave states that resemble 
REM and NREM sleep in EEG, respectively. In rsfMRI, phases of higher and lower 
baseline BOLD signal were observed and assumed to represent REM- and NREM-
like states, respectively (dose 1.0 g/kg iv; (Zhurakovskaya et al., 2016)). In the REM-
like state, higher thalamocortical fc (between thalamus and ipsilateral somatosensory 
and motor cortex) than during NREM-like state was observed, while relatively higher 
cortico-cortical fc (between somatosensory and motor cortices) was observed during 
NREM-like states. In contrast, connectivity between the hippocampus and other brain 
regions was not state-dependent. A specific investigation of the olfactory system 
(dose 1.5 g/kg ip; (Wilson et al., 2011)) used respiratory rate to determine slow and 
fast wave states. During slow wave state, correlations on fc maps were more and 
ROI-ROI connectivity was significantly increased for all constellations involving 
piriform cortex or the dorsal hippocampus, with the single exception of connectivity 
between piriform cortex and amygdala. As both studies indirectly determined fast and 
slow wave states, it is unknown whether the defined states exactly paralleled the 
states known from EEG measurements. However, alternating states were clearly 
observed in rsfMRI and affected fc across widespread regions. Application of 
urethane for rsfMRI without tracking the different states is therefore likely to introduce 
bias.  
The increase of fc over an interval of 1 h reported by Paasonen et al. (2016a) may 
thus reflect either measurements at two different states or a trend of increasing fc in 
both states over time.  
  
3.4.1.2.12  Multiple comparisons  
Finally, Paasonen et al. (2016a) report a direct comparison of isoflurane, 
medetomidine, α-chloralose, urethane and thiobutabarbital. Results for the isoflurane 
versus medetomidine, medetomidine versus α-chloralose and urethane over time 
comparisons were also reported in previous sections. Fc was stable over time under 
isoflurane (1.3%), medetomidine (0.01 mg/kg iv bolus, 0.1 mg/kg/h iv CRI) and in a 
subgroup of animals under thiobutabarbital (140 mg/kg ip). Fc significantly increased 
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over time under α-chloralose (60 mg/kg iv initial dose, 30 mg/kg iv top-up every 60 
min), urethane (1.25 g/kg ip) and the second thiobutabarbital subgroup. Correlation 
between fc and response to phMRI with nicotine, averaged over a set of cortical 
regions and a set of subcortical regions, was not significant in either category under 
urethane and α-chloralose, significant for subcortical regions only under 
medetomidine, and significant for both categories under isoflurane and 
thiobutabarbital.  
 
3.4.1.2.13 Summary  
In summary, studies consistently report reduced fc in the anaesthetised compared to 
the awake state, with the limitation that isoflurane was the only anaesthetic 
investigated. There is a trend across anaesthetics that lower doses of isoflurane, 
medetomidine and propofol are associated with higher fc strength, spatially more 
extended connections, larger networks and/or a greater repertoire of dynamic brain 
states (Liu et al., 2011; Tu et al., 2011; Wang et al., 2011; Nasrallah et al., 2012; Liu 
et al., 2013a; Nasrallah et al., 2014a; Gill et al., 2017; Ma et al., 2017). However, this 
trend is neither consistently found (isoflurane: (Pan et al., 2011; Liu et al., 2013b), 
medetomidine: (Pawela et al., 2009)) nor monotonic (propofol: (Liu et al., 2013a)). 
Some articles analysed BOLD signal amplitudes or power spectra. They consistently 
reported reduced amplitudes and/or power under higher concentrations of isoflurane 
(Wang et al., 2011; Liu et al., 2011, 2013b; Nasrallah et al., 2014a), but not 
medetomidine (Nasrallah et al., 2014a). Regarding power spectra, Williams et al. 
(2010) did not report significant differences between isoflurane and 
dexmedetomidine. However, longer exposure to isoflurane before switching to 
dexmedetomidine significantly suppressed total power in different frequency bands 
as well as maximum power for up to 3 hours after the switch.  
A subset of articles used specific measures which, generally spoken, asses 
information content of the resting state BOLD signal: entropy and mutual information 
under different levels of isoflurane and awake (Hamilton et al., 2017); Hurst exponent 
at different levels of isoflurane (Wang et al., 2011); degrees of freedom at different 
isoflurane levels and a medetomidine/isoflurane combination (Kundu et al., 2014); 
Lempel Ziv complexity under different levels of propofol (Hudetz et al., 2016). Across 
anaesthetics they consistently report reduced information content under deeper 
levels of anaesthesia as well as in comparison to the awake state. 
While dose matters, time also matters. Shortly after a bolus of anaesthetics, 
anaesthesia or sedation levels are deepest, decreasing then over time, which may be 
mirrored in increasing fc strength or spatially more extended connectivities over time 
(e.g. after a single bolus of medetomidine and ketamine (Bettinardi et al., 2015)). This 
effect may also explain why fc was lowest after start of a dexmedetomidine-CRI on 
top of isoflurane and then increased over time (Brynildsen et al., 2017). Especially for 
(dex)medetomidine-CRIs, however, evolution of fc over time demonstrated complex 
patterns. Although Paasonen et al. (2016a) observed stable fc between two resting 
state scans separated by 1 h, the study by Pawela et al. (2009) suggests that fc 
under a constant rate of medetomidine decreases when experimental times exceed 
90 to 120 min, but – counterintuitively – increases when infusion rates are increased 
after that critical period. Considering that not only pharmacokinetics, but also the 
brain’s properties of a dynamic system, i.e. the potential to adapt to constant 
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conditions – as illustrated by Magnuson et al. (2014) – can influence resting state 
measurements over time, the timing of resting state measurements under a specific 
anaesthesia protocol is crucial. 
 
3.4.1.3 Effects of different states of anaesthesia on BOLD responses to peripheral 
stimulation  
Twenty references investigated the effect of states of anaesthesia on peripheral 
stimulation paradigms. The majority of references used an electrical paw stimulation 
protocol. Three references used mechanical stimulation (air puffs, whisker 
deflection), two references injected irritating substances into the paw and one 
reference investigated a visceral stimulus. Those references are discussed 
separately at the end of the chapter.  
Unless stated otherwise, robust activation was observed in S1 contralateral to the 
stimulated paw in all electrical paw stimulation studies.  
 
3.4.1.3.1 Electrical stimulation – (dex)medetomidine, isoflurane and combined 
(dex)medetomidine/isoflurane  
Three references investigated the effect of medetomidine doses on responses to 
electrical paw stimulation. Nasrallah et al. (2014a) did not find a significant difference 
in BOLD signal increases across doses and thereby confirmed findings from a 
previous study of that group (Nasrallah et al., 2012), which observed no significant 
difference in BOLD signal increase and number of activated voxels within S1 
between the same three rates of medetomidine infusion (0.1,0.2 and 0.3 mg/kg/h ip 
starting 40 min after a bolus of 0.05 mg/kg ip in both studies). 
Pawela et al. (2009) investigated the evolution of responses to different stimulation 
frequencies over time under constant or increased secondary medetomidine infusion 
rate (0.1 mg/kg/h iv for 120 min, 0.1, 0.15, 0.2 or 0.3 mg/kg/h iv secondary infusion 
rate, 30 min equilibration prior to 90 min of image acquisition in both parts of the 
experiment). Under the initial 0.1 mg/kg/h, both the number of activated voxels and 
the AUC of the BOLD signal change significantly increased with higher stimulus 
frequencies. The frequency dependence of the number of activated voxels was 
significantly lower (lower slope) in the second half of the experiment than in the first 
when the infusion rate was left constant or increased to 0.15 mg/kg/h, whereas 
higher infusion rates conserved it (slope not significantly different). However, 
secondary infusion rates did not affect the frequency dependence of the BOLD signal 
intensity. That means that in prolonged experiments area of activation but not signal 
intensity may change over time in a stimulation frequency-dependent way when 
infusion rates are left constant.  
Taken together, these studies present complementary evidence of no significant 
differences between medetomidine infusion rates at short term (40 to approximately 
100 min after start of the constant rate infusion (CRI) (Nasrallah et al., 2012, 2014a)) 
but complex patterns after around 2 h of CRI. 
In addition to medetomidine, Nasrallah et al. (2014a) also compared three 
concentrations of isoflurane. In contrast to medetomidine, responses to stimulation 
decreased under higher isoflurane concentrations. Graphs suggest that BOLD 
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responses to 3 mA, 9 Hz stimulation were of similar amplitude under medetomidine 
and 2% isoflurane, however, this finding should not be generalized to other 
frequencies, as frequency-dependence of the BOLD response is observed under 
most anaesthetics and tends to be agent-specific.   
Finally, two studies added a (dex)medetomidine-CRI to constant isoflurane levels. 
Brynildsen et al. (2017) acquired stimulation scans every 15 min over 2.5 h after start 
of the dexmedetomidine-CRI. BOLD response in S1FL significantly increased after 
the first 30 min (phase 1) but was not significantly different between phase 2 and 3 
(60 min each). No differences over time are reported for the activated areas (S1FL, 
S2, ventral posteromedial (VPM) and VPL nuclei of thalamus, plus cingulate and 
retrosplenial cortex).   
Nasrallah et al. (2014b) acquired stimulation scans from 40 min after start of the CRI 
on and observed an increase in the area of activation under isoflurane plus 
medetomidine compared to the baseline under isoflurane alone, which was not 
observed when only the vehicle was infused. BOLD signal change under isoflurane 
plus medetomidine was also significantly higher than under isoflurane alone.  
Regarding the time frames after initiation of the CRI, data acquired in the latter study 
(Nasrallah et al., 2014b) would correspond to data acquired in phase 2 of the first 
study (Brynildsen et al., 2017). However, as one article only reports signal intensities 
and localization of the activations relative to isoflurane and the other only relative to 
other timepoints of the dexmedetomidine “on top” infusion, results cannot be directly 
summarized, i.e. we do not know whether the “lower than later” response early after 
initiation of the dexmedetomidine-CRI would be of comparable size as the “lower 
than under medetomidine” response under isoflurane. 
Both medetomidine and isoflurane were also compared to α-chloralose, around 
which a second set of references clusters. Two references compared α-chloralose 
with medetomidine. Sanganahalli et al. (2009) reports that while under both 
anaesthetics BOLD signal in S1FL strongly increased in response to stimulation, the 
optimal stimulation frequency (at 2 mA) differed between anaesthetics: under α-
chloralose (46 +/- 4 mg/kg/h ip) it was 3 Hz and under medetomidine (0.1 mg/kg/h ip) 
9 Hz. Accordingly, amplitudes and shape of the BOLD signal significantly differed 
between anaesthetics at 3 and 9 Hz stimulation frequency. For the other frequencies 
between 1 and 24 Hz which were also investigated no results are explicitly reported 
(limited detail of results because reference is a conference abstract). Inter- and intra-
subject reproducibility of BOLD responses was reportedly higher under α-chloralose. 
In contrast, Weber et al. (2006) stimulated animals with 3 Hz at the same intensity as  
Sanganahalli et al. (2009) and did not find a significant difference in BOLD signal 
increase or the area of activation in S1 between sessions under medetomidine (0.05 
mg/kg sc bolus followed by 0.1 mg/kg/h sc) or α-chloralose (50 mg/kg iv initial dose, 
36 mg/kg iv top-up every 60 min). One out of four animals showed additional 
activation in S2 under medetomidine and two out of three under α-chloralose. Time 
from bolus administration under halothane until a response to stimulation could be 
measured was longer under medetomidine (81 +/- 10 min) than under α-chloralose 
(61 +/- 3) with the doses used in that study.  
Taken together, conflicting results were found as to whether signal increase in S1 
was different under medetomidine and α-chloralose. Other findings presented in the 
two studies available were complementary. 
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3.4.1.3.2 Electrical stimulation – α-chloralose versus various  
One study found higher signal intensity (significantly larger area under the curve) 
during the first, but not second of two stimulation periods under α-chloralose (80 
mg/kg iv bolus, 40 mg/kg/h iv CRI) than under isoflurane (1.2%) (Sommers et al., 
2009). Localization of the activation did not differ between anaesthetics; in both 
conditions it was centred in S1. A conference poster reports for two animals a 10% 
lower baseline BOLD signal, but higher responses to forepaw stimulation from 80 to 
90 min on after anaesthesia was changed from isoflurane (2%) to α-chloralose (50 
mg/kg iv bolus, 40 mg/kg/h iv CRI) (Gsell et al., n.d.). Higher BOLD signal response 
was thus consistently reported under α-chloralose at different doses of both 
isoflurane and α-chloralose. 
 
Furthermore, some studies compared α-chloralose to currently less commonly used 
anaesthetics.  
Compared to halothane (1%), responses to forepaw stimulation were more localized 
and tended to be stronger (no information on significance provided) under α-
chloralose (45 +/-9 mg/kg/h ip) (Maandag et al., 2007). While activations in regions 
other than S1 spread to ipsilateral and posterior regions under halothane (including 
lateral areas of the hippocampus (H) as well as some secondary areas of the visual 
(V) and auditory (A) cortices), they were limited to contralateral S2 and M1/M2 under 
α-chloralose. Activation patterns outside S1 were more reproducible under α-
chloralose and activation in S1 detected more consistently (“nearly all” versus 
“majority of the experiments”). 
 
In comparison to pentobarbital (143-173 mg/kg ip), α-chloralose (50 mg/kg ip) was 
reported to produce a “tighter” cluster of activated voxels in S1 (visually only small 
cluster under pentobarbital) and upon visual inspection signal fluctuations 
corresponded more clearly to the stimulus time course under α-chloralose (Kuo et 
al., 2005). Frequency-dependence of the BOLD signal was observed under both 
anaesthetics and under both, highest signal intensities were obtained with 3 Hz 
stimulation frequency. Except at 3 Hz, where responses were significantly higher 
under α-chloralose, no significant differences in signal intensities were found.  
Finally, comparison with urethane (1.25 g/kg ip) revealed anaesthetic-specific 
frequency-dependencies of the BOLD responses to paw stimulation (Huttunen et al., 
2008). BOLD signal intensities were significantly different at all stimulation 
frequencies; while under α-chloralose (60 mg/kg iv, 30 mg/kg iv top-up after 60 min) 
responses were only observed at 1 and 3 Hz, they were present only at 3 Hz and 
higher under urethane. Localization of the responses exclusively in S1 and centre of 
the activation did not differ between conditions.  
In summary, single reports suggest an overall more favourable profile of BOLD 
responses to paw stimulation under α-chloralose than under halothane and 
pentobarbital and a range complementary to urethane of stimulation frequencies for 
which a response can be observed.  
 
3.4.1.3.3 Electrical stimulation – awake versus anaesthetised  
Peeters et al. (2001) first imaged paralysed awake animals, then the same animals 
under α-chloralose anaesthesia. Paralysed animals showed higher volumes of 
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activation both in contralateral S1 and the less specific ROIs of contra- and ipsilateral 
somatosensory cortex, as well as a trend for higher signal intensities, however, 
localization of the activations was more variable.  
In a cross-over of propofol and the awake state, Lahti et al. (1999) found significantly 
higher signal increase in cortical areas and confirmed the regular occurrence of 
activity in the ipsilateral somatosensory cortex in the awake state. 
Stronger signal increase or larger areas of activation, but less specific localization 
than under anaesthesia were thus consistently reported for awake imaging.  
 
3.4.1.3.4 Mechanical stimulation  
Instead of electrical stimulation, Chang et al. (2016) used innocuous air puffs to the 
side of the hindpaw when comparing responses to stimulation in trained awake and 
isoflurane-anaesthetised animals. While significant positive signal changes were 
observed in bilateral S1HL, thalamus and cingulate cortex, and negative signal 
changes in bilateral S2, hypothalamus and ipsilateral insular cortex upon stimulation 
in awake animals, only when significance thresholds were lowered, activation in 
S1HL could be detected under 3% isoflurane. Correspondence of the signal time 
course with the stimulus time-course was visually more obvious in awake animals.  
Dashti et al. (2005) also used air puffs, but over the eye, to characterize BOLD 
responses under isoflurane (1.6%) and equithesin (6.5g chloral hydrate, 1.44g 
pentobarbital, 2.7g magnesium sulphate, 15 ml alcohol, 52.5 ml propylene glycol). 
Under equithesin, only 1 out of 16 stimulation scans showed activation in 
somatosensory cortex, whereas activation was consistently detected under 
isoflurane. 
Additionally, de Celis Alonso et al. (2011) compared responses to whisker deflection 
in a longitudinal study of two sessions each of isoflurane and α-chloralose. Numbers 
of activated voxels (in S1, S2 and VPM nucleus of the thalamus) were significantly 
lower in both isoflurane scans than in both α-chloralose scans. Signal intensity in all 
three regions was significantly lower in the first, but not in the second isoflurane scan 
compared to both α-chloralose scans. Generally, activations were more widespread 
under α-chloralose, with activations also detected in CPu, retrosplenial cortex and 
ipsilateral S1.  
Taken together, two studies inconsistently report the presence of BOLD signal 
responses to air puff stimulation under isoflurane, while responses to whisker 
deflection were observed under isoflurane, but weaker and spatially more localized 
than under α-chloralose. 
 
3.4.1.3.5 Chemical somatosensory stimulation  
Another two studies injected irritating substances into the paw under different doses 
of isoflurane or comparing isoflurane with α-chloralose. 
Setting observation of both an early and a late response to formalin injection as the 
criterion, Asanuma et al. (2008) found that both 1.0 and 1.2% isoflurane fulfilled it, 
but not 0.6, 0.8 and 2.0% (animals were ventilated and paralysed at all 
concentrations). Chen et al. (2008) briefly report weaker BOLD responses to formalin 
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injection under a not specified concentration of isoflurane than under 70 mg/kg ip α-
chloralose. This relation was conserved when animals were pre-treated with 
morphine. As responses under isoflurane appear to be dose-dependent, but the 
isoflurane concentration is not reported in the latter study, and different outcome 
measures were used, it is unclear whether results of the two studies were consistent. 
 
3.4.1.3.6 Visceral stimulation  
Finally, one reference analysed responses to visceral stimulation. This study 
compared α-chloralose, isoflurane and awake imaging regarding effects on BOLD 
signal responses to intragastric L-Glutamate administration (Tsurugizawa et al., 
2010). Positive BOLD signal change was observed in a variety of – mainly shared – 
regions under the awake and α-chloralose-anaesthetised condition, but only in a few 
regions under isoflurane. In contrast, negative BOLD signal changes were commonly 
observed under isoflurane, but only sporadically under α-chloralose and not in awake 
animals.  
 
3.4.1.3.7 Summary  
References investigating responses to peripheral stimulation used a variety of 
stimulation modalities and anaesthetic protocols, resulting in maximally 3 references 
per comparison of interest and modality. If findings are summarized across 
stimulation modalities, α-chloralose appears to produce an overall more desirable 
profile of responses than isoflurane, although in which parameters exactly responses 
are superior to those acquired under isoflurane varies. The most commonly 
mentioned parameter is signal intensity, which was typically higher if α-chloralose 
was used (Chen et al., 2008; Gsell et al., n.d.), although two studies also found this 
difference only in some runs (Sommers et al., 2009; de Celis Alonso et al., 2011). 
Two studies reported activation in more extended areas under α-chloralose than 
isoflurane (Tsurugizawa et al., 2010; de Celis Alonso et al., 2011), while another 
reported that the centre of activation was not different (Sommers et al., 2009). Across 
stimulation modalities, activations were observed in more extended regions in awake 
animals than in isoflurane- or propofol-anaesthetised animals (Lahti et al., 1999; 
Tsurugizawa et al., 2010; Chang et al., 2016), while findings in comparison to α-
chloralose were inconsistent (Peeters et al., 2001; Tsurugizawa et al., 2010), which 
may or may not be related to the different stimulation modalities used in those 
studies.  
Overall, the heterogeneity of the data prevents strong conclusions.  
 
3.4.1.4 Effects of different states of anaesthesia on BOLD responses to central 
stimulation  
Eleven references compared BOLD responses to central stimuli between different 
states of anaesthesia. Seven applied pharmacological or chemical stimuli, three used 
direct electrical stimulation of brain regions and one reference used optogenetic 
stimulation. Results are summarized for each stimulation modality separately. 
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3.4.1.4.1 Pharmacological/chemical stimulation  
Two references report comparisons of multiple anaesthetics for pharmacologic MRI 
(phMRI). One study compared medetomidine (0.1 mg/kg iv bolus, 0.1 mg/kg/h iv 
CRI), isoflurane (1.3%), α-chloralose (60 mg/kg iv, top-up 30 mg/kg iv after 60 min), 
urethane (1.25 g/kg ip) and thiobutabarbital (TBB, 140 mg/kg ip) for nicotine phMRI 
(Paasonen et al., 2016b). The urethane and thiobutabarbital groups were each 
divided into a mechanically ventilated and spontaneously breathing group. In all other 
groups, animals were ventilated. ROIs were defined both by summarising ICA 
components with high signal time course correlations and in reference to an anatomic 
atlas. With the ICA approach, activation was detected in similar regions across 
groups. As in a subset of ventilated TBB animals mainly negative signal changes 
were observed, the ventilated TBB group was further divided in two subgroups (TBB1 
positive, TBB2 negative signal changes). Considerable variability was observed in 
anatomically defined ROI both between regions and anaesthetics. In subcortical 
regions, no significant difference was found between anaesthetics. In cortical regions, 
area under the curve of the signal time course was significantly higher in both 
urethane groups than under all other anaesthetics, under TBB1 than under α-
chloralose and isoflurane, and under medetomidine than under α-chloralose.   
The other study investigated activations after administration of two different doses of 
levo-tetrahydropalmatine (l-THP) under medetomidine (0.1 mg/kg sc bolus, 0.1 
mg/kg/h iv CRI), isoflurane (1.4-1.6%) and urethane (1.2 g/kg ip) (Liu et al., 2012). 
Activation was defined as AUC of percent signal change of individual voxels 
compared to injection of saline. ANOVA revealed significant effects of l-THP dose 
and anaesthetic agent in specific, partially overlapping regions (anaesthetic alone: 
cingulate cortex, insula, hypothalamus, CPu, globus pallidus, amygdala, retrosplenium, 
parietal cortex, ventral tegmental area, and raphe nucleus) and widespread l-THP dose-
anaesthetic interaction effect in 15 regions (largest clusters in hippocampus and 
somatosensory cortex). Under the lower dose of 5 mg/kg l-THP, least extended, 
consistently positive activations were observed under isoflurane, more extended, 
mostly positive activations under medetomidine, and mostly negative activations 
under urethane. The higher dose of 20 mg/kg l-THP elicited more extended 
activations under all anaesthetics and added some negative responses under 
isoflurane. The highest number of areas was activated under urethane, but those 
were exclusively negative activations.  
Taken together, while Paasonen et al. (2016b) found strongest positive BOLD 
responses under urethane, Liu et al. (2012) observed only negative responses under 
urethane. However, due to the different stimulation drugs for phMRI, findings are 
complementary rather than contradictory.  
Awake imaging was compared to medetomidine sedation (Airaksinen et al., 2012) 
and isoflurane anaesthesia (Tenney et al., 2003) in two different epilepsy models. 
Airaksinen et al. (2012) observed in a kainate model that not all electrophysiologically 
detected seizure activity was accompanied by BOLD signal changes. In the awake 
group, seizures which were accompanied by a BOLD response were significantly 
longer than those which were not accompanied by a response, whereas such a 
relation was not evident under medetomidine (0.05 mg/kg sc bolus, 0.1 mg/kg/h sc 
CRI). The occurrence of seizures as well as BOLD responses, was however not 
significantly different between groups, and localization of the activations was also 
similar, leading to the authors’ conclusion that medetomidine was a suitable sedative 
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to study seizure activity in the kainate model. Tenney et al. (2003) briefly report that 
BOLD responses were “dramatically reduced” under 2% isoflurane in comparison to 
awake animals in the γ-butyrolactone model of absence seizures. Activation maps 
show a difference in spatial extent of BOLD responses, but the text does not specify 
which aspects of the BOLD response were reduced. 
Taken together, BOLD responses during seizures were higher than or similar to 
those observed under anaesthesia in awake animals in two different models of 
epilepsy. 
Three references studied activations after a single bolus of ketamine in isoflurane 
anaesthetised animals. Littlewood et al. (2006b) compared the responses to two 
subanaesthetic doses of ketamine (10 or 25 mg/kg sc) with responses to saline under 
1.5% isoflurane. BOLD signal time courses in specific regions were correlated with 
locomotor activity observed in awake animals over time at the corresponding doses 
and significant activations were observed in “frontal, hippocampal, cortical and limbic 
areas”. At the higher dose of ketamine, some negative activation (in the inferior 
colliculus) was also found. Input functions of the high and low doses were exchanged 
to demonstrate dose-dependent effects. When the locomotor input function of 10 
mg/kg ketamine was used for phMRI of both doses, activations in limbic and cortical 
areas appeared significantly stronger under 25 mg/kg and 10 mg/kg, respectively. 
Dose-dependencies were stronger when results of microdialysis (from ventral 
pallidum and nucleus accumbens) were used as the input function instead of the 
locomotor input function. Signal time courses after ketamine and vehicle injection 
differed only in selected ROIs. No significant difference was found in whole brain 
signal intensity.  
Another study from the same group administered racemic ketamine, the S-
enantiomer or the R-enantiomer (25 mg/kg each), or only the vehicle on top of 1.6% 
isoflurane and observed for racemic and S-ketamine overall similar activations, 
especially in limbic regions, although cortical and hindbrain activations were less 
pronounced after S-ketamine (Littlewood et al., 2006a). Again, differences in signal 
time courses between racemic or S-ketamine and vehicle were observed only in ROI 
which were activated in statistical parametric mapping (SPM) maps. 
A third study investigated the interactions of TAK-063, a potential anti-psychotic, and 
ketamine, which is commonly used as a model for schizophrenia (Tomimatsu et al., 
2016). Ketamine (10 mg/kg sc) alone on top of 1.5-1.8% isoflurane induced positive 
BOLD signal changes in cortex, hippocampus, CPu and amygdala and negative 
signal changes in brainstem, cerebellum and hypothalamus. Previous administration 
of TAK-063 prevented negative signal changes, decreased the positive signal 
change in cortical and hippocampal areas and led to stronger positive activation in 
the CPu. At the lower of two doses, TAK-063 additionally increased signal in 
thalamus and hypothalamus. 
Taken together, all three studies consistently report activation in cortex, hippocampus 
and variable other regions after administration of a subanaesthetic dose of ketamine 
or S-ketamine. 
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3.4.1.4.2 Electrical stimulation  
Three references compared anaesthetic protocols for direct electrical brain 
stimulation.  
Austin et al. (2005) implanted two electrodes subdurally over left hindpaw motor 
cortex and compared BOLD responses to stimulation under different concentrations 
of halothane (0.7, 0.8, 0.9, 1.0, 1.2, 1.5%) plus N2O and at different timepoints after 
switch to α-chloralose. Under all halothane concentrations BOLD responses in the 
ipsi- and contralateral motor cortex were observed without significant differences in 
area of activation between concentrations. Independent of concentrations, activations 
in additional regions, for example S2, were observed in some animals. Amplitude of 
the BOLD response did not significantly differ across concentrations and the duration 
of the response was only at 1.5% halothane and only in the stimulated cortex 
significantly longer than under other concentrations. Under α-chloralose, activations 
were for the first 2 h also limited to bilateral motor cortices, later, however, significant 
activations in other cortical and subcortical areas were observed. The activated area 
within the motor cortices was 1 h after the initial bolus lower than under halothane but 
grew larger over time 2-6 h after the initial bolus (significant relative to 1 h from 3 h on 
in both cortices). Throughout the experiment, responses were slower under α-
chloralose than under halothane (significant difference to halothane at all timepoints), 
although the latency decreased over time. Similar trends for increased latencies after 
change to α-chloralose were observed in secondary activated regions. 
In contrast, Lai et al. (2015) and Chao et al. (2014) both studied deep brain 
stimulation. Lai et al. (2015) stimulated VPM at frequencies of 1, 2, 5, 10, 15, 20, 25 
and 30 Hz. At 10, 15 and 20 Hz, signal amplitudes in somatosensory cortex were 
significantly higher under α-chloralose (60 mg/kg iv bolus, 30 mg/kg/h iv CRI) than 
under isoflurane (1.0-1.25%). Under both anaesthetics, however, robust responses 
were observed, which were highest at 20 Hz and higher at 10-20 Hz than at 1Hz. 
Chao et al. (2014) found frequency and intensity dependent BOLD responses in S1 
upon stimulation of ventroposterior thalamus (VP) under dexmedetomidine (0.025 
mg/kg sc bolus, 0.05 mg/kg/h sc CRI), but stable signal time courses and localization 
of the activation across sessions under the same frequency/intensity combination. In 
contrast, signal amplitudes and number of activated voxels in S1 varied considerably 
between sessions with identical stimulation parameters in isoflurane-anaesthetised 
(1.0-1.3%, adjusted according to depth of anaesthesia as assessed by respiratory 
rate) animals.  
Taken together, while one reference found robust activation in S1 under isoflurane 
(Lai et al., 2015) the other observed highly variable activations at the same 
concentration (Chao et al., 2014). However, electrode location, stimulus waveforms 
(bi- versus monophasic square waves), current intensities (2 mA versus 0.1-0.3 mA) 
and impulse durations (1/f ms, i.e. 0.1 ms at 10 Hz, versus 0.4 ms) differed between 
studies, indicating that responses under isoflurane depend on stimulation 
parameters. On the other hand, both a deep brain stimulation (Lai et al., 2015) and a 
subdural stimulation study (Austin et al., 2005) found robust activations in the 
expected regions under α-chloralose within the first 2 h after the initial bolus. 
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3.4.1.4.3 Optogenetic stimulation  
Finally, one study used an optogenetic approach to stimulate the infralimbic part of 
medial prefrontal cortex in awake animals and under isoflurane (1.0-1.15%) (Liang et 
al., 2015b). Activations were spatially more extended and had a higher BOLD signal 
amplitude in awake animals. Awake animals showed activations in several cortical 
and subcortical areas. This pattern was reproducible within and consistent across 
animals. In contrast, under isoflurane activations were observed only around the fibre 
tip, in insula and orbital cortex. Signal intensities in activated regions ranged from 2% 
to 3-4% during stimulation in awake animals and never exceeded 1% in 
anaesthetised animals (standard errors of the means not overlapping in graphic). 
 
3.4.1.4.4 Summary  
Taken together, electrical brain stimulation yielded robust responses under α-
chloralose whereas robust responses were inconsistently found under isoflurane. 
Responses to subanaesthetic doses of ketamine were overall similar between 
studies, seizure activity was detected with variable success under different 
anaesthetics/sedatives in different epilepsy models, and differences specific for the 
tested substance were observed in phMRI when comparing multiple anaesthetic 
protocols. 
 
3.4.1.5 Effects of different states of anaesthesia on baseline BOLD signal  
Studies which could not clearly be allocated to one of the previous experimental 
paradigms are described in this section containing three references which all 
investigated some version of baseline BOLD signal under different states of 
anaesthesia, typically with the aim to understand how the BOLD signal relates to 
other measures. 
Gong et al. (2014) observed BOLD signal changes in three layers of olfactory bulb 
under 1.8 and 3.5% isoflurane. In all layers (glomerular, mitral and granulous cell 
layer), BOLD signal increased when the isoflurane concentrations increased and 
decreased when the isoflurane concentration was decreased – the contrary of what 
was observed for local field potentials (LFP). Additionally, significant differences in 
the magnitude of signal changes were found between layers (which was also not the 
case for LFP).  
Tsurugizawa et al. (2016) used high resolution imaging to investigate the effect of 
different isoflurane concentrations (1.5, 2.0, 2.5, 3.0%) on BOLD signal originating 
from capillaries (called “tissue” BOLD signal) and large arteries and veins (called 
“vessel” BOLD signal) in somatosensory cortex. In somatosensory cortex as a whole, 
BOLD signal was significantly higher at 2.0 and 2.5% isoflurane than at 1.5% and 
decreasing again at 3.0%, resulting in an inversed U-shape. The same pattern was 
observed when only tissue or vessel areas of the ROI were analysed, however, 
vessel BOLD signal at 2.5% isoflurane was significantly higher than tissue BOLD 
signal.  
Abe et al. (2017) investigated relations between the BOLD signal and LFP as 
opposed to apparent water diffusion coefficient (ADC) and LFP under two doses 
each of isoflurane (1.5 and 2.5%) and medetomidine (0.05 mg/kg sc bolus, CRI 0.1 
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mg/kg/h for 40 min, then 0.3 mg/kg/h iv). While baseline BOLD signal increased with 
higher isoflurane dose (significantly higher at 2.5 than 1.5% in most areas), it 
decreased with the higher medetomidine dose (significantly lower at 0.3 mg/kg/h than 
at 0.1 in most areas). 
Studies thus consistently report an increase in baseline BOLD signal when isoflurane 
concentration is increased from 1.5 to 2.5% (Tsurugizawa et al., 2016; Abe et al., 
2017), but disagree whether the trend continues in higher ranges (1.8-3.5% (Gong et 
al., 2014)) or is reversed (Tsurugizawa et al., 2016). The findings of Abe et al. (2017) 
suggests that this increase is not limited to the regions studied by Tsurugizawa et al. 
(2016) and Gong et al. (2014) and that this signal increase is a specific feature of 
isoflurane, as it was not observed under medetomidine. 
 
3.4.1.6 Conclusion  
3.4.1.6.1 Awake versus anaesthetised  
Imaging of awake animals was compared to results obtained under isoflurane, α-
chloralose, propofol and medetomidine in various stimulation paradigms, and to 
rsfMRI results obtained under isoflurane. Stronger BOLD response to hypercapnia 
was observed in awake animals than under isoflurane, but responses to severe 
hypoxia were more pronounced under isoflurane. Signal intensity upon peripheral 
electrical stimulation was higher in awake animals than under propofol. Compared to 
α-chloralose, signal intensity was similar in awake animals, but area of activation was 
higher and spatial reproducibility lower in awake animals. When mechanical 
peripheral stimulation was applied, both the presence of activations in the respective 
area of S1 and the number of additionally activated regions were higher in awake 
animals than under isoflurane. The total number of activated regions was also higher 
in awake animals than under isoflurane in a visceral stimulation paradigm, but similar 
to under α-chloralose-anaesthesia. In the same study, negative signal changes were 
more common under isoflurane than under α-chloralose and under α-chloralose than 
in awake animals. In two different epilepsy models, awake imaging proved equivalent 
to medetomidine regarding occurrence and localization of activations during seizures, 
and superior to isoflurane in the general term of “BOLD response” during seizures 
(not defined which aspects of response). Finally, one optogenetic study reports a 
higher number of activated regions in awake animals upon light stimulation. Across 
stimulation modalities, stronger responses  – in terms of signal intensity and/or 
activated area both in “expected” and additional regions – were thus commonly (Lahti 
et al., 1999; Peeters et al., 2001; Brevard et al., 2003; Sicard et al., 2003; Tenney et 
al., 2003; Liang et al., 2015b; Chang et al., 2016;), but not consistently (Tsurugizawa 
et al., 2010; Airaksinen et al., 2012) found in awake animals. Only one article 
reported a higher amplitude of signal change under isoflurane (Duong, 2007), but this 
was at the same time the only article in which stimulation resulted in a BOLD signal 
decrease. 
Resting state studies consistently report reduced fc under isoflurane compared to the 
awake state based on three datasets (Liang et al., 2012a; Liang et al., 2013; Liang et 
al., 2015a; Chang et al., 2016; Hamilton et al., 2017; Ma et al., 2017; Smith et al., 
2017). Generally, both responses to stimulation and fc were stronger in awake than 
in anaesthetised animals (nine of eleven datasets).  
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Figure 12. Comparison of response to stimulation and fc in awake versus 
anaesthetised animals (no data available for baseline BOLD signal). stronger = 
higher signal intensity upon stimulation and/or spatial extent of activated area in 
awake animals or higher fc strength and/or spatial extent of connectivities; (stronger) 
= response to stimulation or fc stronger in some, but not all aspects in awake 
animals; no sign. diff. = no significant difference between awake and anaesthetised. 
“weaker” and “(weaker)” analogous to “stronger” and “(stronger)”. One data point per 
dataset and anaesthetic. If re-analysis found a significant difference only in some 
aspects, “(stronger)” was selected. 
 
 
3.4.1.6.2 Dose effects  
Across anaesthetics and experimental paradigms, dose-dependence of BOLD results 
was a common, but not universal phenomenon. Baseline BOLD signal increased 
(Gong et al., 2014; Abe et al., 2017) or followed an inverse U-shape (i.e. intensity 
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decreasing again after a peak was reached (Tsurugizawa et al., 2016)) when 
isoflurane concentrations were increased, whereas higher medetomidine doses 
decreased baseline BOLD signal intensity (Abe et al., 2017). While medetomidine 
infusion rates did not affect responses to peripheral electrical stimulation within the 
first two hours (Nasrallah et al., 2012, 2014a), frequency-dependence of responses 
was partially dose-dependent thereafter (Pawela et al., 2009). Amplitude of the BOLD 
signal response to peripheral electrical stimulation decreased with higher isoflurane 
concentrations (Nasrallah et al., 2014a). In contrast, early as well as late response to 
sc formalin injection was only observed at intermediate (within a range of tested) 
isoflurane concentrations (Asanuma et al., 2008). Dose-dependence of the spatial 
pattern and presence of negative signal changes was also observed when ketamine 
or S-ketamine were administered at subanaesthetic doses on top of isoflurane 
(Littlewood et al., 2006b). However, neither area of activation within the motor cortex, 
nor the pattern of additionally activated regions, nor amplitude of the BOLD signal 
differed across a range of halothane concentrations combined with a constant 
concentration of N2O when motor cortex was stimulated with subdural electrodes 
(Austin et al., 2005).  
In rsfMRI there was a trend across anaesthetics that lower doses of isoflurane, 
medetomidine and propofol are associated with higher fc strength, spatially more 
extended connections, larger networks and/or a greater repertoire of dynamic brain 
states (Tu et al., 2011; Wang et al., 2011; Liu et al., 2011, 2013a; Nasrallah et al., 
2012, 2014a; Gill et al., 2017; Ma et al., 2017;)). However, this trend was neither 
consistently found (isoflurane: (Liu et al., 2013b; Pan et al., 2011), medetomidine: 
(Pawela et al., 2009)) nor monotonic (propofol: (Liu et al., 2013a)). 
Taken together, dose-dependence was a common finding, but the direction of effects 
was sometimes controversial. 
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Figure 13. Dose dependence of baseline BOLD signal, responses to stimulation, and 
fc in rats. No = no dose dependent effect was observed; partial = dose dependence 
was observed for some outcomes, analyses or animals, but not consistently; yes = a 
dose dependent effect was clearly observed. One point per dataset per anaesthetic. 
If original article and re-analysis disagreed, partial dose dependence was selected. 
 
 
3.4.1.6.3 Pairwise comparison of anaesthetics across experimental paradigms  
Specific comparisons of anaesthetics re-occurred across experimental paradigms 
and findings are summarized in the following section. 
 
Isoflurane versus α-chloralose 
Baseline signal was in a single report observed to be lower under α-chloralose than 
under isoflurane in two animals (Gsell et al., n.d.). The same report also found higher 
change under α-chloralose in signal intensity upon electrical forepaw stimulation. 
This finding was partially confirmed by a larger study (Sommers et al., 2009) which 
found in the first, but not second of two stimulation periods significantly larger AUC of 
the signal intensity under α-chloralose than under isoflurane, without a difference in 
localization of the activation. Mechanical peripheral stimulation resulted in one out of 
two scans in higher amplitude of the signal intensity and in two out of two scans in 
higher numbers of activated voxels within defined regions under α-chloralose (de 
Celis Alonso et al., 2011). The number of additionally activated regions was also 
higher under α-chloralose. Another study reported stronger BOLD response to sc 
formalin injection under α-chloralose than under isoflurane without further specifying 
the term BOLD response (Chen et al., 2008). In line with the findings reported so far, 
fewer regions were activated under isoflurane than under α-chloralose when a 
visceral stimulus was applied. However, more extended negative signal changes 
were observed under isoflurane than under α-chloralose (Tsurugizawa et al., 2010).  
Deep brain stimulation supports the observation of tendentially stronger and/or more 
extended responses to stimulation under α-chloralose than isoflurane. Signal 
amplitudes were higher under some, but not all stimulation frequencies under α-
chloralose (Lai et al., 2015). Nevertheless, under both anaesthetics, responses were 
robust and followed the same patterns of frequency dependence. In contrast, no 
significant difference between α-chloralose and isoflurane was found in AUC of the 
signal intensity in nicotine phMRI (Paasonen et al., 2016b). Re-analysis of parts of 
the same dataset regarding fc was the only information available on how α-chloralose 
and isoflurane compare in rsfMRI (Paasonen et al., 2016a). Correlation of region-
specific baseline fc with phMRI response was assessed by the authors as high under 
isoflurane and “mainly poor” under α-chloralose. 
In summary, there is a trend across peripheral and central stimulation modalities that 
fMRI under α-chloralose yields higher amplitudes or AUC of BOLD signal intensities 
and/or spatially more extended activations, both in expected and additional regions. 
For baseline and rsfMRI, the available information was insufficient to detect any 
trends (one reference each).  
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Medetomidine versus α-chloralose 
Inconsistent results are reported for responses to electrical paw stimulation under 
medetomidine compared to α-chloralose. While one reference (Weber et al., 2006) 
found no difference in the change of signal intensity or the activated area at 
stimulation with 3 Hz (the only difference was the time between bolus administration 
and the first successful measurement of a response to stimulation, which was longer 
under medetomidine), another (Sanganahalli et al., 2009) observed peak responses 
at different stimulation frequencies for medetomidine and α-chloralose (9 and 3 Hz, 
respectively) and accordingly significantly different signal amplitudes at those (higher 
under medetomidine at 9 Hz, higher under α-chloralose at 3 Hz).   
In a nicotine phMRI study, AUC of the signal intensity was in cortical regions 
significantly higher under medetomidine than α-chloralose, but not significantly 
different between anaesthetics in subcortical regions (Paasonen et al., 2016b). Re-
analysis of parts of the same dataset regarding fc retrieved “more consistent” 
correlation of baseline fc with responses to nicotine, primarily in subcortical regions, 
under medetomidine than under α-chloralose. Finally, one reference assessed 
scaling exponent β and found that values were in cortical, but not subcortical regions 
higher under medetomidine than under α-chloralose (Herman et al., 2011).  
In summary, there was no consistent trend in responses to stimulation and not 
enough data to detect a trend for rsfMRI. 
 
Urethane versus α-chloralose 
Responses to electrical paw stimulation were observed at different, partially 
overlapping frequency ranges for urethane (3-15 Hz) and α-chloralose (1-3 Hz), but 
not quantitatively compared where they overlapped (Huttunen et al., 2008). In phMRI, 
AUC of the signal intensity after nicotine administration was significantly higher under 
urethane than under α-chloralose in cortical regions, but no significant difference was 
found in subcortical regions (Paasonen et al., 2016b). When parts of the previous 
dataset were re-analysed, no correlation was observed under urethane between the 
response to nicotine and baseline fc, and “mainly poor” correlations under α-
chloralose (Paasonen et al., 2016a). 
Taken together, the information available is too sparse to identify a general pattern.  
 
Halothane versus α-chloralose 
Responses to electrical paw stimulation were more localized and reproducible under 
α-chloralose than under halothane when measured 2 h after switching from 
halothane to α-chloralose (Maandag et al., 2007). For superficial direct electrical 
stimulation of the brain, it depended on the time elapsed since the initial α-chloralose 
bolus how responses compared to those observed under halothane (Austin et al., 
2005). One hour after the bolus, area of activation in the stimulated region was 
significantly smaller under α-chloralose than under halothane, however, the area of 
activation increased significantly over time. As for activation in additional areas, 
significantly more additional regions were activated under α-chloralose than under 
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halothane from 2 h post bolus on. Only latency of the BOLD response was 
significantly higher under α-chloralose than halothane throughout the experiment.  
Taken together, response to stimulation may be more localized under α-chloralose 
under certain circumstances (e.g. dose, timing). No information was found for rsfMRI 
for the comparison in question. 
 
Barbiturates versus α-chloralose 
Response to electrical paw stimulation was significantly higher under α-chloralose 
than under pentobarbital only at one of four applied stimulation frequencies (Kuo et 
al., 2005). In nicotine phMRI, AUC of signal intensities was significantly higher in a 
subgroup of thiobutabarbital-anaesthetised animals than in α-chloralose-
anaesthetised animals, but only in cortical, not in subcortical regions (Paasonen et 
al., 2016b). Re-analysis of the data with a focus on fc found “high and consistent” 
correlations under thiobutabarbital as opposed to “mainly poor” correlations of region-
specific baseline fc with response to nicotine under α-chloralose (Paasonen et al., 
2016a).  
Taken together, although in both data sets differences in opposite directions (once 
stronger response under α-chloralose, then under barbiturates) were observed in 
subgroups, responses to stimulation appeared to be in an overall comparable range. 
Again, only information from single reports was available on rsfMRI. 
 
Isoflurane versus (dex)medetomidine 
In deep brain stimulation, reproducibility of signal amplitude, area of activation and 
localization of activations were higher under dexmedetomidine than under isoflurane 
(Chao et al., 2014). One phMRI study found more extended activations and mixed 
positive and negative signal changes under medetomidine, while under isoflurane 
more localized, primarily positive signal changes were observed (Liu et al., 2012). 
Another phMRI study however did not find a significant difference in AUC of signal 
intensity between medetomidine and isoflurane (Paasonen et al., 2016b). 
In re-analysis of parts of the same data set, region-specific correlation values of 
baseline connectivity with response to nicotine were high in both groups, especially in 
cortical regions under isoflurane and subcortical regions under medetomidine 
(Paasonen et al., 2016a). Two more studies found lower and more localized 
correlations in seed maps under medetomidine and higher correlations in pairwise 
ROI analysis, which were not limited to homotopic bilateral ROI, under isoflurane 
(Williams et al., 2010; Kalthoff et al., 2013). In ICA incidence of cortical and striatal 
networks was higher and networks showed more consistent segregation patterns 
under medetomidine (Kalthoff et al., 2013), but no difference was found in power 
spectra of the BOLD signal (Williams et al., 2010). An abstract also noted “generally 
higher” inter-and intrahemispheric connectivity under isoflurane (Boonzaier et al., 
2017). 
Taken together, there was no common pattern of differences between medetomidine 
and isoflurane in responses to stimulation across and even within stimulation 
modalities. In contrast, lower and more localized correlations both between a seed 
and other voxels and between ROI pairs were consistently observed under 
medetomidine and interpreted as more specific fc.  
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Isoflurane versus isoflurane/(dex)medetomidine 
While the activated area became more extended and the amplitude of signal 
significantly increased after addition of a dexmedetomidine-CRI to isoflurane, in the 
same study interhemispheric S1FL and thalamic connectivity significantly decreased 
and correlations in the 0.01-0.04 Hz range were significantly reduced in both areas 
(Nasrallah et al., 2014b). A second study found that the degrees of freedom of the 
BOLD signal under combined isoflurane/medetomidine (1.5% isoflurane plus 0.45 
mg/kg sc bolus, 0.2 mg/kg/h iv CRI medetomidine) equalled those observed under 
2% isoflurane (Kundu et al., 2014). 
As limited data is available per experimental paradigm, general trends or ”signature 
patterns” cannot be identified. 
 
Isoflurane versus urethane 
In phMRI, urethane provided significantly higher AUC of signal intensity than 
isoflurane in cortical regions (Paasonen et al., 2016b) and higher spatial extent of 
responses (Liu et al., 2012). It appears thus that the magnitude of responses tends to 
be higher under urethane, however, the direction of signal change was positive in 
one study (Paasonen et al., 2016b) but negative in the other (Liu et al., 2012), 
whereas those observed under isoflurane were mainly positive in both studies.  
When parts of the first dataset were re-analysed with a focus on fc, no correlation 
between baseline fc and response to phMRI was observed under urethane in 
contrast to isoflurane (Paasonen et al., 2016a).  
 
(Dex)Medetomidine versus urethane 
Responses to pharmacological stimulation measured as area under the curve of 
signal intensity changes were stronger under urethane than under medetomidine in 
two studies. However, while one study found primarily positive signal changes under 
urethane (Paasonen et al., 2016b), negative signal changes dominated in the other 
(Liu et al., 2012). For medetomidine, both studies report mostly positive signal 
changes. The areas in which activations were seen were at least in one study similar 
between urethane and medetomidine (Paasonen et al., 2016b).  
Fc was stable over time under medetomidine and a correlation found in subcortical 
regions between fc and response to nicotine (Paasonen et al., 2016a). In contrast, 
neither temporally stable fc nor a correlation with responses to pharmacological 
stimulation was found under urethane.  
However, as limited data is available and interactions between anaesthetic and test 
substance are to be expected in phMRI, generalization of these observations is not 
warranted.  
 
3.4.1.6.4 Time effects  
Responses to stimulation were in the first phase after administration of a bolus 
weaker than in later phases – despite maintenance of anaesthesia with a CRI or top-
up boli at a lower dose – in terms of signal intensity (Brynildsen et al., 2017) or area 
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of activation (Austin et al., 2005). Sometimes responses to stimulation were 
completely suppressed for 60 to 80 minutes after the initial bolus of medetomidine or 
α-chloralose (Weber et al., 2006; Gsell et al., n.d.). 
Likewise, fc strength increased or connectivities became spatially more extended 
after administration of a bolus of dexmedetomidine or α-chloralose (Bettinardi et al., 
2015; Paasonen et al., 2016a; Brynildsen et al., 2017). However, the same was not 
true after administration of a subanaesthetic ketamine bolus, where differences in 
both directions were observed between two timepoints of measurement, depending 
on the region and the method of analysis.  
When anaesthesia was maintained over longer periods, for example with a 
medetomidine-CRI, patterns became more complex (Pawela et al., 2009). 
Stimulation frequency dependence of the activated area as well as fc between ROI 
pairs decreased unless the rate of the CRI was increased (Pawela et al., 2009). 
Additionally, the duration of previous isoflurane exposition affected ROI-ROI and 
whole brain fc as well as power of the signal fluctuations under a dexmedetomidine-
CRI (Magnuson et al., 2014). 
Nevertheless, one study also reported stable fc over time under isoflurane and under 
a medetomidine-CRI (Paasonen et al., 2016a). 
Finally, urethane has a particular relation to time, as fc consistently displayed a cyclic 
behaviour (Wilson et al., 2011; Zhurakovskaya et al., 2016) which is in agreement 
with cyclic patterns observed in EEG.  
Taken together, time-dependent effects were found in the majority of studies 
addressing the effect of timing of image acquisition on the BOLD results. 
 
 
3.4.2 Mice  
3.4.2.1 Effects of different states of anaesthesia on BOLD responses to peripheral 
stimulation  
Five references compared BOLD responses to electrical paw stimulation under 
different states of anaesthesia.  
In one study the activated area and the signal intensity change did not significantly 
differ between three rates of medetomidine infusion (0.1, 0.6 or 1.0 mg/kg/h ip 
starting 15 min after a bolus of 0.3 mg/kg ip) (Nasrallah et al., 2014c). In all groups 
focal activation in S1 was detected and time courses of the signal change were 
similar between groups. However, the time point of measurement was relevant: 
irrespective of the infusion rate, activation was only detected from 60 min after bolus 
on.  
Schroeter et al. (2017) focused on the laterality of BOLD responses to hindpaw 
stimulation with 0.7 mA at 1.2% and 1.5% isoflurane in C57BL/6 mice and found at 
both concentrations almost identical signal amplitude in contra- and ipsilateral S1. 
The authors note that amplitude of signal change and interindividual variability 
differed across isoflurane levels, however, they do not specify the direction of those 
differences or provide any quantitative measure.   
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Two studies compared responses to hindpaw stimulation among isoflurane, 
medetomidine, propofol and urethane, and Schroeter et al. (2014) additionally 
compared two doses per anaesthetic. Schroeter et al. (2014) found distinct spatial 
activation patterns (displayed in activation maps) and distinct signal time courses. 
Number and size of activated clusters tended to be larger under isoflurane and 
propofol than under medetomidine and urethane. However, with all anaesthetics 
activations were widespread and no significant difference was observed between 
ipsi- and contralateral responses. Except for propofol, lower anaesthetic doses 
yielded larger signal amplitudes upon stimulation. In the case of urethane and 
medetomidine, the dose also affected the signal time course by decreasing onset 
times and eliminating the initial dip at the lower doses.  
Using randomly spaced single pulse train instead of block stimulation, Schlegel et al. 
(2015) confirmed spatially specific activation maps for the four anaesthetics, which 
were independent from the model used to generate them. Again, signal time courses 
were anaesthetic-specific, but for each anaesthetic, time courses within cortical ROI 
were similar and signal amplitudes highest in contralateral S1HL. While isoflurane 
and urethane showed both an initial dip and post-stimulus undershoot, medetomidine 
and propofol-anaesthetised animals displayed “pronounced negative and positive 
signal transients”. In contrast to the other three groups, responses in thalamus were 
not reliably detected under urethane.  
Shim et al. (2018) also observed bilateral responses to forepaw stimulation (1 mA) 
under isoflurane (1.0-1.1%), but unilateral responses under ketamine/xylazine (25 
and 1.25 mg/kg ip, respectively). While under isoflurane a response was always 
observed, only 47 out of 58 ketamine/xylazine sessions showed a detectable 
response. 
Taken together, bilateral responses to unilateral stimulation are consistently reported 
for isoflurane, urethane and propofol. Under medetomidine, however, both uni- and 
bilateral responses were reported. Finally, a single study observed unilateral 
responses under ketamine/xylazine.   
 
3.4.2.2 Effects of different states of anaesthesia on BOLD responses to central 
stimulation  
A single optogenetic study compared responses to light stimulation of S1 in awake 
animals with those obtained under 0.7% isoflurane (Desai et al., 2011). In awake 
animals 11 ROI were activated, but only 6 under isoflurane. 4 of the 5 designated 
“key ROI” (S1, contralateral S1, S2, M1 and CPu; criterium that detected in all awake 
animals) were also found in anaesthetised animals, but the signal change was 
significantly lower in all of them. The goodness of fit between observed BOLD 
responses and canonical haemodynamic response function was significantly lower 
under isoflurane, and the peak correlation coefficient was reached with significantly 
higher delay of onset. Pairwise ROI-ROI correlations following optical stimulation 
were also significantly lower under anaesthesia according to ANOVA. Interestingly, 
all correlations which were significantly reduced in post-hoc analysis were 
connections involving the striatum.  
Overall, this study suggests that BOLD responses and stimulated fc are significantly 
reduced in anaesthetised animals.  
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3.4.2.3 Effects of different states of anaesthesia on resting state BOLD 
measurements  
3.4.2.3.1 Medetomidine doses and timepoints  
Five studies investigated the impact of doses and/or timepoints of imaging on rsfMRI 
under medetomidine.  
Grandjean et al. (2014) found that interhemispheric connectivity was higher both for a 
seed in sensory cortex and a seed in dorsal striatum under the lower of two 
investigated doses of medetomidine (low: 0.05 mg/kg iv bolus followed by 0.1 
mg/kg/h CRI; high: 0.1 mg/kg iv bolus followed by 0.2 mg/kg/h iv CRI). Furthermore, 
under the lower dose, interhemispheric connectivity was observed for two additional 
seeds in sensory cortex which did not show bilateral correlations under the higher 
dose. Re-analysis of the same dataset with a focus on local connectivity did not show 
significant differences in ReHo between the two doses, neither in voxelwise nor in 
ROI analysis (Wu et al., 2017). However, small differences in ReHo between the two 
doses had an influence, to which of the other anaesthetic protocols significant 
differences were found. 
Shah et al. (2016) obtained rsfMRI 20 and 50 min after administration of a single 
medetomidine bolus (0.3 mg/kg sc, no CRI thereafter). At 50 min the ICA component 
which was most similar to the default mode network contained more regions than at 
20 min. Seed-based analysis confirmed significantly lower connectivity of left 
cingulate cortex with retrosplenial cortex and hippocampal regions, i.e. the posterior 
parts of default mode network, at 20 min.  
Nasrallah et al. (2014c) compared data acquired under three different rates of 
medetomidine-CRI (0.1, 0.6 and 1.0 mg/kg/h ip after 0.3 mg/kg ip bolus) and at two 
timepoints each (30 and 120 min after bolus). Under 0.1 mg/kg/h, interhemispheric 
connectivities between various ROI (S1, S2, visual cortex, CPu, thalamus, 
hippocampus) were generally high at both timepoints. At 30 min, no significant 
difference between 0.1 and 0.6 mg/kg/h was found, but at 120 min, fc between 
bilateral thalamic nuclei was significantly reduced. Under 1.0 mg/kg/h, 
interhemispheric fc was significantly reduced in most ROI, except CPu, at both 
timepoints. Within S1, the mean peak frequencies of the correlation did not 
significantly differ between infusion rates. Between the two resting state scans an 
electrical forepaw stimulation paradigm was applied. Interestingly, the latency and the 
amplitude of signal change in the stimulation scans was significantly correlated to the 
strength of interhemispheric S1 correlation: the slower and weaker the response to 
stimulation was, the weaker the bilateral S1 connectivity was. 
Mechling et al. (2014) compared connectivity matrices of two consecutive scans 
acquired 30 and 45 min after the medetomidine bolus (0.3 mg/kg sc bolus, 0.6 
mg/kg/h sc CRI) and found only in 1.4% of functional clusters a significant difference 
in connectivity strength. Those did not affect the number of functional clusters or their 
property of small worldness. Contrary to the findings of Nasrallah et al. (2014c), no 
significant change in the connectivity of thalamic nuclei was detected. 
Taken together, higher doses of medetomidine were consistently reported to reduce 
fc between ROI. A single study could not extend these findings to local connectivity. 
Reported effects of the timing of image acquisition on resting state measures were 
inconsistent: While Shah et al. (2016) clearly observed an effect of time (20 versus 
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50 min) after a single bolus of medetomidine, Mechling et al. (2014) did not find a 
significant difference between 30 and 45 min after bolus under a CRI, and in the 
study of Nasrallah et al. (2014c), the effect of the timepoint of image acquisition was 
dose-dependent (only observed for the intermediate infusion rate).  
 
3.4.2.3.2 Medetomidine/isoflurane timepoints  
Shah et al. (2016) observed that raw T2* signal was weakest 20 min after 
administration of a single medetomidine bolus (0.3 mg/kg sc) on top of 1.5% 
isoflurane, but significant differences to the baseline (1.5% isoflurane) were present 
for 50 min after bolus. 
Grandjean et al. (2017) acquired resting state scans 20 and 55 min after the 
medetomidine bolus (0.05 mg/kg iv) under combined medetomidine (0.1 
mg/kg/h)/isoflurane (0.5%) anaesthesia. Static fc was higher in the second scan in 
several components (barrel field 1 and 2, limb, visual and cingulate/retrosplenial 
cortices, ventral hippocampus), but lower in others (dorsal and lateral striatal 
component). Nevertheless, the same atoms (“elementary building blocks of whole-
brain dynamic connectivity representing specific dynamic functional states”) were 
identified with dictionary learning in both scans and only in 3 out of 20 atoms 
significant increases in atom fluctuation were observed at the second timepoint.  
Taken together, raw signal intensity as well as stationary fc were reduced 20 min 
after a bolus of medetomidine on top of isoflurane compared to later 
measurements.  
 
3.4.2.3.3 Medetomidine versus isoflurane versus medetomidine/isoflurane  
Two studies based on the same dataset compared fc under multiple anaesthetic 
protocols (Grandjean et al., 2014; Wu et al., 2017).  
Specifically for medetomidine (0.1 mg/kg iv bolus followed by 0.2 mg/kg/h iv CRI 
standard dose, 0.05 mg/kg iv bolus followed by 0.1 mg/kg/h alternative dose), 
isoflurane (1.0% standard, 1.5% alternative concentration) and the combination 
thereof (lower medetomidine dose plus isoflurane 0.5%), Grandjean et al. (2014) 
found that interhemispheric connectivity was prominent between cortical seeds, but 
absent in subcortical seeds under isoflurane, whereas strong subcortical but limited, 
dose-dependent (in one out of three sensory seeds under 0.1 mg/kg/h, in three out of 
three under 0.5 mg/kg/h) cortical interhemispheric fc was observed under 
medetomidine. Under medetomidine/isoflurane, significant bilateral correlations were 
present in both cortical and subcortical seeds. Interhemispheric connectivity in a 
sensory seed was significantly higher under isoflurane 1% than under medetomidine 
0.1 mg/kg/h, under isoflurane 1.5% than under both medetomidine doses, under 
medetomidine/isoflurane than under both medetomidine doses and under 0.05 
mg/kg/h than under 0.1 mg/kg/h medetomidine. For a seed in dorsal striatum, 
interhemispheric fc was comparable under medetomidine/isoflurane and 
medetomidine 0.05 mg/kg/h, and significantly higher under medetomidine/isoflurane 
than under isoflurane 1%, as well as under medetomidine 0.05 mg/kg/h than under 
medetomidine 0.1 mg/kg/h and both isoflurane doses. When results were compared 
with analysis without global signal regression, extended correlations with a sensory 
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seed were observed under isoflurane, while those under medetomidine were “clearly 
better confined”. Unregressed medetomidine/isoflurane data also showed confined 
correlations. Peaks of the respective frequency distributions were at 0.01, 0.15 and 
0.2 Hz for isoflurane, medetomidine/isoflurane and medetomidine. Approximate 
entropy, a measure for stochastic behaviour of signal fluctuations over time, was 
significantly higher under medetomidine/isoflurane than under both medetomidine 
doses. 
Re-analysis of the same dataset, with the exception of isoflurane 1.5%, by Wu et al. 
(2017) focused on local connectivity, measured by ReHo. When voxelwise ReHo 
maps were generated, generally high values were observed in cortical areas, under 
medetomidine and medetomidine/isoflurane additionally in CPu, and under isoflurane 
and medetomidine/isoflurane additionally in hippocampus. Comparison of voxelwise 
ReHo over the entire brain showed significantly higher ReHo in cortical areas under 
isoflurane and medetomidine/isoflurane than under the high dose of medetomidine, 
whereas in the CPu, ReHo was significantly lower under isoflurane than under both 
medetomidine concentrations. Analysis of ReHo within 6 ROI revealed no significant 
differences between anaesthetic protocols in hippocampus and insular cortex, plus 
for the three anaesthetics reported here in the thalamus, but significantly higher 
ReHo under medetomidine/isoflurane than under the high dose of medetomidine in 
cingulate cortex, and significantly higher ReHo under medetomidine/isoflurane as 
well as under isoflurane than under the high dose of medetomidine in sensory cortex 
(barrel field). In CPu, ReHo was significantly lower under isoflurane than under the 
high dose of medetomidine as well as under medetomidine/isoflurane. 
Schroeter et al. (2017) focused on strain differences in interhemispheric connectivity 
between C57BL/6, acallosal I/LnJ and BALB/c mice. Isoflurane concentrations of 1.3 
and 1.5% were used as well as a combination of 0.5% isoflurane and medetomidine 
(0.05 mg/kg iv bolus, 0.1 mg/kg/h iv CRI). The authors report that anaesthetic depth 
affected amplitude of signal fluctuations and interindividual variability (without 
specifying the direction or providing any quantitative information), but not “qualitative” 
aspects of rsfMRI, such as that interhemispheric connectivity was absent for most 
regions in acallosal animals.  
Taken together, Grandjean et al. (2014) and Wu et al. (2017) found strong fc in 
cortical areas under isoflurane, in subcortical areas under medetomidine and strong 
fc in cortical as well as subcortical areas when medetomidine and isoflurane were 
combined. This pattern was observed for both interhemispheric and local 
connectivity. However, both articles also demonstrate that fc patterns and strength 
are sensitive to the dose of medetomidine. As Schroeter et al. (2017) did not specify 
the effects of the investigated protocols, integrating these findings with those of the 
other two articles is not possible. 
 
3.4.2.3.4 Multiple comparisons  
Three articles based on two datasets addressed comparisons between multiple 
anaesthetics. In addition to isoflurane, medetomidine and medetomidine/isoflurane, 
Grandjean et al. (2014) and Wu et al. (2017) also investigated urethane (1.5 g/kg ip 
standard dose, 1.2 g/kg ip alternative dose) and propofol (30 mg/kg iv bolus, followed 
by 120 and later 150 mg/kg/h iv standard dose; 45 mg/kg iv bolus, followed by 187 
and later 225 mg/kg/h iv alternative dose). Under all protocols bilateral connectivity 
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for a seed in sensory cortex was found, but only under isoflurane and propofol 
bilateral correlations were observed for additional seeds in sensory cortex 
(Grandjean et al., 2014). Striatal interhemispheric connectivity was limited to 
medetomidine protocols, however, for a seed in the limbic system, interhemispheric 
connectivity was additionally observed under urethane. Neither interhemispheric 
connectivity for a seed in the cingulate cortex nor correlations between the thalamus 
and sensory seeds were observed under any of the anaesthetic protocols. 
Quantitatively, interhemispheric correlations in the cortical seed were of comparable 
magnitude (no significant difference) under both isoflurane concentrations, 
medetomidine/isoflurane and propofol. Cortical interhemispheric connectivity was 
significantly lower under urethane, and significantly higher under urethane than under 
the high dose of medetomidine. Urethane and the low dose of medetomidine 
produced similar cortical interhemispheric connectivity strengths. For the striatal 
seed, interhemispheric connectivity strength was significantly lower under propofol, 
urethane and isoflurane than under medetomidine/isoflurane or the low dose of 
medetomidine.   
Wu et al. (2017) included only standard doses (except for medetomidine) for the 
analysis of local connectivity. Voxelwise analysis revealed generally high ReHo 
values in cortical areas under all anaesthetic protocols. In CPu, ReHo values were 
high under urethane, along with medetomidine. When voxelwise ReHo over the 
entire brain was compared between groups, significantly higher cortical ReHo was 
found under propofol than under the high dose of medetomidine, and under 
isoflurane and medetomidine/isoflurane than under urethane. In contrast, ReHo was 
significantly lower in CPu under isoflurane than under all medetomidine containing 
protocols and urethane. ReHo in the hypothalamus and thalamus was significantly 
lower under medetomidine/isoflurane and the high dose of medetomidine, than under 
urethane and propofol, respectively. In ROI analysis, ANOVA identified significant 
differences between anaesthetic protocols in 4 out of 6 ROI (no difference in insular 
cortex and hippocampus). In sensory cortex, local connectivity was significantly lower 
under urethane than under isoflurane and medetomidine/isoflurane. In CPu, propofol 
significantly reduced ReHo compared to all medetomidine containing protocols. 
Finally, local connectivity within the thalamus was significantly higher under propofol 
than under isoflurane, medetomidine/isoflurane and the high dose of medetomidine 
and also significantly higher under urethane than under the high dose of 
medetomidine. 
Jonckers et al. (2014) compared isoflurane (1%), α-chloralose (120 mg/kg ip) and 
urethane (2.5 g/kg ip) anaesthesia with awake imaging for rsfMRI. Results for the 
comparison of awake versus anaesthetised are described in the next section. In the 
authors’ judgment, ICA identified “overall the same regions” and components were 
partially overlapping. Qualitatively, the authors describe spatially less confined 
components under isoflurane than under α-chloralose and urethane. For ROI-
analysis, seeds were placed in left M1, S1 and CPu and fc assessed as cluster size 
of correlated voxels, maximal t value (Tmax) of correlated voxels and correlation 
coefficient between bilateral homotopic regions. Cluster size was significantly higher 
in the right CPu under α-chloralose than under the other two anaesthetics. Tmax was 
in right S1 significantly higher under isoflurane and the other two agents, but in right 
CPu significantly higher under α-chloralose than under the respective other two 
agents. A significant difference in bilateral correlation coefficients was suggested by 
ANOVA for M1 and S1, but significant in post-hoc Bonferroni test only in S1, between 
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higher correlation coefficients under isoflurane and lower correlation coefficients 
under α-chloralose. Correlation coefficients in CPu were low in all groups. Taken 
together, significant differences between anaesthetics were observed in this study in 
one out of six, two out of six and one out of three possible locations for the outcome 
measures of cluster size, Tmax and bilateral correlation coefficients. Overall, in the 
authors’ interpretation these findings demonstrate reduced cortical interhemispheric 
fc under isoflurane relative to urethane and α-chloralose.  
In summary, the two datasets share only the comparison of isoflurane with urethane. 
Under isoflurane cortical interhemispheric connectivity was consistently higher than 
under urethane, whereas no significant difference was found in striatal 
interhemispheric connectivity (Grandjean et al., 2014; Jonckers et al., 2014). Local 
connectivity followed the same trend in cortex but was in CPu significantly higher 
under urethane than under isoflurane in a single report (Wu et al., 2017). Overall, 
similar trends were observed by Grandjean et al. (2014) and Wu et al. (2017) for 
interhemispheric and local connectivities, i.e. anaesthetic protocols under which 
higher interhemispheric connectivity was found relative to others tended to show 
higher local connectivity as well, however, these analyses were based on the same 
dataset.  
 
3.4.2.3.5 Awake versus anaesthetised  
Two references compared rsfMRI from awake mice with rsfMRI from anaesthetised 
mice.  
Using ICA, Yoshida et al. (2016) observed uni- and bilateral cortical and limbic 
networks in awake habituated mice (daily restraining in a mock scanner for 2 h over 8 
days) as well as in medetomidine-sedated animals (0.3 mg/kg sc bolus, 0.6 mg/kg/h 
sc CRI), but basal ganglia networks were only found in sedated animals. Depending 
on methods of analyses, connectivities (of individual voxels with independent 
components) were significantly higher in awake animals in retrosplenial cortex and 
hippocampus. Analysis of pairwise ROI-ROI correlations, however, revealed only a 
trend (i.e. not significant) for higher connectivities in awake animals.  
Jonckers et al. (2014) analysed fc in awake animals (acclimatisation over 8 days with 
increasing duration of restraint) and under isoflurane (1%), α-chloralose (120 mg/kg 
ip) and urethane (2.5 g/kg ip) anaesthesia. ICA identified in the authors’ judgement 
overall similar and partially overlapping components in all groups, but a CPu 
component was not found in awake animals in contrast to all anaesthetised groups. 
When seed were placed in left M1, S1 (barrel field) and CPu, significantly higher 
cluster sizes of correlated voxels in awake animals than in all anaesthetised groups 
were only observed for the seed in S1 (significant in both hemispheres). Maximal t 
values were significantly higher in awake than in urethane- and α-chloralose-
anaesthetised animals in the left motor cortex for the seed in M1, in the right 
somatosensory cortex for the seed in S1, and significantly higher than in all three 
anaesthetised groups in left somatosensory cortex for the seed in S1. Cross-
correlation coefficients of left and right somatosensory cortex, but not motor cortices 
and CPu, were significantly higher in awake than anaesthetised animals. 
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Taken together, in both studies some aspects of fc were stronger/higher in awake 
animals – but not in all regions and not in all outcome measures trends reached 
significance – while other aspects were similar in awake and anaesthetised animals.  
 
3.4.2.3.6 Summary  
In summary, higher doses of medetomidine were consistently reported to reduce fc 
between ROI but reported effects of the timing of image acquisition under 
medetomidine alone or on top of isoflurane on resting state measures were 
inconsistent. 
Fc tended to be strong in cortical areas under isoflurane, in subcortical areas under 
medetomidine and strong in cortical as well as subcortical areas when medetomidine 
and isoflurane were combined.  
Under isoflurane cortical interhemispheric connectivity was higher than or not 
significantly different from under urethane, and no significant difference was found in 
striatal interhemispheric connectivity. While cortical interhemispheric connectivity was 
lower under medetomidine than under urethane, ReHo was under both agents 
relatively high.  
Finally, awake imaging yielded tendentially stronger fc than anaesthetised imaging. 
 
3.4.2.4  Conclusion  
Although limited data is available on peripheral stimulation, it appears that bilateral 
activation after unilateral stimulation is a common problem and was reported under 
most of the investigated anaesthetics. 
In rsfMRI, anaesthetics tended to be characterized by regional differences in fc 
strength, with some anaesthetics enhancing rather cortical and others rather 
subcortical fc. 
Overall, response to stimulation and fc were tendentially stronger in awake than 
anaesthetised animals. While significantly higher response to optogenetic stimulation 
and stronger fc were observed in awake animals in an optogenetic stimulation study 
(Desai et al., 2011), trends were less pronounced in resting state studies and fc was 
only in some aspects significantly stronger in awake than anaesthetised animals 
(Jonckers et al., 2014; Yoshida et al., 2016). 
Dose-dependence, at least partial, was observed in all three resting state datasets 
and in two out of three stimulation datasets for four different anaesthetics. 
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Figure 14. Dose dependence of responses to stimulation and fc in mice (no data 
available for baseline BOLD signal). No = no dose dependent effect was observed; 
partial = dose dependence was observed for some outcomes, analyses or animals, 
but not consistently; yes = a dose dependent effect was clearly observed. One point 
per dataset per anaesthetic. If original article and re-analysis disagreed, partial dose 
dependence was selected. 
 
Those studies that investigated time dependence all used medetomidine alone or on 
top of isoflurane. They often, but not universally found an effect on at least some 
outcomes. Responses to electrical paw stimulation were only detectable from 60 min 
after bolus administration on, irrespective of the doses used (Nasrallah et al., 2014c). 
The same study found that at the intermediate infusion rate, thalamic 
interhemispheric fc was significantly lower than at the low infusion rate at 120 min, 
but not 30 min after bolus administration. For other regions and the high and low 
infusion rates however, no time-dependent differences were reported. This is in 
agreement with a study which did overall not find a significant difference in the 
number of functional clusters or their property of small worldness between two 
timepoints (30 and 45 min after bolus) (Mechling et al., 2014). In contrast, a third 
study reported that the number of regions contained in the component which is most 
similar to the default mode network was lower, and the connectivity of a seed in 
cingulate cortex with retrosplenial and hippocampal regions is reduced at 20 min 
compared to 50 min after bolus administration (Shah et al., 2016). The same study 
also assessed time dependence of raw T2* after administration of a medetomidine 
bolus on top of isoflurane and found lowest values and spatially most extended 
differences (relative to isoflurane) at 20 min after bolus administration. Grandjean et 
al. (2017) confirmed that stationary fc of several components was lower at 20 than at 
55 min after bolus, but for other components the opposite was true. The number of 
functional units, the “atoms”, was meanwhile stable over time and only 3 out of 20 
atoms showed higher fluctuations at the second time point of measurement. 
Taken together, when time dependence was detected, fc did not uniformly increase 
with time elapsed since bolus administration. 
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Figure 15. Time dependence of responses to stimulation and fc in mice (no data 
available for baseline BOLD signal). No = no time dependent effect was observed; 
partial = time dependence was observed for some outcomes, analyses or animals, 
but not consistently; yes = a time dependent effect was clearly observed. One point 
per dataset per anaesthetic. If original article and re-analysis disagreed, partial time 
dependence was selected. 
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4 Discussion  
 
In this systematic review it was shown that paO2, paCO2 and arterial blood pressure 
affect BOLD signal across various experimental paradigms. 
Responses to stimulation as well as fc are generally stronger in awake animals than 
in anaesthetised animals. When anaesthetised animals are imaged, anaesthetic 
dose- and time-dependent effects have to be expected. Strength and/or spatial 
extent of fc as well as responses to stimulation typically differ between different 
anaesthetics. 
4.1 Physiological parameters under anaesthesia and the BOLD 
signal  
 
Anaesthesia is a state of reversible unconsciousness which is accompanied by 
important changes in physiological parameters. Changes in paCO2 and paO2 
commonly occur under anaesthesia and have the potential to bias BOLD fMRI 
results.  
4.1.1 paCO2  
 
Direct depression of respiratory centres and peripheral muscle relaxation reduce 
minute alveolar ventilation in spontaneously breathing anaesthetised animals and 
lead to hypercapnia (Duke-Novakovski et al., 2016). Hypercapnia increases baseline 
signal while reducing response to stimulation. Studies either experimentally altered 
inspiratory gas compositions to test the effect of hypercapnia, adding 1 to 10 % of 
CO2 to the baseline gas mix, or studied naturally occurring fluctuations. Significant 
changes were already observed with 1% CO2 admixture, corresponding to an 
increase in paCO2 of 5 mmHg (Nasrallah et al., 2015). Among two observational 
studies, one did not find that the magnitude of the BOLD response to (electrical paw) 
stimulation depended on paCO2 (Sumiyoshi et al., 2012), but the other described 
abolished responses when paCO2 exceeded 35 mmHg (Ramos-Cabrer et al., 2005). 
In human studies fluctuations in EtCO2 as small as 1.1 mmHg are reported to 
correlate with fluctuations in global BOLD signal intensity (Wise et al., 2004). Local 
increases in pCO2 trigger vasodilation to increase perfusion of areas with increased 
metabolism (Shockley and LaManna, 1988). Accordingly, increases in systemic 
paCO2 increase global CBF. The relation between paCO2 and CBF is almost linear 
between 20 and 80 mmHg (Reivich, 1964). When cerebral perfusion is increased 
without concomitant increase of CMRO2, venous oxygenation increases and so does 
the baseline BOLD signal (Kim and Ogawa, 2012). Contrariwise, CBF response to 
stimulation is reduced when baseline CBF is already high (Cohen et al., 2002). 
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By which mechanisms and to which extent hypercapnia affects fc is less clear. A 
single study found increased interhemispheric S1FL connectivity and increased 
amplitude of signal fluctuations under one of several tested CO2 concentrations, 
however, spatial extent of fc maps was unchanged and there was no correlation 
between paCO2 and amplitude of signal fluctuations or between responses to 
stimulation and fc, so that the authors question the cardiovascular origin of the 
observed changes. In humans, hypercapnia was also shown to affect 
interhemispheric connectivity between homotopic regions (Marshall et al., 2015) and 
a recent publication claims that fc mapping is possible with data from cerebrovascular 
reactivity studies, when the effects of CO2 are subtracted (Hou et al., 2019). Taken 
together, effects of hypercapnia – or even increases of paCO2 within physiological 
ranges – on rsfMRI measures should be expected until proven otherwise. Throughout 
image acquisition, paCO2 or at least endexspiratory CO2 as a surrogate for arterial 
paCO2 should therefore be monitored to avoid influences of variable paCO2 on BOLD 
fMRI results. 
Monitoring CO2 levels is not only important in spontaneously breathing animals, but 
also in mechanically ventilated animals. Setting minute ventilation lower or higher 
than the actual requirement will over time lead to hyper- or hypocapnia. Although 
much less investigated than hypercapnia, hypocapnia induced by hyperventilation 
increased the amplitude of signal change and the activated area in an electrical 
forepaw stimulation study (Hsu et al., 1998), which is little surprising considering that 
hypocapnia provokes strong vasoconstriction and reduction of CBF (Severinghaus 
and Lassen, 1967). Monitoring of CO2 allows ventilatory settings to be adjusted 
before significant changes in paCO2 develop and thus helps to keep paCO2 within a 
narrow range during the experiment.  
 
4.1.2 paO2  
 
Hypoxaemia is another common complication of anaesthesia. The combination of 
reduced respiratory muscle activity (reducing the lung volume), atelectasis, 
ventilation-perfusion mismatch and hypercapnia results in reduced paO2 (Lumb, 
2019). Hypoxaemia decreases baseline signal and has variable effects on response 
to stimulation. With lower baseline arterial oxygenation, venous oxygenation 
decreases and so does BOLD signal intensity (Kim and Ogawa, 2012). Variable 
responses to stimulation may be partially explained by the fact that in one study, 
animals were breathing spontaneously and hyperventilating during hypoxic challenge 
(Sicard and Duong, 2005). The resulting hypocapnia led to vasoconstriction 
overruling hypoxic vasodilation. In the other study, animals were artificially ventilated 
– nevertheless, this study also reported small, insignificant decrease of CBF under 
hypoxia (Huang et al., 2013). Furthermore, SpO2 was reduced to 75% and 81% in 
the first study (FiO2 of 0.09 and 0.12) but only to 87% in the second (FiO2 0.15). It is 
conceivable that in the latter study, arterial oxygenation was still high enough that the 
higher CBF response which was measured (compared to baseline) could account for 
the higher BOLD response. 
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Whatever the effects of different levels of hypoxaemia on BOLD responses are: paO2 
or SpO2 should be monitored during fMRI and O2 supplemented to prevent 
desaturation. FiO2 should be high enough to prevent hypoxaemia, but low enough to 
prevent confounding effects of hyperoxia. Hyperoxia increases baseline signal, fc 
and potentially also response to stimulation (this was however not consistently 
found). The proposed mechanism is that elevated paO2 reduces the amount of O2 
dissociating from haemoglobin, because O2 dissolved in the plasma readily diffuses 
into surrounding tissues (Liu et al., 2019). Baseline gas mixtures in the included 
studies ranged from room air to 47% inspiratory oxygen. Most studies used 100% O2 
as hyperoxic condition, but one study found significantly increased baseline signal 
already at 40% O2 (Baskerville et al., 2011). Based on current evidence, FiO2 in the 
range of 0.25 to 0.40 appears reasonable for BOLD fMRI, but further research is 
needed to identify optimal concentrations. 
Data presented here about the effects of paCO2 and paO2 alterations on BOLD result 
are almost exclusively from rats, as only one study investigated different gas 
compositions in mice. Results of that publication are however in line with rat data. An 
additional observational study in mice found a linear association between O2 delivery, 
calculated as SpO2 times CBV, and BOLD signal change during somatosensory 
stimulation. 
That the described effects were observed under different anaesthetic protocols and 
generally in spontaneously breathing as well as ventilated animals shows that the 
effects are robust. Consequently, paCO2 and paO2 need to be measured, controlled 
and kept constant throughout the experiment in all BOLD fMRI experiments.  
 
4.1.3 Arterial blood pressure  
 
The third parameter for which relatively ample literature was found is arterial blood 
pressure. While arterial blood pressure increases are consistently reported to 
increase baseline BOLD signal and response to stimulation, decreases are 
inconsistently reported to decrease baseline BOLD signal and their effect on 
response to stimulation is controversial (from decreased over unchanged to 
enhanced responses). 
Blood pressure increases were produced by noradrenaline boli or infusions of 
maximally 1 min in four out of five studies. Noradrenaline is generally assumed not to 
affect cerebral vasculature due to the blood brain barrier (Hardebo and Owman, 
1980). Accordingly, MAP and thereby cerebral perfusion pressure should increase 
without affecting autoregulation. In principle, cerebral autoregulation should maintain 
CBF at constant levels for MAP of 50 to 140 mmHg by adjusting cerebral vascular 
resistance (Zaharchuk et al., 1999). To which degree autoregulation is preserved 
under anaesthesia depends however on the agent used. α-chloralose, which was 
used in four of the experimental hypertension studies, is reported to partially preserve 
autoregulation, although the upper limit may be reduced (Wang et al., 2010). For the 
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included studies it is often not obvious or difficult to reconstruct whether the induced 
blood pressure increases were within or beyond the autoregulatory limits reported by 
Zaharchuk et al. (1999). For example, baseline blood pressure is not reported in the 
studies by Qiao et al. (2007) and Tuor et al. (2002). It appears that while some BP 
increases exceeded 140 mmHg MAP (Wang et al., 2006), others were mainly within 
autoregulatory limits (Tuor et al., 2007). Irrespective of the blood pressure increases 
produced, the included studies generally ascribe the increase in baseline BOLD 
signal to hyperperfusion of the brain. In such a state of high perfusion pressure and 
rather constricted arterioles at baseline, increased responses to stimulation are 
plausible, as stimulation-induced dilation of arterioles will lead to a strong CBF 
response and a clear “surplus” of O2 delivery.  
Blood pressure decreases, on the other hand, were commonly induced by blood 
withdrawal. Approximately 1 to 10 ml/kg were withdrawn per step and at various 
rates. Additional variance was induced by the fact that one study (Kalisch et al., 
2001) performed several steps of blood withdrawal and subsequent re-infusion. 
Although studies took care to avoid haemorrhagic shock, the higher volumes of 8-10 
ml/kg may have activated compensatory mechanisms including release of vasoactive 
substances (Kalisch et al., 2001).  
Across studies, both decreases within and below autoregulatory limits were usually 
observed within the same study. Except for Hempel et al. (1999), which states that a 
reduction of signal amplitude in response to stimulation was only observed when 
blood pressure fell below the autoregulatory limit, results usually refer to the total of 
blood pressure decreases. Nevertheless, some studies report more pronounced 
effects on baseline signal with larger blood pressure decreases (Wang et al., 2006). 
Compared to the blood pressure increase studies, more diverse anaesthetics were 
used in the blood pressure decrease studies. Besides α-chloralose, studies used 
isoflurane, halothane and in one case propofol. However, a significant correlation 
between blood pressure and BOLD signal was found under all three anaesthetics in 
one study investigating isoflurane, halothane and propofol, and with the limited 
number of included studies, no clear effect of anaesthesia on the detection of blood-
pressure dependent effects was seen. Assuming that cerebral autoregulation was 
active, a decrease in cerebral perfusion pressure would increase CBV, which may, 
under certain circumstances, account for a higher total amount of deoxyhaemoglobin 
and accordingly lower signal intensity (Liu et al., 2019). When blood pressure was 
reduced below autoregulatory limits or in cases in which autoregulation may have 
been impaired, reduced cerebral perfusion readily explains the decrease in baseline 
BOLD signal: cerebral hypoperfusion increases O2 extraction fraction and thus 
decreases venous oxygenation, which translates into lower BOLD signal intensity. 
For response to stimulation, the situation is more complex: an abstract reports 
significantly enhanced responses to stimulation at 40 and 60 mmHg MAP induced 
with application of negative lower body pressure, but CBF was conserved at 60 
mmHg and reduced at 40 mmHg (Herman et al., 2007), so the underlying 
mechanisms for the enhanced BOLD response must have been different at the two 
levels. In contrast, responses to stimulation were decreased after blood withdrawal to 
MAP values below autoregulatory limits (Hempel et al., 1999) or did not significantly 
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change (despite a trend towards lower responses) when trimetaphan camsilate was 
administered (Wang et al., 2006). The anaesthetic used can hardly explain those 
contradictory trends as all three experiments were performed under α-chloralose 
anaesthesia. Similarly, negative lower body pressure produces similar 
haemodynamic changes as haemorrhagic hypotension (Johnson et al., 2014) so that 
the methods used to provoke hypotension appear unlikely to have influenced the 
cerebral haemodynamic response to stimulation. Assuming a situation of cerebral 
hypoperfusion, one would expect that the CBF response to stimulation is reduced, 
first because arterioles are at baseline already rather dilated and second because 
cerebral perfusion pressure is low enough that an additional decrease in vascular 
resistance will only return a small increase in CBF. In such a situation, a smaller 
increase in additional O2 delivery and thus a smaller BOLD signal increase would be 
expected. However, BOLD signal depends on CBF, CBV and CMRO2 and the 
changes in CBV during hypotension are as controversial as the findings of stimulation 
studies (discussed by Zaharchuk et al. (1999)). Further studies would be required to 
characterise how systemic hypotension modulates BOLD responses to stimulation. 
Interestingly, mean CBF is maintained when MAP approaches the autoregulatory 
limit, but CBF fluctuations increase and thereby BOLD signal fluctuations increase 
(Kannurpatti et al., 2008).  
Blood pressure changes can affect BOLD fMRI results in two situations:  
First, hypotension, defined as MAP below 60 mmHg or systolic arterial blood 
pressure below 80 mmHg (Duke-Novakovski et al., 2016), is a common complication 
of anaesthesia. Second, stimuli applied during fMRI can provoke concomitant arterial 
blood pressure increase or, less commonly, decrease. Many substances tested in 
phMRI change arterial blood pressure for variable durations. Additionally, noxious or 
intense peripheral stimuli, such as application of irritating substances, can increase 
arterial blood pressure. For example, arterial blood pressure increases, and BOLD 
signal increases are significantly linearly correlated after formalin injection (Tuor et 
al., 2002). Especially abrupt blood pressure changes could override autoregulation 
for a short duration and introduce artefactual – positive or negative – activations. A 
study in rats did not find a significant correlation between the BOLD response to 
electrical paw stimulation and MAP (MAP ranging from 60 to 140 mmHg); however it 
is unknown whether paw stimulation elicited blood pressure changes (Sumiyoshi et 
al., 2012). In mice, stimulation-associated cardiovascular responses are suspected to 
account for bilateral responses to unilateral electrical paw stimulation (Schroeter et 
al., 2014; Schlegel et al., 2015; Schroeter et al., 2017). Cardiovascular responses 
were however characterised only by pulse oximetry (heart rate and pulse distension) 
and arterial blood pressure was not measured in those studies. Interestingly, 
cardiovascular changes were not detected when randomised single pulses were 
applied and activation of ipsilateral cortex was reduced, although not abolished. As 
bilateral responses to unilateral stimulation were even observed in acallosal mice, a 
cardiovascular or at least unspecific neural arousal response seem to best explain 
those unspecific activations.  
Overall, despite some controversies about the underlying mechanisms and the 
direction of effects, arterial blood pressure changes have to be expected to modulate 
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the BOLD signal and may introduce artefactual activations or correlations when not 
detected and corrected for. Blood pressure should therefore be measured during 
fMRI. A single report suggests that correcting test-substance-induced hypotension in 
phMRI with a phenylephrine-CRI allowed detection of specific responses, which were 
otherwise obscured by arterial blood pressure correlated BOLD signal decreases. 
While this approach may be useful under specific circumstances, it should not be 
applied generically, as “overcorrection” of blood pressure also bears the risk to 
introduce artefacts.  
 
4.1.4 General considerations  
 
It is important to consider physiological parameters not as isolated entities: changes 
in one parameter will likely trigger changes in others. For example, spontaneously 
breathing animals exposed to hypercapnic or hypoxic inspiratory gas mixtures will 
increase minute ventilation in an attempt to normalise paCO2 or paO2, and at the 
same time also change partial pressures of the respective other gas. In other words, 
hypoxaemic spontaneously breathing animals become hypocapnic with time. 
Similarly, during apnoea or severe hypoventilation, paCO2 and paO2 in- and decrease 
concurrently. But not only respiratory aspects are interrelated. Mild hypercapnia or 
hypoxaemia increases arterial blood pressure and heart rate via sympathetic 
stimulation (Kuznetsova and Kulikov, 2014; Prabhakar, 2015), whereas severe 
hypoxaemia decreases arterial blood pressure (Kannurpatti and Biswal, 2004; Sicard 
and Duong, 2005). Furthermore, body temperature modulates both cardiovascular 
parameters and metabolism which in turn affects O2 consumption and CO2 
production (Kurz et al., 1996). 
This interdependence of physiological parameters may explain some of the variability 
of the results. Additionally, a range of anaesthetics was used across studies. 
Although those studies which compared effects of physiological parameter alterations 
on BOLD fMRI result found qualitatively similar effects, some quantitative differences 
were noted, which may also add variability to the results.  
Finally, interventional studies more commonly reported an influence of physiological 
parameters on the BOLD signal than observational studies: 36 out of 39 
interventional, but only 3 out of 6 observational studies found a significant effect. A 
possible explanation is that induced changes of physiological parameters were larger 
than naturally occurring changes. Alternatively, other physiological parameters may 
have been better controlled for in interventional studies, but when the percentage of 
studies which ventilated all animals is taken as an indicator for the control of 
physiological parameters, interventional and observational studies are in a similar 
range with 67% (26 of 39 studies) and 57% (4 of 7 studies), respectively. 
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4.2 States of anaesthesia and the BOLD signal  
 
Comparison of anaesthetic protocols, or more precisely, different states of 
anaesthesia including awake state, revealed in rats as well as mice three general 
effects: differences between awake animals and anaesthetised animals, dose-
dependence and time-dependence of results. 
Results for dexmedetomidine and medetomidine were pooled in the present study as 
sedative and cardiovascular effects and pharmacokinetics of the two drugs are 
similar in rats (Savola and Virtanen, 1991) and mice (Burnside et al., 2013). Doses of 
medetomidine and dexmedetomidine are generally considered equivalent when 
dexmedetomidine is administered at 50% of the medetomidine dose (Burnside et al., 
2013). 
 
4.2.1 Awake versus anaesthetised  
 
There was a clear trend for stronger and/or more extended fc and responses to 
stimulation in awake animals. Awake imaging was compared to imaging under 
isoflurane, medetomidine, propofol, α-chloralose or urethane. Irrespective of the 
anaesthetic used, fc was at least partially stronger in awake animals in rats as well as 
in mice. Responses to stimulation were more variable: one study each under 
medetomidine and α-chloralose found no significant difference to the awake state in 
rats (for mice, only a single stimulation study was available). In one case, the 
response to stimulation was even stronger under isoflurane: during severe 
hypoxaemia, BOLD signal decreased more in anaesthetised than in awake rats. 
Hypoxic stimulation differs from other types of stimulation by the fact that a decrease 
of BOLD signal intensity is expected as opposed to an increase in conventional 
stimulation paradigms such as somatosensory stimulation. This single study points at 
the possibility that when the response to a stimulus arises from a system being 
disturbed, higher responses may be observed in anaesthetised animals which have 
lower capacities to compensate. 
Albeit overall stronger fc and responses to stimulation in awake animals, one has to 
keep in mind that the goal of fMRI is not to measure the highest signal intensities, 
correlation coefficients or spatial extents of networks or activations, but the most 
accurate. Some studies (e.g. Peeters et al. (2001)) concluded that although stronger, 
responses were also less specific in awake animals. In human fMRI it is a known 
problem that awake humans don’t exclusively think about the task they are given and 
that “unrestrained cognition” in the case of rsfMRI literally can go in any direction 
(Chou et al., 2017). Generally, such effects can be expected in awake rodents too. 
Specifically, stress experienced during fixation in a loud environment could be a 
major contributor to unspecific responses to stimulation or widespread, unspecific 
connectivity.  
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The circumstances under which animals underwent awake imaging varied between 
studies. Some studies (six datasets, six references) fixed anaesthetised rats on the 
animal cradle and acquired fMRI scans once the animals were considered to have 
recovered from anaesthesia. Waking up tightly restrained in an unfamiliar, loud 
environment is a stressful event for a rodent. Some studies report respiratory rates 
(Brevard et al., 2003) and heart rates, MAP and arterial blood gases (Duong, 2007), 
within normal ranges for awake animals but at the same time, one of them (Duong, 
2007) noted that struggling movements “markedly decreased after the first hour”, 
indicating that animals were stressed despite apparently normal respiratory rates. 
Two studies (Peeters et al., 2001; Airaksinen et al., 2012) kept the animals paralysed 
after discontinuing inhalant anaesthesia. In one of those studies (Airaksinen et al., 
2012), status epilepticus was induced during which animals were considered 
unconscious, but prior to this, baseline images were acquired in paralysed awake 
animals. Awareness during muscle paralysis is known to be highly stressful for 
humans and can lead to post-traumatic stress disorder (Sandin et al., 2000; 
Lennmarken et al., 2002). Discontinuing anaesthesia in paralysed animals is thus an 
inacceptable practice to prevent motion artefacts in awake imaging. One of the 
studies in question observed less specific and more variable responses to 
stimulation, which the authors judged as outweighing the larger signal changes. 
When it comes to stress, the aims of science and animal welfare are congruent: 
reducing stress improves data quality and animal welfare. 
An approach to reduce stress during awake imaging is to use acclimation protocols. 
Most acclimation protocols encountered in the included studies are modifications of 
the protocol presented by King et al. (2005). It involves fixing anaesthetised rodents 
in the position required for imaging and leaving the animals restrained for a defined 
timespan once they regained consciousness. The procedure is repeated daily over 
several days. “Mock scanners” with or without recordings of MRI sounds as well as 
the actual scanners can be used. To reduce discomfort, lidocaine paste is applied on 
pressure points. In the original protocol, respiratory rate was significantly lower from 
day three and heart rate and corticosterone levels were significantly lower from day 5 
on compared to the first training session. In contrast to the original protocol, which 
used ketamine/medetomidine for initial anaesthesia, all eight datasets included in this 
review used isoflurane. Among those eight datasets a cluster of three from the same 
group (at Penn State University), from which eight publications arose, used a version 
in which the duration of restraint was increased in steps of 15 min until the target 
duration was reached. Stress levels were not addressed in those publications. A 
publication in mice, using a very similar modification of the protocol, found that 
respiratory rate was significantly higher than in freely behaving mice and did not 
decrease throughout trainings and concluded that mere repetition of the exposure 
failed to decrease stress in mice (Jonckers et al., 2014). 
Approaches to refine awake imaging include fixing animals via implanted head posts 
instead of stereotaxic ear- and bite bars and to use noise-reducing earplugs 
(Tsurugizawa et al., 2010). Similar to King et al. (2005), Tsurugizawa et al. (2010) 
found a decrease of respiratory and heart rate on days four and five of training, 
respectively. Beyond repeated exposure, a study in mice used chocolate sprinkles 
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during and at the end of the restraining period as positive reinforcement (Desai et al., 
2011), however, they did not report signs of stress over the course of the training. 
Even if stress decreases over the course of the acclimation protocol – which appears 
to be the case in rats, but not in mice, concerns remain with the use of anaesthesia 
for initial immobilisation as well as with repeated exposure to stress: first, effects of 
anaesthesia on brain functions might last longer than unconsciousness. Humans 
experience increased cognitive failures up to 3 days after regaining consciousness 
(Tzabar et al., 1996). Similarly, findings of Magnuson et al. (2014) indicate that 
effects of isoflurane exposure last longer than residual isoflurane concentrations can 
be expected to be present in the body (Sommers et al., 2009). For set-up in awake 
imaging, animals are typically anaesthetised much shorter than in the study of 
Sommers et al. (2009), only for a few minutes, and waiting periods of around 30 min 
before imaging is started are common, but those rely on subjective estimations rather 
than experimental data. Carry-over effects from anaesthesia on fMRI results can 
therefore not be excluded. Second, anaesthesia per se induces a physiologic stress 
response (Altholtz et al., 2006). Third, isoflurane and sevoflurane both become more 
aversive with repeated exposure in rats and mice (Wong et al., 2013; Moody and 
Weary, 2014; Bertolus et al., 2015; Hohlbaum et al., 2017). Inhalant anaesthesia for 
immobilisation is therefore a persistent source of aversion and (at minimum 
physiological) stress in acclimation protocols. Finally, although stress during restraint 
appears to decrease in rats over the course of the acclimation protocol, it is at least 
initially present and repeated exposure to stress may itself alter outcomes. Henckens 
et al. (2015) found increased connectivity in “somatosensory, visual and default mode 
networks” in rats which were immobilised 2 h per day on 10 consecutive days. On the 
other hand, Liang et al. (2014) did not find a significant difference in the time spent 
on open arms of an elevated plus maze, a measure for anxiety, between animals 
acclimated with their protocol and control animals. However, behaviour in the 
elevated plus maze was assessed 12 days after the last acclimation session (Liang 
et al., 2014). While the described acclimation protocols may improve image quality by 
reducing motion artefacts, cardiovascular arousal and eventually stress during 
imaging, repeated stress during acclimation is a potential confounder.  
As any awake imaging which uses anaesthesia to position the animals in the scanner 
faces the risk of carry-over effects from anaesthesia on fMRI results, two studies 
acclimated animals to restraint without using anaesthesia. One study simply omitted 
anaesthesia and restrained awake mice for 2 h per day on 8 consecutive days in a 
mock scanner. Heart rate significantly decreased from day 7 of training on and the 
weight of faecal pellets was not significantly higher than in the control group from day 
6 on. Notably, muscle activity was already on day two significantly lower than on day 
1, suggesting that decreased struggling indicates learning effects rather than a 
reduction in perceived stress. Stress was not as severe that animals stopped gaining 
weight during the acclimation period. In the second study (Chang et al., 2016), rats 
were stepwise (30 min per day, 8 to 10 days within a 14-day period) trained to enter a 
snuggle sack and stay in there, to tolerate fixation by headposts (set-up so that they 
could initially free themselves), to tolerate receiving air puffs and to MRI noise. There 
was no significant difference between the awake and anaesthetised scan in 
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respiratory rate, and respiratory rate in the awake condition was with 74 +/- 6 breaths 
per minute lower than in a range of other awake imaging studies (King et al., 2005). 
Corticosterone levels did not significantly differ during training from baseline, which 
indicates that the animals were not chronically stressed by the training phase. 
However, despite training, corticosterone levels were significantly higher immediately 
after awake imaging than at baseline or during training, indicating that acclimation 
could not completely eliminate the stress of the actual imaging session. 
Despite at first view promising levels of responses and fc, common awake imaging 
protocols risk to yield unspecific results and pose constraint on the animals. In order 
to enhance translation of findings in animal studies to humans, animals need to be 
specifically trained to voluntarily undergo awake imaging. 
 
4.2.2 Dose effects  
 
An effect of anaesthetic doses on fMRI results was commonly observed, but not for 
all anaesthetics at the same frequency and reported effects were not necessarily 
monotonic. 
While dose-dependence was clearly observed for isoflurane, it was less pronounced 
for medetomidine (see figures 13 and 14).  Dose-dependent rsfMRI results were 
observed under propofol, but responses to stimulation were not dose-dependent in a 
single study in mice. For halothane, urethane and S-ketamine, only single reports 
were found.  
Among isoflurane studies, the investigated concentrations ranged from 0.5 to 3.0%, 
corresponding to 0.35 to 2.1 x MAC (Flecknell, 2015). rsfMRI studies in rats under 
isoflurane indicate monotonic decrease of fc strength between multiple “units” with 
increasing isoflurane concentrations and non-monotonic dose-dependence of 
interhemispheric fc strength, spatial extent of fc and signal fluctuations. The trends 
for interhemispheric fc strength and spatial extent of connectivities would be 
compatible with an inversed U-shape, whereas an overall decreasing trend with a 
local minimum close to MAC was observed for signal fluctuations. Comparison with 
findings in mice is not possible, as the only dataset available did not report the 
direction of differences in signal fluctuations between isoflurane levels. Regarding 
baseline BOLD signal, studies in rats consistently report an increase in baseline 
BOLD signal when isoflurane concentration is increased from 1.5 to 2.5% 
(Tsurugizawa et al., 2016; Abe et al., 2017), but disagree whether the trend 
continues in higher ranges (1.8 to 3.5%,  (Gong et al., 2014) or is reversed 
(Tsurugizawa et al., 2016). The amplitude of responses to electrical peripheral 
stimulation decreased in both species when the concentration of isoflurane was 
increased from 1 to 3% (Nasrallah et al., 2014a) and from 1.0 to 1.5% (Schroeter et 
al., 2014). 
For medetomidine, data about rsfMRI and electrical paw stimulation in rats originated 
from the same three studies investigating both modalities. While a limited dose-
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dependent effect on response to stimulation was observed only after more than 2 h 
of CRI, interhemispheric fc strength of S1 was consistently reduced with higher 
infusion rates within the first 2 h and correlation coefficients between multiple ROI 
showed dose-dependent development over time thereafter. In mice a similar trend for 
clearer dose-dependence of rsfMRI than responses to stimulation was found. While 
two studies consistently report reduced interhemispheric fc between sensory, striatal 
and thalamic seeds with higher infusion rates, conflicting results were reported as to 
whether amplitudes of signal change are higher under lower infusion rates (one study 
per position). rsfMRI studies in mice did however not agree on the specific infusion 
rates for which a difference can be observed. 
Generally, no significant changes in amplitudes of signal fluctuation were reported in 
rats, but significant reductions were observed in specific frequency bands in specific 
areas. Interestingly, in CPu neither interhemispheric fc nor amplitudes of signal 
fluctuation were significantly reduced with higher infusion rates. In mice one study 
found preserved interhemispheric fc of the CPu under an even higher infusion rate 
(1.0 mg/kg/h ip) than in rats (0.1-0.3 mg/kg/h ip or iv). As the CPu has a lower α2-
receptor density than the cortex (Unnerstall et al., 1984), it is not surprising that 
sensitivity of that area to medetomidine doses is less pronounced than in other areas. 
 
Dose-dependence of the BOLD signal arises from the interaction of dose-dependent 
agent-specific neural and cardiovascular effects.  
Generally, neural activity is reduced with deeper levels of anaesthesia, as evident in 
EEG and local electrophysiological recordings (Alkire et al., 2008). Under isoflurane 
EEG shows a burst suppression pattern around 1.8-2% isoflurane (Masamoto et al., 
2009; Liu et al., 2011; Nasrallah et al., 2014a), and an almost flat line with minimal 
EEG power across all frequencies at 3% (Nasrallah et al., 2014a), indicating a global 
suppression of neural activity. Somatosensory evoked potentials are markedly 
decreased when isoflurane concentrations are increased and almost absent at 3% 
isoflurane (Nasrallah et al., 2014a) and evoked field potentials responses to block 
stimulation decrease with increasing isoflurane concentrations (Masamoto et al., 
2009). The picture is somewhat more complex for (dex)medetomidine: generally, 
(dex)medetomidine induces a NREM sleep-like pattern in EEG (Huupponen et al., 
2008) and frequencies decrease while amplitudes increase with higher medetomidine 
plasma concentrations (Bol et al., 1999). Square root power of low frequencies in 
EEG relative to dexmedetomidine plasma concentrations follows a sigmoid curve 
(Bol et al., 1997; Bol et al., 1999; Bol et al., 2000), meaning that a plateau of EEG 
effects is reached above a plasma concentration of approximately 4 ng/ml. As a 10 
min infusion of dexmedetomidine at the rate of 180 ug/kg/h – without preceding 
bolus, as typically used in imaging studies – resulted in peak plasma levels of 16.7 
+/- 1.3 ng/ml (Bol et al., 1997), the lower doses of 0.1 to 0.3 mg/kg/h medetomidine in 
Nasrallah et al. (2014a) may have reached the according plasma concentrations for 
medetomidine, explaining why no significant difference in EEG power was detected. 
Together with the observation that somatosensory evoked potentials did not 
significantly differ between 0.1 and 0.3 mg/kg/h infusion rates, and the observation 
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that above a certain threshold dose only the duration of sedation, but not the intensity 
increases with higher bolus doses in rats (Doze et al., 1989) and dogs (Vainio et al., 
1989), it appears possible that a plateau of neural depression is reached with 
commonly used doses. However, both clinically appreciable sedation scores and 
power of the EEG provide rather undifferentiated assessments of neural activity. For 
example, while there was no difference in EEG total power, Nasrallah et al. (2014a) 
found a significant reduction of interhemispheric coherence of the EEG in the γ-band 
under higher infusion rates corresponding to reduced interhemispheric connectivity. 
Conceptually, anaesthesia-induced neural depression is more than the “sum of 
individual neurons’ reduced activity”. While the few-lead EEG measurements used in 
the cited studies may detect a reduction in information, the integration of this 
information cannot be assessed (Alkire et al., 2008). 
Nevertheless, for most anaesthetics, the neural activity triggering changes in BOLD 
signal intensity should be reduced with higher doses of the anaesthetic. 
As the BOLD signal is an indirect measure of neural activity, dose-dependent 
cardiovascular effects interact with dose-dependent neural effects. 
Isoflurane causes dose-dependent vasodilation, thereby increasing CBF, and dose-
dependent MAP reductions (Lenz et al., 1998; Ohata et al., 1999; Constantinides et 
al., 2011). The increase of baseline BOLD signal intensity with higher concentrations 
can be explained by the combination of increased CBF and reduced O2 consumption 
due to depression of neural metabolism, resulting in a lower O2 extraction when 
higher doses of isoflurane are used (Ohata et al., 1999; Gong et al., 2014). Dose-
dependent cerebral vasodilation may further contribute to the reduced BOLD 
responses to stimulation (Ohata et al., 1999): Maximal dilation of vessels in response 
to stimulation is limited when vessels are already dilated at baseline. Consequently, 
local increases in blood flow and thus increases in oxygenated haemoglobin are 
limited (Gao et al., 2017). Higher fc values and more extended fc maps at higher 
isoflurane concentrations could be explained by lower MAP at higher concentrations. 
Mice have significantly lower MAP at 2 than at 1% isoflurane (Constantinides et al., 
2011) and a decrease of MAP from 110 +/- 10 to 68 +/- 7 mmHg was shown to 
increase CBF fluctuations, which enhanced spontaneous BOLD signal fluctuations 
(Kannurpatti et al., 2008), thereby increasing the likelihood that some fluctuations 
reach significance. The suspected inverse U-shape or at least non-monotonic trends 
observed for some rsfMRI outcomes could be explained by two mechanisms. First, 
the effect of increased CBF may be offset by reduced neural activity at some point. 
Second, very high isoflurane concentrations may reduce MAP below autoregulatory 
limits, so that despite cerebral vasodilation CBF cannot be maintained.  
In contrast to isoflurane, (dex)medetomidine is a vasoconstrictor (Ganjoo et al., 1998) 
and its effect on cerebral vasculature is not dose dependent (Ohata et al., 1999). 
That responses to stimulation showed in most studies no dose-dependence is not 
surprising when neither neural responses to stimulation nor cerebral vessel diameter 
are dose-dependent. Evoked responses in primary sensory cortices are furthermore 
in general relatively insensitive to anaesthetic depth (Alkire et al., 2008). There is 
evidence from electrophysiological recordings as well as from rsfMRI that association 
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networks are more sensitive to anaesthetic depth than sensory networks (Sellers et 
al., 2013; Liang et al., 2015a). Indeed, rsfMRI results were also under 
(dex)medetomidine in most of studies at least partially dose dependent. If cerebral 
haemodynamics are less affected by different doses of (dex)medetomidine than by 
different concentrations of isoflurane, those partial dose-dependences in rsfMRI may 
reflect altered neural activity. That the two rsfMRI studies in mice did not agree on the 
specific infusion rates for which a difference can be observed, can be explained by 
several factors. First, Nasrallah et al. (2014c) administered the same initial bolus of 
0.3 mg/kg to all groups before continuing with 0.1, 0.6 or 1.0 mg/kg/h infusion rates, 
whereas Grandjean et al. (2014) gave double the initial bolus in the higher infusion 
rate group (0.1 mg/kg followed by 0.2 mg/kg/h versus 0.05 mg/kg followed by 0.1 
mg/kg/h). A single sc bolus in rats had an elimination half-life time of 1.6 h and peak 
concentration in the brain was reached after 15 to 20 min (Salonen, 1989). After iv 
administration an average plasma/effect-site equilibration half-life of 8.6 min is 
reported for dexmedetomidine (as assessed by EEG in Bol et al. (1997)). 
Consequently, a single bolus, even if administered ip or iv, should still have an effect 
at 30 min post bolus, when the first measurements were acquired in both studies 
(Grandjean et al., 2014). Additionally, isoflurane was discontinued in Nasrallah et al. 
(2014c) only 15 min before the first scan, so there may have been a residual effect, 
and the CRI was started only 15 min before the first scan, a time span after which 
steady state plasma levels are not yet established. The cumulative dose of 
medetomidine in Nasrallah et al. (2014c) was thus 0.325 mg/kg in the low rate group 
and 0.45 mg/kg in the intermediate rate group. The relative difference between 
groups was accordingly larger at the later timepoint (120 min), where bolus effects 
should have vanished and differences been dominated by the infusion rate. Second, 
methods of analysis and outcome measures differed between the two studies 
(Nasrallah et al. (2014c) seed based, Grandjean et al. (2014) ICA based). 
 
4.2.3 Time effects  
 
While dose matters, time matters too. In rats and mice, responses to stimulation were 
reduced after a bolus of (dex)medetomidine (Brynildsen et al., 2017) or α-chloralose 
(Austin et al., 2005), or abolished for 60 to 80 min (Weber et al., 2006; Nasrallah et 
al., 2014c; Gsell et al., n.d.). Likewise, fc strength increased or connectivities became 
spatially more extended over time after administration of a bolus of dexmedetomidine 
or α-chloralose in rats (Bettinardi et al., 2015; Paasonen et al., 2016a; Brynildsen et 
al., 2017). In mice, results were less consistent for time-dependent effects of 
(dex)medetomidine CRI, alone or on top of isoflurane. While in some aspects of fc an 
increase was observed, others were unchanged or specific connections weakened 
(Grandjean et al., 2017). Changes of fc over time can occur in both directions 
concurrently, as observed for a subanaesthetic dose of ketamine on top of isoflurane 
(Gass et al., 2014). Finally, complex patterns of changes and interactions with doses 
were observed for prolonged medetomidine infusions (Pawela et al., 2009). 
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When it comes to time dependence of fMRI results, two key factors must be 
considered: first, reaching constant concentrations at the effect site, i.e. in the brain, 
is not trivial with injectable anaesthetic agents. Second, even if a constant exposure 
is maintained, anaesthesia targets a dynamic system: neurons and networks can 
adapt over time so that a constant exposure will not necessarily result in constant 
effects. Moreover, changes in the system’s state can outlast the duration of 
exposure.  
After a single bolus, plasma concentrations as well as concentrations at the effect 
site (i.e. in the brain) typically reach a peak before declining again. Accordingly, 
anaesthesia is deepest some time after the bolus – depending on route of 
administration, distribution etc of the agent – and wears off thereafter (Grimm, 2015). 
Transient abolishment or reduction of responses to stimulation after a bolus may thus 
mirror the time-course of concentrations at effect site. To prolong the duration of 
appropriate depth of anaesthesia for imaging, many studies start CRIs after the initial 
bolus (e.g. when using (dex)medetomidine, propofol or sometimes α-chloralose) or 
repeat boli at a certain interval (especially with α-chloralose). With repeated bolus 
administration, concentrations will rather fluctuate within a certain range than being 
constant (Flecknell, 2015). But constant rates of administration don’t guarantee 
constant concentrations of the anaesthetic in the brain either, because 
pharmacokinetics of many agents are best described by a multi-compartment model 
(Flecknell, 2015). 
For medetomidine, peak plasma concentrations are reached 10 min after sc 
administration of a bolus of 80 ug/kg in rats. Maximal concentrations in the brain are 
five times higher than in plasma and reach the peak 15-20 min after bolus (Salonen, 
1989). Elimination half-life time is 1.6 h after sc administration and the elimination 
rate in the brain is similar to plasma, just somewhat delayed (Salonen, 1989). Short iv 
infusions of a constant rate (10 min) or stepped rates (50 min, 10 min per step) of 
dexmedetomidine result in mean plasma/effect site equilibration time of 8.6 min (Bol 
et al., 1997). Measurements of plasma concentrations during a prolonged CRI in rats 
are however not available. In ponies and dogs, constant plasma levels and constant 
levels of sedation are reached with CRIs after an initial bolus (Bettschart-
Wolfensberger et al., 1999; Lamont et al., 2012).  
Although α-chloralose has been used for decades in laboratory animal anaesthesia, 
details on its pharmacokinetics in rodents are not available. In the literature, α-
chloralose is commonly reported to produce light anaesthesia for 8-10 h (Flecknell, 
2015). Most studies included in this review either re-dosed animals after a certain 
time or used a CRI. Doses and intervals were however highly variable and there 
appeared to be no association with the route of administration (ip or iv): initial doses 
ranged from 25 to 120 mg/kg (one study each, 40-80 mg/kg in rest of studies), top-up 
doses from 20 to 40 mg/kg, intervals from 30 to 120 min (most studies 45 or 60 min) 
and infusion rates from 10 to 50 mg/kg/h. Plasma concentrations over time were not 
investigated in those studies, and are to the best of our knowledge not published for 
any of those protocols.  
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As discussed for dose-dependence of the results, variations in plasma concentration 
over time will affect both the neural (via concentrations in the brain) and 
cardiovascular basis of the BOLD signal. 
In contrast to injection anaesthesia, concentrations at the effect site can be kept 
within a narrow range when using modern inhalant anaesthetics like isoflurane or 
sevoflurane which are almost not metabolised (0.17% of isoflurane (Eger, 1984) and 
1-5% of sevoflurane (Patel and Goa, 1996)). Once an equilibrium between partial 
pressure of the inhalant anaesthetic in the alveolus and the blood and the brain has 
been established, partial pressure in the brain follows alveolar partial pressure. In 
intubated animals, measurement of end-tidal inhalant concentrations allows non-
invasive, constant breath by breath real-time monitoring of alveolar concentrations of 
the inhalant. In the non-rebreathing systems which are typically used for rodents, 
where the inhalant is delivered with a high fresh gas flow, any change in vaporizer 
setting will rapidly change partial pressure of the inhalant agent and establish a new 
equilibrium (Grimm, 2015). Hence, inhalants have the double advantage that 
constant exposure is easy to provide and easy to monitor.  
To achieve constant levels of anaesthesia, constant concentrations of the agent at 
the effect site are however not enough. Tolerance to certain drugs develops with 
repeated or prolonged exposure, either by enhanced drug metabolism and/or 
distribution, or by reduced neuronal sensitivity (Tripathi, 2013). With repeated 
ketamine administration for example, hepatic enzymes are induced and sleeping 
times decrease in rats (Livingston and Waterman, 1978; Albrecht et al., 2014). 
Propofol on the other hand showed signs of pharmacodynamic tolerance in EEG 
measurements in rats within 90 min of infusion (Ihmsen et al., 2005). Tolerance was 
not studied in any of the included references investigating ketamine or propofol, but 
Pawela et al. (2008) found that rats under a constant rate of medetomidine infusion 
woke up after 3.5 to 4 h, independent of the rate (0.1 or 0.3 mg/kg/h iv). Increasing 
the rate of infusion 2.5 h after bolus increased the duration of sedation to 6 h (Pawela 
et al., 2008), which the authors interpreted as a strong indicator for the development 
of tolerance. Unfortunately, plasma concentrations were not measured in that study, 
so that differentiation between pharmacokinetic and -dynamic mechanisms was not 
possible.  
In conclusion, optimal timeframes for image acquisition under (dex)medetomidine or 
any other injectable anaesthesia protocol have to be determined based on 
pharmacokinetic and -dynamic data for the respective agents in the target species, to 
ensure that anaesthesia approaches a steady state during the whole imaging period. 
As tolerance does not occur with inhalants (Stratmann et al., 2009), steady state 
anaesthesia is readily achieved with isoflurane or sevoflurane anaesthesia. However, 
as the brain is a dynamic system, even if a constant level of anaesthesia is provided, 
this disturbance of the system may induce changes in the system which outlast the 
duration of exposure. One study reports that the duration of previous isoflurane 
exposure affected rsfMRI outcomes in rats under identical dexmedetomidine CRIs 
beyond the washout period of isoflurane (Magnuson et al., 2014). As many studies 
use isoflurane for induction and preparation before switching to (dex)medetomidine 
or other injectable anaesthesia protocols, exposure to isoflurane prior to imaging has 
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to be standardised in all animals and reported to allow comparison of results from 
different studies. Further research is needed to confirm and characterise the impact 
of duration of exposure on subsequent measurements. Beyond those practical 
implications, the findings of Magnuson et al. (2014) raise the possibility of time-
dependent effects during prolonged imaging despite (apparently) constant levels of 
anaesthesia. 
 
4.2.4 Comparisons between specific anaesthetics  
 
Historically, α-chloralose was a standard anaesthetic in neuroscience because it 
preserves functional-metabolic coupling (Ueki et al., 1992), and it was commonly 
used in the first 15 years of BOLD fMRI. As rsfMRI of rodents became popular only in 
the mid-2000s, α-chloralose is in this review overrepresented in stimulation studies. 
When comparing across all stimulation paradigms for rats, there was a trend for 
higher signal changes and/or area of activation, including activations outside the 
primarily targeted region, under α-chloralose than isoflurane. Optimal frequencies for 
electrical paw stimulation appeared to differ between α-chloralose and medetomidine 
or urethane and potentially pentobarbital. Responses to stimulation were more 
localised and specific under α-chloralose than under halothane, but only for the first 
1-2 h after bolus, which highlights the impact of doses and timepoints on the 
performance of one anaesthetic relative to another. Only one study investigated α-
chloralose in mice and found that cortical interhemispheric connectivity was lower 
under α-chloralose than isoflurane. Despite overall robust responses to stimulation, 
α-chloralose has been replaced over the past years due to its major disadvantages. 
First of all, due to long, excitatory recovery phases, its use should be limited to 
terminal studies (Flecknell, 2015), which precludes longitudinal fMRI studies. 
Additionally, ip administration causes local inflammation and, in some species, 
adynamic ileus (Silverman and Muir III, 1993). Although de Celis Alonso et al. (2011) 
claim that α-chloralose can be used for longitudinal studies when administered iv, this 
practice has to be questioned: 2 out of 18 animals died after an α-chloralose 
anaesthesia, recovery times were around 2-3 h, and in contrast to isoflurane 
anaesthesia, tail flick responses were still delayed and rotarod performances reduced 
24 h after α-chloralose anaesthesia and food intake did not normalise within 48 h, 
indicating an overall considerable burden for the animals. But even if α-chloralose is 
to be used for terminal studies, the following disadvantages should be considered: 
Due to slow onset of action (15 min after iv administration) and excitatory induction 
phases, α-chloralose is generally not considered a suitable anaesthesia induction 
agent (Flecknell, 2015; Zahner and Arras, 2016). Consequently, anaesthesia has to 
be induced with another agent, which introduces the risk of carry-over effects. 
Pharmacokinetics of α-chloralose are not well known and doses/protocols vary widely 
between groups. Furthermore, as α-chloralose is not registered as a medical product, 
it has to be prepared in the laboratory (based on pure α-chloralose or sometimes 
extracted from chloralose-based rodenticides), so that the quality of the end product 
is often unknown (Zahner and Arras, 2016). 
92 
 
Common alternatives to α-chloralose are isoflurane and medetomidine. Both yielded 
satisfactory results in stimulation studies. They have – in rats – however not been 
directly compared with each other for peripheral stimulation studies. Responses to 
deep brain stimulation were in a single report more reproducible in their signal 
amplitude, area of activation and localization of activations under dexmedetomidine 
than under isoflurane. In phMRI, results for the comparison of isoflurane and 
medetomidine were inconsistent, however this is to be expected because 
interference of anaesthesia with phMRI responses will inevitably depend on the 
tested substance. 
In mice, BOLD fMRI was established later than in rats and accordingly, studies used 
from the beginning on more often isoflurane and medetomidine (than “early” rat 
stimulation studies). Stimulation studies in mice face the major problem of bilateral 
activations despite unilateral somatosensory stimulation, which is contrary to what is 
expected based on electrophysiological studies and fMRI studies in other species, 
and therefore generally interpreted as artefacts from (cardiovascular) arousal. 
Bilateral activations were observed under isoflurane, urethane and propofol. Under 
medetomidine, responses were unilateral in one study but bilateral in another. A 
recent publication obtained unilateral responses with a ketamine/xylazine protocol 
(Shim et al., 2018). As animals were markedly bradycardic throughout the study, 
findings could be explained by a suppressed cardiovascular response to stimulation. 
Indeed, heart rate did not increase upon stimulation, whereas Schroeter et al. (2014) 
found an increase in heart rate in animals under medetomidine. On the other hand, 
electrical stimulation is unpleasant even when not painful. Both ketamine and 
xylazine have strong analgesic properties and could thus reduce the response to 
such an unpleasant stimulus. Further studies are needed to confirm the results and 
eventually establish optimal doses and time points for imaging. As 
ketamine/dexmedetomidine is locally less irritating at ip administration than 
ketamine/xylazine, but causes more pronounced cardiorespiratory depression at 
comparable levels of anaesthesia (Wellington et al., 2013), the optimal α2-agonist to 
combine ketamine with may also be discussed. 
Interestingly, adding a dexmedetomidine-CRI (of 0.3 mg/kg/h) to isoflurane close to 
MAC (1.3%) increased the activated area as well as the signal amplitude relative to 
the baseline under isoflurane in rats (Nasrallah et al., 2014b). This combination was 
not tested in any of the included studies for stimulation in mice.  
For resting state however, the combination of a low dose of isoflurane and 
medetomidine appeared to combine the strengths of both agents in mice. While 
isoflurane was associated with stronger cortical and medetomidine with stronger 
subcortical fc, the combination resulted in strong cortical and subcortical fc. This 
observation deviates from the reduced interhemispheric S1FL and thalamic fc after 
addition of a dexmedetomidine CRI to isoflurane reported in a study in rats. As the 
latter study combined doses used for imaging under monoanaesthesia with isoflurane 
or dexmedetomidine, the deeper level of anaesthesia may partially account for the 
decrease in fc. When isoflurane and (dex)medetomidine were compared in rats, 
correlation coefficients between ROIs as well as in seed maps were higher under 
isoflurane, but also less localised, and one study noted that segregation patterns in 
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ICA were more reproducible under medetomidine, leading to the general pattern of 
more specific, but weaker fc under medetomidine, which may have contributed as 
well to the reduced fc when dexmedetomidine was added to isoflurane.  
Interestingly, studies in mice, all by the same group, found both in stimulation and 
resting state experiments similarities between urethane and medetomidine. Fewer 
and smaller activated clusters were detected under urethane and medetomidine than 
under isoflurane. ReHo, a measure of local connectivity, was under both agents 
relatively high. Cortical interhemispheric connectivity under urethane appeared to be 
higher than under medetomidine, but lower than under isoflurane. In rats, responses 
to phMRI were (at least in cortical regions) of higher magnitude than under isoflurane 
or medetomidine, but exclusively negative in one study. Regardless of its profile 
compared to other anaesthetics, urethane however appears to be an unfavourable 
candidate for fMRI studies due to its cycling behaviour. Additionally, it can only be 
used for terminal studies, and is carcinogenic and therefore an occupational safety 
risk for the handler.   
Now that changes in physiological parameters can affect the BOLD signal as well as 
differences in anaesthetic protocols can, how can we know whether the differences 
between anaesthetic protocols, doses and timepoints of measurements were truly 
due to the anaesthetic factor and not biased by physiological parameter effects? The 
answer is that we can’t. Indeed, in some references we noticed deviations in 
physiological parameters from normal range or differences in physiological 
parameters between two sets of measurements. However, our approach was not to 
dissect individual studies for suspected confounders, but to see whether, despite the 
heterogeneity of studies, effects of doses, timepoints of imaging or using a specific 
agent instead of another were detectable – with the reasoning that if there were 
effects detectable across a wide variety of experimental conditions and sources of 
bias, there likely is some true effect behind the reported findings, justifying careful 
further investigation. 
 
4.3 Limitations  
 
This systematic review was limited by the fact that only in a quarter of the included 
references data was extracted in duplicate. Despite good agreement in those 
references, some mistakes or misinterpretations made during data extraction may 
have gone undetected in the rest of the references, which could have been avoided 
by consequent double extraction. An even more important limitation is however that 
only one reviewer was available for study selection. Subjectively unclear references 
were discussed with a supervisor and all borderline cases documented, but this 
approach does not provide the same degree of objectivity as study selection by two 
independent reviewers. Additionally, in- and exclusion criteria had to be further 
specified during study selection because the initial version did not cover all the 
situations encountered. Especially for clarification of the exact inclusion and 
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exclusion criteria, discussion with a second reviewer would have supported 
objectivity and consistency of classifications. 
On the side of included references, a major limitation of this review is that all included 
publications scored as having a high risk of bias. Accordingly, the strength of 
evidence is limited for any of the reported findings. The primary reason why studies 
were classified as having a high risk of bias was lack of blinding during the 
experiment and/or for data analysis. Lack of blinding during the experiment is 
common in basic research (van der Worp et al., 2005; Hooijmans et al., 2014; 
Macleod et al., 2015; Vogt et al., 2016). Often the same person is responsible for 
planning and performing the experiment and later analysing data. But even if it is not 
feasible for the responsible investigator to be blinded during the experiment due to 
lack of personnel or resources, fMRI data could be analysed in a randomised, blinded 
way (Hooijmans et al., 2014). Not a single publication mentioned randomised, blinded 
data analysis. Many stated instead that the pipeline of analysis was “fixed” or 
required minimal input from the operator and was thus free from bias. While (semi-) 
automated analysis may reduce bias to a certain degree, the pipeline of analysis is – 
based on personal experience – usually not completely pre-set but optimised once 
data is available. This fine-tuning leaves some room for bias. Apart from blinding, in a 
substantial percentage of publications concerns associated with study design were 
present, such as fixed order of conditions, inadequate crossover, differences in fluid 
administration between experimental groups (i.e. pooling of drugs) or insufficient 
detail of reporting of relevant aspects of study design. Reporting of measures against 
internal bias was – in line with published findings (Macleod et al., 2015) – generally 
low: aspects of sequence generation, allocation concealment and whether the 
animals underwent the experiment in a randomised order were rarely reported. 
Risk of bias being high in all studies means that strength of evidence is overall weak, 
and it is possible that future research will complement or correct our current 
understanding of how physiological parameters and states of anaesthesia influence 
BOLD fMRI in rodents (Higgins et al., 2011; de Vries et al., 2015). A uniform level of 
risk of bias means further that consistency of findings for a certain comparison or 
factor is the only means to grade the strength of evidence between findings within 
this review. In the original systematic review protocol, we had planned to use the four 
criteria of risk of bias across included studies and consistency, directness and 
precision of findings to grade the strength of evidence (Owens et al., 2009; Berkman 
et al., 2015). This set of criteria was then reduced to risk of bias across studies and 
consistency of findings, because it became clear upon re-consideration that only 
studies providing direct evidence for effects of physiological parameters or states of 
anaesthesia would be included and that the precision of findings could hardly be 
assessed. 
Besides concerns about general methodologic quality of the included studies, 
examples for potentially confounding factors addressed by this review were observed 
in some of the included studies. For example, Brynildsen et al. (2017) investigated 
evolution of responses to paw stimulation and fc over time after initiation of a 
dexmedetomidine CRI, but over the observation period respiratory rates increased in 
all animals and paCO2 decreased on average from 62 to 50 mmHg in a bench-top 
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group. On the other hand, Nasrallah et al. (2015) compared responses to paw 
stimulation and fc under different inspiratory gas compositions, including several 
concentrations of CO2, to a “normal” condition in which animals were ventilated to a 
paCO2 of 27 mmHg, which is clearly below reference ranges (Brun-Pascaud et al., 
1982). 
In general, the included studies exhibited considerable heterogeneity regarding study 
design, experimental procedures (e.g. whether surgery was performed prior to 
imaging, whether anaesthesia was induced with another agent than maintained, 
respiratory management and (baseline) inspiratory gas compositions), magnetic field 
strength, and subjectively also in applied MRI sequences and data analysis, although 
those two aspects were not considered in data extraction. Although search filters 
were set for publication year 1990 or later, only few publications from the 1990s were 
included. As no limitations were defined for the outcome measures except that it had 
to be directly derived from the BOLD signal, a vast variety of outcome measures was 
encountered in the included studies. The original idea of differentiating between 
qualitative and quantitative outcomes was abandoned because it proved difficult to 
draw a clear line in individual cases: should a verbal description of extent of 
activation for example be considered as qualitative or quantitative measure? 
The diversity of fMRI paradigms and primary outcome measures together with the 
diversity of anaesthetics combined for comparison, of doses of each anaesthetic and 
timeframes investigated, resulted in generally few reports per comparison and many 
unique reports. On one hand, this diversity narrowed the number of comparisons for 
which enough data was found to arrive at a conclusive summary. On the other hand, 
if despite all heterogeneity between studies an effect was consistently reported, it 
increases the likelihood that the reported observations are actually due to a real 
effect and not just the result of a biased study. It further means that an effect is 
relatively robust across conditions, which increases the external validity of that given 
effect. 
 
 
4.4 Practical implications  
 
Despite the discussed limitations, the available data indicate that BOLD fMRI 
measurements risk to be confounded by unstable physiology or unstable effective 
anaesthetic concentrations. Accordingly, results cannot be reliably compared 
between studies when different drugs, doses or time points of image acquisition are 
used and when paO2, paCO2 and MAP are not monitored and accounted for.  
In the following section, practical implications of our findings are discussed together 
with general aspects of good anaesthetic practice.  
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4.4.1 Monitoring  
 
Based on the findings of this review, fMRI studies should monitor oxygenation, 
ventilation and cardiovascular parameters. As part of good anaesthetic practice, 
reflexes and body temperature should also be monitored. 
4.4.1.1 Ventilation and oxygenation  
There are different options to monitor ventilation and oxygenation. Respiratory rate is 
commonly measured with MRI-compatible sensors. For anaesthetic safety, 
respiratory rate is an important parameter to monitor, because apnoea or severe 
respiratory depression can be fatal. In spontaneously breathing animals, respiratory 
rate additionally helps to estimate anaesthetic depth, with higher than expected rates 
typically indicating superficial levels of anaesthesia and lower than expected rates 
indicating (too) deep levels of anaesthesia, although other reasons for changes in 
both directions are possible and values as well as changes of respiratory rate need to 
be interpreted in context (a complete guide on how to interpret each physiological 
parameter in relation to all others is beyond the scope of this review). Although 
providing useful information, monitoring of respiratory rate alone is however 
insufficient if abnormal ventilation and oxygenation are to be excluded.  
The most accurate way to assess ventilation and oxygenation is direct measurement 
of paCO2 and paO2 in arterial blood. However, this is invasive and the number of 
samples which can be taken before blood loss becomes substantial is limited. 
Substantial blood loss not only imposes physiological stress on the animal, but 
potentially affects the BOLD signal by inducing hypotension or by the resulting 
haemodilution when the withdrawn volume is replaced. An additional limitation of 
arterial blood sampling is that measurements are inherently intermittent. Depending 
on the duration of the experiment, the feasible number of samplings may not provide 
a sufficient temporal resolution. Approximately 0.1 ml of blood are required per 
analysis (Institute for Physiology, 2016) and maximally 10% of total blood volume 
should be sampled, which corresponds to 2.56 ml and 0.14 ml in a rat of 400 g and a 
mouse of 25 g (NC3Rs, 2019a,b). In mice, multiple samplings are therefore basically 
excluded. 
Oxygenation can alternatively be monitored by pulse oximetry. Pulse oximetry is 
continuous, non-invasive, easy to use, and MRI-compatible devices are available. It 
provides real-time non-invasive monitoring of arterial haemoglobin O2 saturation and 
has the additional advantage that heart rate is displayed along with SpO2. Pulse 
oximetry is a powerful tool to ensure that animals are not hypoxaemic. Due to the 
sigmoid relation between paO2 and SpO2, it is however not able to differentiate 
between normal paO2 observed at room air (around 100 mmHg) and increased paO2 
under hyperoxic conditions (up to 500 mmHg) (Duke-Novakovski et al., 2016). 
Grading of moderate levels of hypoxaemia (paO2 60-90 mmHg) by pulse oximetry is 
also not very accurate, as those values correspond to SpO2 of approximately 88 to 
95% (Cartheuser, 1993). 
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As discussed earlier, optimal FiO2 for BOLD fMRI in anaesthetised animals is likely in 
the range of 0.25 to 0.40. The inspired oxygen concentration provided should be 
continuously measured with a relevant gas analyser, that is calibrated at regular, by 
manufacturers predetermined, intervals.  
Measurement of end-tidal CO2 by capnometry or -graphy can be used as an estimate 
for paCO2. It is important that capnographs designed for rodents are used (Beck et 
al., 2014). Due to small tidal volume of rodents, it is crucial that devices were 
calibrated against paCO2 as significant discrepancies can be found, documented for 
example in Nasrallah et al. (2015). To obtain accurate measures, animals need to be 
intubated. A theoretical alternative to capnometry is the use of transcutaneous pCO2 
measurement. Such a transcutaneous sensor to detect blood pCO2 was tested in one 
of the included studies (Ramos-Cabrer et al., 2005). Due to considerable inter-
individual differences in correlation with paCO2, dependence of measurements on 
skin perfusion, and the risk for skin lesions due to the high temperature of the sensor 
reported in that study, we currently discourage use of transcutaneous pCO2 sensors. 
Another theoretically possible approach to control paCO2 is to ventilate all animals 
with settings determined in pilot bench-top experiments. While this approach may on 
average keep paCO2 and paO2 within reasonable limits, it requires first that the ideal 
parameters are determined under identical conditions as in the experiment and 
second has the major limitation that eventual outliers are not detected when no 
additional monitoring is used. Notably when low animal numbers are used, individual 
outliers may have a relevant impact on the results if undetected (which is a general 
problem of measuring physiological parameters in a bench-top group only). 
Additionally, if the pre-set ventilatory parameters do not exactly match individual 
requirements, hyper- or hypoventilation can develop over time. While ventilating 
allows to control paCO2, adequate monitoring (i.e. blood gas analysis or 
capnography) must be used to confirm that CO2 levels are maintained within a target 
range. We discourage the use of artificial ventilation without monitoring of end-tidal 
CO2. 
A practical consideration with mechanical ventilation is that neuromuscular blocking 
agents are often required to prevent animals from “fighting” the ventilator (Ramos-
Cabrer et al. (2005). In a clinical setting the degree of neuromuscular blockade is 
monitored, for example by train of four electrical stimulation, to avoid residual 
paralysis when animals are recovered (Duke-Novakovski et al., 2016). This is 
however difficult in rodents due to their small size and unlikely to be routinely used in 
the laboratory setting, which means that animals are at increased risk for respiratory 
complications during recovery, due to residual neuromuscular block. 
 
4.4.1.2 Cardiovascular monitoring 
As shown by the effects of blood pressure changes on the BOLD signal, blood 
pressure needs to be measured in anaesthetised animals during fMRI. To date, blood 
pressure is typically measured invasively by catheterization of an artery which is in 
particular in mice technically demanding, time consuming and probably not 
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practicable if multiple scanning sessions are planned in one individual. MRI-
compatible non-invasive methods of blood pressure monitoring are available for 
rodents (e.g. systems from IITC Inc. Life Science), were however not used in any of 
the included studies. If measurements acquired with non-invasive devices proof to be 
accurate, the quality of anaesthetic monitoring could be improved without increasing 
invasiveness of an experiment.  
Although heart rate was not shown to directly correlate with BOLD signal, it should be 
monitored during fMRI, as changes in heart rate can indicate responses to 
stimulation, changes in anaesthetic depth or also changes in paCO2 and paO2. Heart 
rate, similar to respiratory rate, is a sensitive, but not specific parameter and 
therefore needs to be interpreted in the context of other physiological parameters, 
experimental stimulation and the anaesthetic protocol used. A convenient method to 
measure heart rate is by pulse oximetry. Alternatively, MRI-compatible ECG 
electrodes can be used (Choquet et al., 2011).  
Some pulse oximeters display a pulse curve. Schroeter et al. (2014) used changes in 
pulse distension, i.e. the waveform amplitude, as an indicator for changes of blood 
pressure. However, this specific measure was not validated and should be 
interpreted with caution. Generally, variation in the waveform amplitude measured by 
the pulse oximeter results from an interplay between vascular resistance and stroke 
volume (Cannesson et al., 2005). Assuming constant vascular resistance over a 
short period of time (in the range of a few seconds), relative changes in the waveform 
amplitude indicate a change in stroke volume. This may be sufficient to detect 
cardiovascular arousal as intended in that study. Inferences on – absolute or relative 
- arterial blood pressure changes are however not warranted (Dorlas and Nijboer, 
1985) and pulse oximetry can therefore not replace blood pressure monitoring.  
 
4.4.1.3 Additional considerations  
In terms of good anaesthetic practice, it is furthermore advisable to monitor depth of 
anaesthesia and temperature. 
Reflexes give a rough clinical estimate of the depth of anaesthesia. Before an animal 
is fixed on the animal holder, righting and limb- or tail-withdrawal reflex should be 
tested, especially if agents were administered ip, as this route is associated with high 
failure rates of around 20% (Miner et al., 1969; Zatroch et al., 2017) so that the same 
levels of anaesthesia will not be reached in all animals. The desired depth of 
anaesthesia may vary depending on the protocol used, but at least righting reflex 
should be lost under exposure to scanner noise. Clinical experience from cats and 
dogs suggests that levels close to surgical anaesthesia are required due to the 
intense stimulus of scanner noise. Reflexes should be checked again at the end of 
the scan to recognise changes in anaesthetic depth which may have occurred during 
image acquisition; especially if injection anaesthesia is used.  
Vanhoutte et al. (2006) showed that BOLD signal intensity decreases when animals 
are experimentally warmed over 38° C. This effect is relevant when stroke models 
are imaged, as spontaneous hyperthermia can occur in those animals (Zaremba, 
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2004). Body temperatures reported by included studies however typically ranged 
from 35.5 to 37.5° C, and no data was available on temperature-dependent effect on 
the BOLD signal in this range. As cerebral metabolism is reduced (Busto et al., 1987) 
and the O2-binding curve of haemoglobin shifted to the left (Armstrong et al., 2005) at 
lower body temperatures, higher blood oxygenation and accordingly BOLD signal 
intensity would be expected at lower body temperatures, but the true effects remain 
to be investigated. Regardless of effects on the BOLD signal, hypothermia has 
detrimental physiological effects as bradycardia and hypotension, prolongs recovery 
and reduces anaesthetic requirements (Armstrong et al., 2005). Rats and mice are 
prone to hypothermia under anaesthesia due to their small body size. To prevent 
complications, the decrease in body temperature should be minimised by warming 
the animal, for example with feed-back controlled MRI-compatible warming mats, and 
body temperature monitored (Flecknell, 2015).  
4.4.1.4 Summary  
Taken together, appropriate monitoring for a BOLD fMRI experiment is continuous, 
invasive and not simple. To control paCO2, probably the most important factor, either 
blood samples have to be drawn or the animals have to be intubated to allow 
accurate capnography. Mechanical ventilation is generally recommended to keep 
paCO2 constant. Mechanical ventilation of rodents via a nose-mask is described 
(Rindfield and McBrian, 2012). However, in 12% of cases the lung was not 
successfully ventilated with this option. If refinement of this method proves feasible in 
further studies and allows accurate monitoring of end-tidal CO2, mechanical 
ventilation via nose-mask could provide a less invasive and technically less 
demanding alternative to intubation. 
For blood pressure monitoring to be more accessible and generally applied, 
validation and/or development of accurate non-invasive blood pressure measurement 
devices for rodent MRI should be a priority. Reliable non-invasive blood pressure 
monitoring would allow BOLD fMRI studies to be non-invasive but at the same time 
sensitive enough to recognise any potentially relevant blood pressure changes during 
the experiment. 
 
4.4.2 Anaesthetic protocols  
 
When it comes to choosing an anaesthetic protocol for BOLD fMRI, not only the 
agents to be used, but also the doses, the timing and practical aspects must be 
considered.  
Generally, steady state anaesthesia is easier to reach and notably to maintain for 
prolonged periods with inhalants. The included studies investigated most commonly 
isoflurane and occasionally halothane. None of them investigated sevoflurane. As 
sevoflurane causes less increase of CBF than isoflurane and better maintains 
cerebral autoregulation (Hänel et al., 1996; Gupta et al., 1997; Lenz et al., 1998), it is 
the inhalant of choice for clinical procedures in neurological patients and would be 
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worth further investigation for rodent fMRI. For specific experimental paradigms, the 
benefits of total or partial injectable anaesthesia may however outweigh the 
advantage of steady state under inhalant anaesthesia.  For example, injectable 
anaesthesia protocols including α2-agonists may be preferable for sensory 
stimulation studies in mice. The fact that already sub-anaesthetic doses of ketamine 
produce distinct activations illustrates that agent-specific effects have to be expected 
and, when known, considered when designing the anaesthetic protocol for an fMRI 
experiment. In the special case of phMRI, it is crucial to avoid anaesthetic agents 
which might interact with the tested substances. Potential interactions have to be 
identified for each tested substance individually. 
Once the anaesthetic(s) for the experiment have been chosen, it must be decided 
whether the same agent(s) can be used for induction of anaesthesia and preparation. 
Generally, switching from one anaesthetic to another bears the risk of carry-over 
effects, especially when injectables are used, but also if appropriate wash-out periods 
are not awaited when switching from inhalant to injectable anaesthesia. Situations in 
which anaesthesia induction with a different agent than later used for the experiment 
is justified are when preparation of the animals includes surgery and the anaesthesia 
planned for imaging would be too superficial for surgery (e.g. a (dex)medetomidine 
CRI) or when the selected agent is not a suitable induction agent, (e.g. α-chloralose). 
Doses should be sufficient to provide a stable level of anaesthesia, but not higher to 
avoid excessive neural depression. If doses are too low, the animals are 
cardiovascularly less stable and more likely to be aroused by experimental 
stimulation or noise from the MRI sequence (Constantinides et al., 2011; Schroeter et 
al., 2014). Optimal doses should be determined under conditions which closely mimic 
the experimental conditions, including scanner noise. Uptake of injectable agent 
varies between routes of administration (sc, ip, iv) which may affect both the required 
doses and the half-life time. Importantly, not all routes of administration are suitable 
for all agents. While medetomidine can be administered sc, ip or iv, propofol for 
example has to be administered strictly iv (Becker et al., 2016). 
When animals of variable body weight are studied, individual dosing of injectable 
agents should be aimed for. For example, if a fixed total dose of anaesthetic is 
administered to rats of 300 g to 400 g bodyweight, a 25% difference in relative dose 
results.  
In order to keep doses as low as possible and therefore to reduce unwanted effects, 
anaesthetic agents can be combined. The concept of balanced anaesthesia, i.e. the 
combination of agents to use synergistic effects while minimising agent specific 
undesired effects, is well established in clinical anaesthesia (Tonner, 2005). A 
balanced anaesthesia protocol combining low doses of isoflurane and medetomidine 
was shown to preserve cortical as well as subcortical connectivities in mice, whereas 
monoanaesthesia with a higher dose of either agent favoured either cortical or 
subcortical connectivity (Grandjean et al., 2014). The same authors noted that 
differences in fc patterns between four different anaesthetic agents were less 
pronounced when a lower dose of each agent was used, which can be explained by 
weaker contribution of the respective agents to haemodynamic as well as neural 
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aspects of the BOLD signal. Balanced anaesthesia for BOLD fMRI may thus allow to 
obtain data which is more representative of normal brain function and therefore 
easier to translate to awake humans. A potential disadvantage of balanced 
anaesthesia is that the pharmacokinetics and -dynamics get more complex the more 
agents are involved. This should however rather en- than discourage thorough 
investigation of potential protocols. 
Whenever protocols are established or existing protocols optimised, a focus should 
be the time span during which anaesthesia reaches or at least approaches steady 
state. Only if anaesthesia is close to steady state throughout image acquisition, 
reliable data can be obtained. Additionally, if anaesthesia is induced with an inhalant 
agent and later switched to injectable agents, the duration of inhalant anaesthesia 
has to be standardised and measured.  
As a general rule, the time taken for each step of an experiment should be 
documented for each animal and standardised as much as possible. Articles should 
report timepoints of image acquisition relative to induction, eventual boli and start of 
CRIs. 
Finally, a few more factors need to be considered: 
If preparation of the animal includes any surgical steps, adequate analgesia should 
be provided to prevent measuring activations from nociception. For catheterisation of 
vessels, topical lidocaine appears a reasonable choice. For more invasive 
procedures such as craniotomies, additional analgesia will typically be required and 
the selection of agents depend on analgesia provided by the underlying anaesthetic 
protocol. 
Atropine or glycopyrrolate are best avoided in premedication when boli of α2-agonist 
are administered, because they suppress (protective) reflex-bradycardia in the first 
few minutes of vasoconstriction after a medetomidine bolus, which can be fatal 
(Savola, 1989). Furthermore, fading concentrations of those parasympatholytics 
counteract cardiovascular stability during imaging.  
It is important to ensure that animals from all experimental groups receive the same 
total amount of fluids, including the calculation of drugs and dilutions of such as well 
as catheter flush solutions. As α2-agonists cause pronounced diuresis (Roman et al., 
1979; Gellai and Edwards, 1988), expected fluid losses should be replaced. 
Last but not least, important strain and sex differences in responses to anaesthetics 
are reported in rats (Waterman and Livingston, 1978; Fink et al., 1982; Russell and 
Graybeal, 1995; Avsaroglu, 2008) as well as in mice (Hohlbaum et al., 2017; 
Schroeter et al., 2017). Researchers should therefore search for information on 
strain-specific sensitivity to anaesthetics when designing a protocol and eventually 
adjust doses.  
We suggest establishing a selection of standard protocols for the most commonly 
used agents to increase the comparability and reproducibility of studies. There will 
always be an effect of anaesthesia on the measurements, but awake imaging is not 
confounder free either: animals were stressed during actual imaging session even 
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after extensive training in snuggle bags (Chang et al., 2016). If performed properly, 
training animals to voluntarily enter snuggle bags and tolerate such a set-up for 
restraint may still be an alternative to anaesthetised imaging in rats, but we doubt that 
this time consuming technique is broadly applicable because it requires a level of 
skills and motivation which cannot be taken for granted in all laboratories. An 
additional limitation to awake imaging is that to our knowledge an equivalent 
technique has not been described in mice so far, which are generally considered to 
be more difficult to train. From an animal welfare point of view, imaging under 
anaesthesia is therefore preferable in most circumstances. Well-designed 
anaesthetic protocols, based on pilot studies under realistic conditions (e.g. with 
scanner noise), and careful monitoring are crucial to obtain interpretable, 
reproducible and comparable fMRI results. 
 
4.5 Systematic reviews in basic science  
 
In basic (life) science, systematic reviews are not common yet. A major challenge in 
the present review was the heterogeneity among the included studies – not only 
concerning details of the experimental set-up, but also in the primary research 
question addressed by those studies. In a relevant proportion of references, the 
primary aim of the study was not to investigate effects of physiological parameters or 
anaesthetic protocols. Those effects were either included as a secondary aim (to 
demonstrate that an effect is reproducible in different conditions) or used to 
investigate specific aspects of the BOLD signal.  
This heterogeneity among studies partially results from the broadness of our 
research question, asking for the feasibility of a method in general rather than for the 
safety or efficacy of a specific intervention as in prototypic pre-clinical systematic 
reviews. Despite the broadness of the question, we considered this a systematic and 
not a scoping review, because we aimed to provide implications for practice (Munn et 
al., 2018). Additionally, we speculate that the diversity of questions addressed by 
original studies within a certain field and the resulting heterogeneity are typical for 
basic science and a challenge to broader application of systematic reviews in basic 
science. 
Nevertheless, basic science could profit from attempts to synthesise the state of 
evidence systematically rather than in a narrative way as is the current standard: the 
systematic literature search avoids bias towards much-cited articles and makes sure 
that all available evidence is considered. A systematic review is therefore less prone 
to being dominated by personal hypotheses than a narrative review. If a meta-
analysis can be performed, systematic reviews additionally give a more realistic 
estimate of true effect directions and magnitudes. Systematic reviews allow “to get 
out the maximum” from research that has already been done on a subject while also 
critically assessing the quality of available evidence and are a powerful tool to plan 
further research (de Vries et al., 2015). This means that resources and animals can 
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be allocated more efficiently and contributes to reducing the number of animals in 
experiments. 
Systematic reviews are greatly facilitated when original reports precisely and 
transparently report their methods and results. The ARRIVE guidelines to improve 
reporting in bioscience were published in 2010 (Kilkenny et al., 2010). Despite 
endorsement by numerous journals and funding agencies, reporting has not 
markedly improved thereafter, and the guideline is currently under revision to make it 
more user-friendly (Percie du Sert et al., 2018). Both the lack of clear statements on 
the significance of results in some studies and unclear descriptions of study design 
and/or methods made it more difficult for us to compare findings between studies. To 
enable systematic reviews in basic science, funding agencies, committees licensing 
animal experimentation and journals should stress that studies are designed and 
reported in a way that they are later eligible for systematic reviews. In the field of 
fMRI, this includes reporting of the timeline of the experiment, notably the timing of 
image acquisition relative to induction and eventual switch to other agents and/or 
inhalant concentrations or infusion rates, in addition to the anaesthesia-related item 
listed in the ARRIVE guidelines. Finally, registration of all animal studies would have 
helped to keep track of which data was re-analysed or newly acquired in the cluster 
of references described in chapter 3.2, and would in general increase transparency. 
Clinical systematic reviews and meta-analyses typically exclude original reports with 
a high risk of bias or stratify results in the meta-analysis by risk of bias (Higgins et al., 
2011). As it was anticipated that many studies would be at high risk of bias, we 
decided to not exclude those, and indeed, all included references scored as being at 
high risk of bias. The SYRCLE risk of bias tool which we used for this review 
(Hooijmans et al., 2014) was developed on the base of the Cochrane risk of bias tool 
to assess randomised clinical trials (Higgins et al., 2011). While it is true that for most 
experimental animal studies there is no good reason why they should not be 
randomised and – at least for outcome assessment – blinded, to date most studies 
are not. This results in studies being automatically classified as at high risk of bias by 
the SYRCLE risk of bias tool. Subtle differences in methodological quality between 
studies with overall suboptimal design are therefore not caught. Although such a 
differentiation would not have changed the overall conclusion that the results of our 
review are likely to be complemented or corrected by further research, appreciating 
subjectively noted differences in the risk of bias tool could support objectivity of a 
systematic review. Until reporting and general scientific quality of animal studies 
improve, systematic reviews of animal studies will have to discuss how to deal with 
the endemic high risk of bias.  
 
4.6 Implications of our findings for BOLD fMRI validity in rodents  
 
As all animal experimentations, rodent fMRI studies must undergo harm-benefit 
analysis. Studies can only be justified when the anticipated benefits outweigh the 
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harms. However, for studies to generate any benefit, the results have to be 
scientifically valid (Würbel, 2017). Würbel (2017) proposed to assess the scientific 
validity of studies by the three aspects of construct, internal and external validity.  
Construct validity was previously defined by these authors as “The degree to which 
inferences are warranted from the sampling properties of an experiment (e.g., units, 
settings, treatments and outcomes) to the entities these samples are intended to 
represent” (Würbel et al., 2014). The construct validity of a rodent model using BOLD 
fMRI for outcome assessment depends on the purpose and the specifications of the 
model used. A detailed assessment of the variety of models in use is beyond the 
scope of this review. However, a question to be raised when rodents are used to 
model complex behavioural and/or emotional functions of the human brain is whether 
imaging anaesthetised animals can provide relevant information. If the answer is no, 
the next question is whether relevant information could be acquired by imaging 
animals in the awake state. As discussed above, awake imaging should only be 
performed in animals which were trained to voluntarily enter and tolerate the restraint 
set-up to minimise confounding effects of stress. Unless animals are carefully trained, 
awake imaging should generally be considered to be at a high risk for confounding 
effects of stress and/or effect of repeated anaesthesia and/or anaesthesia used for 
positioning of the animal. If neither anaesthetised nor awake imaging is anticipated to 
allow capturing the state of interest, performing the experiment is not warranted 
(insufficient construct validity).  
Internal validity was previously defined as “The extent to which the design, conduct, 
and analysis of the experiment eliminate the possibility of bias so that the inference of 
a causal relationship between an experimental treatment and variation in an outcome 
measure is warranted” (Würbel et al., 2014). Regarding the use of anaesthesia, it is 
difficult to draw a clear line between construct and internal validity: For specific 
models, whether relevant information can be acquired from anaesthetised animals 
may well depend on the anaesthetic(s) and even doses used. Assuming that 
construct validity is given for a certain rodent fMRI study using a certain anaesthetic 
agent, the timing of image acquisition as well as monitoring and control of 
physiological parameters are part of the conduct of the experiment and therefore 
relevant for the internal validity of a study. Neglecting potential effects of 
physiological parameter alterations and the chosen anaesthetic protocol (including 
timing) on the BOLD signal introduces bias and thus reduces the internal validity.  
External validity is generally defined as the extent to which findings can be 
generalised (Würbel et al., 2014). While it is true that over-standardisation reduces 
external validity and consequently reproducibility of research findings, we strongly 
believe that heterogeneity should be included in studies in a controlled, systematic 
way and not by failure to control for potential confounders.  
Establishing standards of monitoring, as well as evidence-based optimal dose ranges 
and imaging timepoints for a selection of anaesthetic protocols is therefore a priority 
for improving the scientific validity of rodent fMRI studies. 
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6 Appendix  
6.1 Abbreviations and glossary  
 
MRI – magnetic resonance imaging 
fMRI – functional magnetic resonance imaging; several modalities exist 
BOLD – blood oxygen level dependent 
BOLD fMRI – an fMRI modality weighted for blood oxygen level dependent contrast 
T2* – “observed” or effective transverse relaxation time, resulting from the 
combination of “true” transverse relaxation time T2 and magnetic field homogeneities 
R2* – “observed” or effective transverse relaxation rate, resulting from the 
combination of “true” transverse relaxation rate R2 and magnetic field homogeneities 
ΔR2* – difference in R2* between two timepoints or states 
 
rs – resting state: in animals defined as absence of external stimulation, in humans 
additionally defined as a state of “unrestrained cognition” 
rsfMRI – resting state fMRI: acquiring fMRI of a subject in the resting state. 
Subsequent analysis relies on slow frequency fluctuations of the BOLD signal (<0.1 
Hz). (Smitha et al., 2017) 
phMRI – pharmacological MRI: the use of fMRI to investigate central effects of test 
substances, in this review specifically investigation of central drug effects by BOLD 
fMRI 
ROI – region of interest 
fc – functional connectivity: “interaction between two different brain regions (…) 
inferred on the basis of correlations among the parameters of neuronal activity” 
(Smitha et al., 2017) 
ICA – independent component analysis: blind source separation algorithm that 
decomposes signal fluctuations of all voxels of the brain in spatially and temporally 
independent components (Smitha et al., 2017) 
ReHo – regional homogeneity: similarity of each voxel’s signal time course with the 
signal time courses of its closest neighbours (Smitha et al., 2017) 
CAP – co-activation pattern: fc is analysed by clustering activation patterns from 
individual frames (Liang et al., 2015a) 
 
CMRO2 – cerebral metabolic rate of oxygen 
CBF – cerebral blood flow 
CBV – cerebral blood volume  
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S1 – primary somatosensory cortex 
S1FL – frontlimb area of the primary somatosensory cortex 
S1HL – hindlimb area of the primary somatosensory cortex 
S1BF – barrel field of the primary somatosensory cortex, area receiving input from 
whiskers 
S2 – secondary somatosensory cortex 
M1 – primary motor cortex 
M2 – secondary motor cortex 
CPu – caudate putamen 
VPM – ventral posteromedial nucleus of the thalamus 
VPL – ventral posterolateral nucleus of the thalamus 
 
sc – subcutaneous 
ip – intraperitoneal 
iv – intravenous 
CRI – constant rate infusion 
 
O2 – oxygen 
N2 – nitrogen 
N2O – nitrous oxide 
CO2 – carbon dioxide 
FiO2 – fraction of inspired oxygen 
pCO2 –partial pressure of carbon dioxide  
paO2 – arterial partial pressure of oxygen  
paCO2 – arterial partial pressure of carbon dioxide 
MAP – mean arterial blood pressure 
 
Hypoxia – low partial pressure of O2 and O2 content in tissues (MacIntyre, 2014) 
Hypoxemia – paO2 < 80 mmHg (Grimm, 2015) 
Hyperoxemia – paO2 > 110 mmHg (Grimm, 2015) 
Hypercapnia – paCO2 > 45 mmHg (Grimm, 2015) 
Hypocapnia – paCO2 < 35 mmHg (Grimm, 2015) 
 
SD – standard deviation 
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6.2 Systematic review protocol: The impact of anaesthesia 
protocols on BOLD fMRI validity in laboratory rodents  
 
As described in the materials and methods section, the study design was adapted 
during the initial phase of the review. For completeness, the original study design, as 
planned on the day the systematic search was conducted, is shown in the following 
paragraphs.  
6.2.1 Stage of the review at time of registration  
An initial systematic search was performed, and records were selected and partially 
analyzed by a single author, when it was decided to update the search with refined 
methodology. 
6.2.2 Objectives  
Blood oxygen level dependent (BOLD) fMRI is the most commonly used modality for 
functional neuroimaging in humans (several thousand studies published per year) 
and widely used in preclinical and basic research rodent models (Martin, 2014; 
Jonckers et al., 2015; Pan et al., 2015). Changes in blood oxygenation levels are 
interpreted as a surrogate for neuronal activation, based on the mechanism of 
neurovascular coupling (i.e. activation of neurons increases local blood flow) 
(Logothetis and Wandell, 2004). As even small movements of the head during image 
acquisition distort the images, animals are typically anaesthetized for image 
acquisition. In terms of animal welfare, scanning under anaesthesia is preferable to 
awake scanning under rigorous fixation (Low et al., 2016). However, anaesthesia 
interferes with interpretation of the BOLD signal on several levels: first, alterations in 
physiological parameters (e.g. hypotension, hypercapnia) can alter local 
hemodynamics in absence of changes in neuronal activity. Second, anaesthetics per 
definition alter neuronal activation and information processing, so that measurements 
may reflect activation under a distinct anaesthetic rather than universal patterns. 
Third, anaesthetics may modulate signal cascades responsible for neurovascular 
coupling. In practice, it is difficult to clearly separate the relative contribution of each 
mechanism. Therefore, one part of the review will focus on studies which directly 
compare different anaesthetic protocols with each other or with awake scanning. We 
want to analyze how different states of anaesthesia affect the BOLD outcome 
measures specified in the respective studies in adult rats and mice. States of 
anaesthesia are defined as distinct if they differ by the drug or dose administered or 
by the time that has elapsed since induction. The other part of the review will focus 
on the specific effects of alterations in physiological parameters on different BOLD 
outcome measures in adult rats and mice. Physiological parameters that can typically 
be altered under anaesthesia are paCO2, paO2, SpO2, respiratory rate, respiratory 
pattern, heart rate, arterial blood pressure and body temperature. 
Due to the vast diversity of post-processing options in BOLD fMRI, any outcome 
measure specified by the individual studies is eligible for analysis, as long as the 
study uses BOLD contrast on the brain parenchyma (whole brain or specific regions 
of interest) in order to draw a conclusion about functional aspects of the brain. 
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Analysis will include studies conducted in healthy animals as well as studies in 
disease models, as emphasis is placed on providing researchers with relevant 
information for deliberately choosing an appropriate anaesthetic protocol for BOLD 
fMRI experiments in laboratory rodents.  
In short, our research question reads as follows: What is the effect of a) different 
states of anaesthesia or b) changes in physiological parameters that can be 
observed under anaesthesia on the BOLD fMRI outcome measure defined by the 
individual study in adult rats and mice? 
Our aim is to demonstrate the extent of anaesthetic protocol-related differences in 
fMRI outcomes, to formulate evidence-based minimal standards for monitoring during 
BOLD fMRI experiments, and ultimately to elaborate recommendations on how to 
choose an appropriate anaesthetic protocol. To our knowledge, this is the first 
systematic review about the impact of anaesthetic protocols on BOLD fMRI validity in 
laboratory rodents. 
 
6.2.3 Methods  
6.2.3.1 Search strategy and study identification  
A systematic search will be conducted in EMBASE, MEDLINE, Scopus and Web of 
Science. Search terms are listed in the table below. Search terms within one block 
are linked with “OR”, while the blocks are linked with “AND”. Terms will be searched 
in titles and abstracts. Correspondent Emtree vocabulary and MeSH, if available, will 
additionally be used for the search in EMBASE and Medline, respectively. Language 
will be restricted to English, German and French. As the first publication describing 
BOLD contrast in MRI appeared in 1990, a filter for publication year 1990 or later will 
be used. 
 
Rodents 
rat OR rats OR mouse OR mice OR rodent OR rodents 
MRI 
((MRI OR MRT OR NMR OR “magnetic resonance imaging”) proximity operator5 
functional) OR fMRI OR BOLD OR “Blood oxygen level dependent” 
Anaesthesia OR physiology 
anesthe* OR anaesthe* OR hypercapnia OR hyperoxia OR hypoxia OR apnea OR 
“blood pressure” OR hypotension OR hypertension OR autoregulation OR 
thermoregulation OR “physiological noise” OR “functional connectivity” OR 
somatosensory OR stimulation OR isoflurane OR sevoflurane OR halothane OR 
medetomidine OR dexmedetomidine OR alpha-chloralose OR chloralose OR a-
chloralose OR urethane OR propofol OR ketamine OR xylazine 
 
Additionally, any publication fulfilling inclusion criteria which is cited in reviews or 
original articles, but was not found by the systematic search, will be included. 
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If a selected study is recorded in the format of a proceeding/abstract/poster, google 
scholar will be used to search for a corresponding full article (for more details, see 
study selection). 
 
6.2.3.2 Study selection  
All records will be imported to endnote and duplicates removed with the “find 
duplicates” function. In a pre-screening phase, titles and abstracts will be screened. 
Records deemed eligible for analysis in the preliminary search automatically pass 
this stage. Records who have made it through pre-screening will undergo full text 
screening for eligibility. Study selection will be performed by a single reviewer. As 
there is not enough evidence to claim that study selection is performed by two 
reviewers (Shamseer et al., 2015), having a single reviewer performing this step can 
be justified against the common recommendations of having two reviewers 
independently screening the search results.  
Inclusion and exclusion criteria are defined as follows: 
 
 Inclusion criteria Exclusion criteria 
Type of study Describing original 
research, reported in an 
article, abstract, 
conference proceeding or 
poster 
Review; data originating 
from different experiment 
which is not described in 
material and methods. 
Type of animals Adult rats and mice of any 
strain.  
Adult defined as sexually 
mature, i.e. >=12 weeks 
or  200 g for rats; >= 8 
weeks or at least 18 g for 
mice. For both species 
the lower limit of 
reproductive activity of 12 
months is used as the 
upper age limit 
(Wolfensohn and Lloyd, 
2013). If articles report to 
use adult animals, but do 
not specifiy the age or 
weight, studies are 
included. If they report to 
used adult animals but 
age and/or weight of 
some animals (e.g. if a 
range is given) are within 
10% of deviation from the 
limits defined here, the 
Other species; 
neonate/juvenile/geriatric 
animals, if  
a) defined as such by the 
study or  
b) not explicitely 
described as adults and 
not fulfilling the age and 
weight limits defined 
under inclusion criteria 
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study is still eligible. 
Disease models are 
eligible. 
Type of intervention BOLD fMRI 
a) Comparison of 
anaesthetic 
protocols or 
anaesthetized vs. 
awake for same 
imaging protocol 
b) alteration of 
physiological 
parameters: either 
deliberately caused 
by an intervention 
or closely 
monitored over 
time with the 
explicit intention 
(mention in 
abstract) of 
analyzing the 
correlation with 
fMRI signals. 
Acceptable paradigms: 
resting state; peripheral 
sensory stimulation (e.g. 
electrical, mechanical, 
chemical, visual, auditory 
or olfactory stimulation) 
including noxious stimuli; 
direct brain stimulation 
(e.g. electrical, 
optogenetic; chemical if 
specifc neurotransmitter 
systems are 
blocked/enhanced in 
order to elucidate the 
effects and mechanisms 
of action of anaesthetics) 
fMRI applied to other 
regions of the body than 
brain (e.g. spine, heart, 
joints); 
modalities of fMRI other 
than BOLD (e.g. arterial 
spin labeling, CBV 
measurements); 
BOLD fMRI studies 
neither comparing states 
of anaesthesia nor 
investigating alterations of 
physiological parameters; 
pharmacologic stimulation 
for other purposes than 
elucidating the effects of 
mechanisms of action of 
anaesthetics by 
blocking/enhancing 
specific neurotransmitter 
systems. 
Outcome measures As defined by the 
respective study as long 
as BOLD contrast is used 
on the brain parenchyma 
to make a statement 
about functional aspects 
of the brain. 
Correlations of BOLD 
signal with other 
functional neuroimaging 
methods, measurements 
of neural activity or 
cerebral hemodynamics 
Language restrictions English, German, French All other languages 
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Publication date 
restrictions 
1990 and later Earlier than 1990 
Other  - Duplicate not recognized 
by endnote; strong 
suspicion of multiple 
reporting 
 
In the title and abstract screening phase, priority exclusion criteria are non-rodent 
species, applications of fMRI to other regions of the body, non-BOLD fMRI modalities 
and reviews. In the full text screening phase, the focus is on excluding records which 
neither compare anaesthetic protocols nor investigate the effect of alterations in 
physiological parameters or which use pharmacologic stimulation for other purposes 
than elucidating the effects of mechanisms of action of anaesthetics by 
blocking/enhancing specific neurotransmitter systems, and data originating from a 
different experiment which is not described in the material and methods section of the 
present publication. If a study describes multiple interventions and outcome 
measures, only data from those experiments meeting the inclusion criteria will be 
analyzed. 
Duplicates not recognized by endnote (e.g. due to different recording of author 
names in different databases) will be manually resolved. If a 
proceeding/abstract/poster and a full article by the same author reporting the same 
experimental protocol with the same primary outcome are found, so that the full 
article most probably describes the same study as the shorter form of publication, 
only the full article is kept. In order to get the best information available about 
individual studies, we will try to find a corresponding full article on google scholar for 
each short form record, using a combination of author names, keywords and 
restriction of the publication date to the first 3 years following the shorter publication. 
If a full article is found, the shorter publication is replaced, otherwise it is kept. 
DistillerSR will be used to assist the screening and data extraction process. 
 
6.2.3.3 Study characteristics to be extracted (for assessment of external validity, 
reporting quality)  
For each study, animal characteristics (species, sex, strain, age, weight, number per 
experimental group ), the exact anaesthetic protocol (drug, dose, route of 
administration, time point of administration, gas mixture, flow, concentration of 
inhalant anaesthetic), surgical preparations for the experiment, presence or absence 
of monitoring of specific parameters and details on the methods and frequency of 
monitoring (temperature, heart rate, oxygen saturation, respiratory rate/ventilator 
setting, end-tidal gas concentrations, blood gas parameters and timing, arterial blood 
pressure, reflexes) are extracted. For records investigating the effect of physiological 
parameters on BOLD fMRI outcome, details of the interventions to alter the 
physiological parameter(s) are additionally extracted. For all studies, magnetic field 
strength, duration of image acquisition and total experiment, type and timing of 
stimulations during BOLD fMRI, primary and secondary fMRI outcome as well as a 
brief description of additional methods used in that study are recorded. A separate 
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column allows to comment on specific issues of the study that are not covered by the 
risk of bias tool (e.g. inadequate methods, failure to discuss potential confounders). 
 
6.2.3.4 Assessment of risk of bias (internal validity)  
One reviewer will assess the risk of bias in each study. 
An adapted version of SYRCLE’s risk of bias tool (ROB tool) will be used. As only 
one reviewer assesses the risk of bias, a first version of the ROB tool will be sent to 
experts from several fields (welfare of laboratory animals, anaesthesia, fMRI), 
together with the original ROB tool and 2-3 representative publications. Their 
feedback will be integrated and, if major revisions are made, a revised version sent 
out for a second round of feedback, the primary question being “Do you think that this 
version of the adapted risk of bias tool is more adequate than the previous?”. 
 
6.2.3.5 Collection of outcome data  
A peculiarity of our study is that the outcomes are heterogeneous; any outcome 
measure defined by an individual study is eligible as long as it results from analysis of 
BOLD fMRI and its purpose is to measure a functional characteristic of the brain.  
For each study it will be extracted whether a) a qualitative and b) a quantitative 
difference was observed between different states of anaesthesia or different values 
of physiological parameters (values of physiological parameters are considered 
different if they are defined as different by the respective study). If a difference was 
observed, it will be specified. For physiological parameters, the absolute values of 
baseline, change and altered state will be extracted. 
A second reviewer will control whether data was extracted correctly because 
mistakes are common at this step of the workflow (Shamseer et al., 2015). 
 
6.2.3.6 Data analysis/synthesis    
Data will be analyzed strictly separated for each species, but following the same 
structure of analysis. 
 
6.2.3.6.1 State of anaesthesia  
Per imaging paradigm, it will be analyzed whether studies comparing the same 
anaesthetics or dosages of the same anaesthetic first consistently report the 
presence or absence of qualitative differences between different states of 
anaesthesia, and second, if qualitative differences are observed, whether they are 
consistent, complementary or conflicting. An analog analysis will be performed for 
quantitative differences. For each comparison, a synthesis will be formulated, and the 
quality of evidence indicated.  
Comparisons for which only single reports exist will be described as such. 
Depending on the number of records about comparisons of states of anaesthesia in 
disease models, those records will be analyzed in a separate subchapter or along 
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with studies performed in healthy animals, but it will be analyzed whether the 
presence and/or nature of observed differences are correlated with the health status 
of animals under investigation. 
 
6.2.3.6.2 Physiological parameters  
Per physiological parameter, it will be analyzed whether in- and decreases, 
respectively, are consistently reported to affect BOLD outcome measures, which will 
be grouped in the same imaging paradigm categories as used in the state of 
anaesthesia section. For changes in PaCO2 and PaO2, the constitution of inspired 
gases will also be considered. If qualitative or quantitative differences are reported, it 
will be analyzed whether they are consistent, complementary or conflicting. It will be 
further analyzed whether the anaesthetic used or the source of change of the 
physiological parameter correlates with the presence and/or nature of observed 
effects. If enough data is available, it will additionally be analyzed whether the 
changes in BOLD signal are correlated with the magnitude of change of the 
physiological parameter’s value. 
For each parameter, it will be concluded whether it potentially affects BOLD 
measurements if unstable. The strength of evidence will be indicated. 
Meta-analysis will be considered, but a definitive decision whether it will be suitable 
cannot be made yet.  
 
6.2.3.7 Grading of evidence  
For each subcategory, the strength of evidence will be graded according to the 
evidence-based practice center approach (EPC) (Owens et al., 2009). The following 
categories will be assessed across records: risk of bias (low/moderate/high), 
consistency (yes/no for direction of effect and effect size), directness (direct/indirect) 
and precision (precise/imprecise). Together, those assessments result in the 
classification of the body of evidence for that specific subcategory as high, moderate, 
low or insufficient. 
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6.3 Inclusion and exclusion criteria  
 
 Inclusion criteria Exclusion criteria 
Type of study • original research 
• short form (conference 
abstract, poster or paper) or 
full article 
• re-analysis of previously 
acquired data 
• review 
• opinion piece  
• book chapters 
• lecture/talk 
• complete congress 
proceedings/abstract 
collections 
• study protocol 
• short form with 
corresponding full article 
• multiple reporting 
• unrecognized duplicate 
Type of 
animals (all 
limits refer to 
the timepoint of 
image 
acquisition) 
• rats >200 g or 8 weeks and 
up to 12 months 
• mMice >18 g or 8 weeks and 
up to 12 months 
• if age/weight not described: 
assumed that animals were 
adult unless stated otherwise 
• both sexes 
• any strain 
• any health status 
• species other than rat or 
mouse 
• rats <200 g or 8 weeks or 
>12 months 
• mice <18 g or 8 weeks or 
>12 months 
• if age/weight not described: 
animals described as pups/ 
neonatal/ juvenile/ 
adolescent/ geriatric/ aged/ 
old… 
Type of 
interventions 
• BOLD fMRI of the brain with  
• comparison of different drugs, 
doses or timepoints of 
imaging relative to induction, 
or anaesthetized versus 
awake for same imaging 
protocol 
• alteration of physiological 
parameters: either 
deliberately caused by an 
intervention or closely 
monitored over time with the 
explicit intention (mention in 
abstract) of analyzing the 
correlation with fMRI signals. 
 
Accepted experimental 
paradigms 
• resting state 
• central stimulation paradigms 
• no MRI 
• other (f)MRI modalities 
• other body regions 
• BOLD fMRI of brain tumors 
• BOLD fMRI studies of the 
brain, but neither comparing 
anaesthetic protocols nor 
investigating alterations of 
physiological parameters 
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o pharmacological 
o electrical 
o optogenetic 
• peripheral stimulation 
o electrical 
o mechanical 
o chemical 
o thermic 
o visual 
o auditory 
o olfactory 
o gustatory 
o visceral 
 
Definition of 
anaesthetics 
• all inhalant anaesthetics (e.g. 
isoflurane, sevoflurane, 
halothane) 
• barbiturates (e.g. thiopental) 
• propofol, alfaxalone 
• ketamine, S-ketamine 
• α-chloralose 
• urethane 
• xylazine, medetomidine, 
dexmedetomidine 
• acepromazine 
• benzodiazepines 
• opioids if part of a balanced 
anaesthesia protocol 
• opioids as sole sedative or 
as intervention in pain 
studies 
Physiological 
parameters 
under 
investigation 
• arterial blood pressure 
• heart rate 
• respiratory rate 
• pCO2  
• pO2  
• SpO2 
• pulse distension 
• body temperature 
• hematocrit  
• all other parameters, e.g. 
blood glucose levels 
• local temperature of the 
brain 
• BOLD response to 
hyperoxia/hypercapnia as 
mere application to compare 
two groups 
Interventions to 
alter 
physiological 
parameters 
• blood withdrawal 
• fluid supplementation 
• pharmacologic manipulation 
of cardiovascular parameters 
• normobaric changes of 
inspiratory gas composition 
• apnoea 
• changes in body temperature 
• hyperbaric inspiratory gas 
Outcome • any measure derived from 
• correlations of BOLD signal 
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measures BOLD signal alone with other modalities (e.g. 
EEG signal) 
Language 
restrictions 
• English 
• German 
• French 
• all other languages 
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6.4 Inclusion and exclusion decisions  
 
6.4.1 Inclusions  
• Boonzaier et al. (2017): fMRI, repeated transcranial magnetic stimulation 
under different anaesthetic protocols, then check with fMRI for changes in fc – 
and there were differences. Decision that only baseline data is included.  
• Schmidt et al. (2006): clearly declare in the abstract that they want to analyse 
the contribution of the change of physiological parameters on fMRI activation 
and they do so by investigating the time course. As the fMRI signal changes 
persisted after HR, BP and RR returned to baseline, the authors conclude that 
the influence of PP changes is negligible in this case. This conclusion is 
clearly written in the abstract (results and discussion don’t really comment on it 
that explicitly). The study separately reports BOLD, CBF and CMRO2. 
Therefore, there is no reason to exclude it. The study was not classified as 
interventional study because transient hypercapnia served just to derive maps 
of the calibration parameter M. 
• Huang et al. (2013): Hypercapnia used as an application, therefore this part of 
the study excluded (and also because no comment on whether the observed 
change was significant, only the difference in response pre/post methylene 
blue investigated for significance (no significant difference found)). However, 
the comparison of responses to paw stimulation under hypoxia versus 
normoxia is included.   
• Vanhoutte et al. (2006): included because explicitly described what happens 
with whole brain BOLD signal intensity when body core temperature in-
/decreased.  
• Baskerville et al. (2011): characterizes T2* response to 40 vs 100 % oxygen in 
penumbra of ischemic lesion. Not considered an application of hyperoxia 
because they explicitly test if 40% is an alternative to 100% which causes 
oxygen artefacts from oxygen in the sinuses. 
• Bock et al. (1998): paw stimulation at baseline, then a 3 min hypercapnia scan 
without paw stimulation, 25 min later another paw stimulation scan; no lasting 
effect of hypercapnia on BOLD response detected. Included because it shows 
that effects of transient hypercapnia are limited to the duration of actual 
hypercapnia, which is relevant for monitoring guidelines. 
• Sedlacik et al. (2015): “Correlation of oxygenation and perfusion sensitive MRI 
with invasive micro probe measurements in healthy mice brain” uses different 
inspiratory gas concentrations and reports among many other outcomes R2*. 
• Pan et al. (2011): “Interestingly, while increasing the level of isoflurane from 
1% to 1.8%, correlated BOLD fluctuations between hemispheres as well as 
coherent theta/delta LFP power fluctuations increased significantly” was at first 
sight the only sentence about rsfMRI results and appears only in discussion 
part. However, the same finding was also reported in results: the authors 
defined a neural suppression index, based on amount of suppression in burst-
suppression EEG, as a proxy for anaesthetic level and report correlation of 
BOLD fluctuations with that neural suppression index. 
• Chen et al. (2008): included because results from figure in text described 
(summary from images in fig. 3), although the word “weaker” may be not 
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optimal – the images suggest that both less extended and lower signal 
change, but no quantitative analysis of % signal change between groups was 
provided. 
 
 
6.4.2 Exclusions 
6.4.2.1 Calibrated / quantitative fMRI without separate reporting of BOLD signal  
• Wu et al. (2002): “Transient relationships among BOLD, CBV, and CBF 
changes in rat brain as detected by functional MRI”. Aims of the study in its 
own words: 1. to experimentally determine how regional relationships between 
CBV and CBF fit the power law, 2. determine the transient relationships 
between CBF and CBV.  The BOLD signal is separately described, but the 
article reports changes in BOLD signal during 7.5% and 10 % hypercapnia 
only in a graph, not in the text. It states that the displayed time courses were 
averages from those voxels that showed significant signal change during 
hypercapnia but does not report how many voxels did show a significant signal 
increase and how they were spatially distributed. Focus of the paper is on 
CMRO2, parameter M, power index α, etc. Excluded as “insufficient detail of 
results” with the reason given here. 
• Shu et al. (2016b): “Brain region and activity-dependent properties of M for 
calibrated fMRI”. Compares medetomidine and α-chloralose only regarding 
parameter M, which is calculated as TE times R2’ and thus not sensu strictu a 
BOLD measure (i.e. directly derived from signal intensity, R2* or T2*).  
• Shu et al. (2016a): “Quantitative β mapping for calibrated fMRI”. Excluded 
because comparison of α-chloralose and medetomidine only regarding 
parameter β, which is part of a formula including CMRO2. Signal intensity, T2* 
or R2* are not reported for the comparison of interest.  
 
6.4.2.2 Application of hyperoxia or hypercapnia  
• Kennan et al. (2004): application of hyperoxia in sickle cell model 
• Elbel et al. (2000): abstract, considered an application of hypercapnia. Only 
the following sentence about hypercapnia: “By adding stepwise up to 10 
percent CO2 to the inspiratory gas mixture a generalized BOLD response was 
induced”. 
• Mahmoud et al. (2016): “AMP-activated Protein Kinase Deficiency Blocks the 
Hypoxic Ventilatory Response and Thus Precipitates Hypoventilation and 
Apnea” : Experimental hypoxia regarded as application (i.e. excluded) 
because of the following sentence: “Brainstem activity during hypoxia was 
therefore assessed by fMRI in anaesthetized mice in light of the fact that 9% 
or less O2 induces cerebral vasodilation sufficient to eliminate the blood 
oxygen –  level dependent (BOLD) signal driven, under normoxia, by 
increases in cerebral blood flow in response to sensory stimulation (27)”. 
• Ciobanu et al. (2015): uses hyperoxia as a “well known paradigm that mimics 
the BOLD response in absence of neuronal activation, by virtue of the 
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diamagnetic character gained by haemoglobin upon activation” to compare 
three different pulse sequences. Excluded as application of hyperoxia. 
• Kim et al. (2014): hypercapnia as an application to test difference between 2 
strains; focus on (correlation with) CBF and CBV; just one graph showing 
increase of BOLD signal during hypercapnia 
• Shih et al. (2011): hypercapnic challenge mentioned in methods, but no results 
reported; probably as an application 
• Mitschelen et al. (2009): hypercapnia "as a stimulus to probe the 
responsiveness of the vasculature" in adult, healthy aged and cognitively 
impaired aged rats 
• Henninger et al. (2007): application of hypercapnia to compare groups after 
traumatic brain injury. Control animals „robust“ BOLD response to CO2 (whole 
brain slice coloured in figure), after TBI “severely” reduced and different 
recovery rates between regions. Nevertheless, it’s an application, analogous 
to hyperoxia in sickle cell models. 
• Paley et al. (2001): primarily application of hypercapnia, hyperoxia and 
hypoxia to test coherence of fMRI and optical imaging, additionally insufficient 
detail of results (no comment on significance of signal change). Focus of study 
on describing an MR device. 
• Zhou et al. (2005): studies the interaction of magnetization transfer and BOLD 
effect : “The purpose of this study was to quantify the MTR changes in the 
brain as a function of arterial PCO2 level and to use this dependence to study 
the interaction between the BOLD and MT effects in the parenchyma”. As 
declared in that sentence, variation of inspired CO2 concentrations served 
primarily to characterize magnetization transfer. Accordingly, there is only one 
sentence in the results that the unsaturated BOLD signal increased by 7% 
during hypercapnia and that this increase was stronger in the saturated 
condition. Or in their words: “It can be seen that there is a change of about 7% 
in the unsaturated signal intensities (standard SE BOLD effect) but an 
increased magnitude up to approximately 15% for the signal intensities under 
off-resonance RF irradiation (combined MT BOLD and standard SE BOLD 
effect) corresponding to a 100 mm Hg change in PCO2.” Excluded as 
application of hypercapnia and insufficient detail of results (no statement on 
significance). 
• Wang et al. (2012): my understanding is that the “total” fMRI signal in this 
article is what is usually called the BOLD signal. It is known that other 
mechanisms contribute to the BOLD signal and what this study does is to 
investigate the contribution of perfusion or large vessel inflow to the total 
signal under hypercapnia, using hypercapnia as a method to increase CBF, 
i.e. an application. The focus is not on characterizing the response of the total 
signal to hypercapnia, but to elucidate the contributing mechanisms. 
 
6.4.2.3 Anaesthetics not reported  
• Williams et al. (2013): “Minocycline interferes with glutamate 
neurotransmission in an animal model of psychosis and with neurovascular 
coupling”. Administers ketamine on top, but anaesthetics used for imaging not 
reported. Additionally, characterising ketamine effects simply as causing 
“widespread activation” would fulfil the criteria for insufficient detail of results. 
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• Dunn et al. (1996): short form, clearly describes regional difference in 
response to hypoxia (cortex vs caudate putamen), but excluded because 
anaesthetics not reported. 
 
6.4.2.4 No results for the comparison of interest  
• He et al. (2008): investigates whether one can conclude from BOLD signal to 
oxygen saturation but doesn’t describe how the BOLD signal differed between 
α-chloralose and isoflurane. Excluded as “no results reported for comparison 
of interest”. 
• Madularu et al. (2017) 
• Pronger et al. (2014): “Mulitimodal neuroimaging with hypercapnia to monitor 
cerebrovascular function after traumatic brain injury and evaluate treatment”. 
Only an abstract; compared isoflurane with medetomidine, but no results 
reported. All four databases and google scholar searched by name of first 
author for potential follow-up articles, but nothing found.  
• Jones et al. (1996): values in a table plus a graph indicate that R2* increases 
during anoxia - I suppose that this must be a consistent and significant 
phenomenon, because the whole results and discussion section just compare 
the change of R2* during anoxia between ischemic and non-ischemic regions 
and between ischemia and reperfusion phases. However, as this study reports 
“numbers”, but does not provide information about the statistical significance 
for the comparison of interest, and does not even descriptively summarize 
what happens to R2* in general during anoxia, it was excluded as “no results 
reported for the comparison of interest” and “insufficient detail of results”. 
 
6.4.2.5 Focus on vascular aspects  
• Desjardins et al. (2014): focus on vascular aspects and correlation of BOLD 
with other modalities; only one graph depicting the time course of the BOLD 
signal after transient hypercapnia. Excluded as no results reported for the 
comparison of interest 
• 1990 Ogawa et al. (1990): described changes apply to vessels, not 
parenchyma 
• Ciobanu et al. (2012): vessels, not parenchyma imaged 
• Uhrig et al. (2014): vessels, not parenchyma imaged 
 
6.4.2.6 Insufficient detail of result only reason  
• Wang et al. (2015): evaluates a method that measures BOLD and CBF 
concurrently. Exposed rats to hypercapnia and ischemia to test the method 
under disturbances. The BOLD signal is reported to increase under 
hypercapnia (4.5 %) and decrease under ischemia (23 %), however, whether 
these changes are significant is not reported. Further analysis of the BOLD 
signal only addresses correlation with other measures. Therefore, the study 
was excluded (reason: insufficient detail of results). 
• Lahti et al. (1997): the subtraction is baseline image awake 1 minus baseline 
image awake 2 and NOT awake vs anaesthetized as assumed previously (see 
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methods section). Regarding the awake vs anaesthetized comparison, there is 
only one sentence in the methods: “The relatively large BOLD signal intensity 
change observed in this study may be due to the increased neuronal activation 
status of conscious animal, compared to the anesthetized counterpart.” This 
information comes without any further characterisation or assessment of 
significance and consequently the study was excluded as insufficient detail of 
results. 
• Lin et al. (1999): ”A marked decrease in  R2* was observed initially (from 
roughly 150 to 500 seconds) in response to the change in the CO2 content of 
the inspired gas followed by a relative plateau throughout the end of the  
experiment. (…) Similar temporal behaviour for ΔR2* in response to 
hypercapnia was observed in all rats.” No comment on significance, therefore 
excluded as “insufficient detail”. The focus of this study is that you cannot 
derive cerebral blood oxygen saturation from ΔR2* because CBV has a strong 
effect. Authors describe method ad quantitative fMRI, but to me more similar 
to TRUST described in the textbook by Uludağ and Uğurbil (2015). 
 
 
6.4.2.7 Singular reasons  
• Nair and Duong (2004) and Ahrens and Dubowitz (2001) placed the mice 
vertically in the scanner (vertical bore). Both studies were excluded 
because we considered haemodynamics in this position not comparable with 
haemodynamics in horizontal positioning. 
• Morton et al. (2002): “Systemic theophylline augments the blood oxygen level-
dependent response to forepaw stimulation in rats”. Used theophylline to 
inhibit cerebral vasodilation in response to neuronal activation and observed 
that the BOLD signal change during paw stimulation increased under 
theophylline while blood pressure and other systemic physiological parameters 
remained stable. As the aim of giving theophylline was explicitly not to 
modulate systemic physiological parameters, this intervention does not qualify 
as investigation of physiological parameter effects and the article was 
excluded. 
• Two related articles: 
o  Kettunen et al. (2001): “Cerebral T1ρ relaxation time increases 
immediately upon global ischemia in the rat independently of blood 
glucose and anoxic depolarization” was considered an “other MRI” 
earlier in screening stage 2 but would have been excluded anyway 
because of the lack of AP/PP. 
o Kettunen et al. (2002): “Effects of intracellular pH, blood, and tissue 
oxygen tension on T1ρ relaxation in rat brain” focuses as well on T1ρ 
as main MRI outcome, but uses different FiO2 and FiCO2. “In the in vivo 
experiments blood relaxation and cerebral blood volume (CBV) results 
were used for a two-compartment model to compute tissue T1 
relaxation separately from the parenchymal MRI data.” In the results, 
there are two sentences about BOLD: “During hypoxia, a negative 
BOLD was evident as T2 was lowered by 3.3 +/- 0.6 ms.” And “the 
increase in T2 due to a BOLD effect was fully expressed at PaCO2 of 
around 80 mmHg, consistent with a previous cat study showing that 
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OER decrease stabilized at a hypercapnia level of around 80 mmHg”. 
The rest of the text deals with T1rho. The study is therefore excluded as 
well and classified as “other MRI”. 
• Kipervaser et al. (2007): “Statistical framework and noise sensitivity of the 
amplitude radial correlation contrast method”. Different anaesthetics (and 
concentrations) are used as a mean to test a statistical model. Excluded as 
other, reason: different states of anaesthesia just to test statistical model 
• Plaschke et al. (2006): chronic effects of hypotension (as a method to induce 
transient cerebral oligemia) are investigated; however for imaging studies 
effects of acute hypotension are relevant 
• Martin et al. (2009); Martin et al. (2013) (abstract and full article with same 
title): applied hypercapnia in awake animals → excluded because not a 
naturally occurring problem in awake animals 
• Ogawa et al. (1993): “The venous blood oxygenation, monitored at the sagittal 
sinus with the blood water T, measurement, were varied by changing the 
depth of anaesthesia with halothane.” → excluded as other. Changing the 
depth of anaesthesia is not an accepted method to modulate physiological 
parameters, because the effects of anaesthetic depth and change in 
oxygenation cannot be separated. 
• Thomas et al. (2002): focus on describing a (back then new) imaging 
sequence, hypoxia only in 2 rats, some changes in T2(*) reported at the end of 
results section. Decrease of T2* during hypoxia; "reproducible" time course 
"changes are in the range 10 – 15 ms for T*2 and 5 – 10 ms for T2. This 
corresponds to a reduction in SpO2 from 95% to a minimum value of 
approximately 60%". They “validate” their observations of T2* under hypoxia 
(5 episodes per animal, 2 animals) against one observation of T2* time course 
under normoxia. Excluded first because only one animal for control and 
second because no comment on significance, also not in methods or 
discussion (although I admit that it is probably reasonable NOT to use 
statistics here, but at some point I have to stick with defined criteria and this is 
clearly a quantitative outcome). 
• Cash et al. (2003): 6 animals undergoing MRI, four “groups”, but not clear how 
many animals per group or if maybe even crossover. Excluded because 
realistic chance that n=1 per condition. “one animal per condition” selected as 
reason of exclusion. 
• Easton et al. (2009): does not fulfil definition of an observational physiological 
parameter study, because intention to investigate effects of systemic 
physiological parameters on BOLD signal not expressed in abstract. But even 
if it would: title and axis are not matching in graphs so that it is not clear which 
graph shows what and results are not interpretable! 
 
6.4.2.8 Abstract collections  
Abstract collections are explicitly labelled as such in the title and, if an “abstract” is 
displayed in DistillerSR, it typically states something like “This proceeding contains 
476 papers”. Abstract collections were not manually screened but excluded in toto.  
• Abstracts from the 11th Congress of the European Association of Neuro-
Oncology (2014) 
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• 11th Turkish Neuroscience Congress (2013) 
• 3rd Biennial Conference on Resting State Brain Connectivity(2012) 
• Abstracts of the 20th Congress of the European Sleep Research Society 
(2010) 
• Abstracts and Programme - EUROANAESTHESIA 2009: The European 
Anaesthesiology Congress (2009c) 
• 9th International Symposium on NeuroVirology (2009a) 
• 2011 5th International IEEE/EMBS Conference on Neural Engineering, NER 
2011 (2011) 
• 13th International Conference on Biomedical Engineering, ICBME 2008 
• (2009b) 
 
  
144 
 
References 
(2009a). 9th International Symposium on NeuroVirology. Journal of NeuroVirology 
15. 
(2009b). 13th International Conference on Biomedical Engineering, ICBME 2008. 
13th International Conference on Biomedical Engineering, ICBME 2008 23. 
(2009c). Abstracts and Programme - EUROANAESTHESIA 2009: The European 
Anaesthesiology Congress. European Journal of Anaesthesiology 26. 
(2010). Abstracts of the 20th Congress of the European Sleep Research Society. 
Journal of Sleep Research 19. 
(2011). 2011 5th International IEEE/EMBS Conference on Neural Engineering, NER 
2011. 2011 5th International IEEE/EMBS Conference on Neural Engineering, NER 
2011. 
(2012). 3rd Biennial Conference on Resting State Brain Connectivity. Brain 
Connectivity 2. 
(2013). 11th Turkish Neuroscience Congress. Journal of Neurological Sciences 30. 
(2014). Abstracts from the 11th Congress of the European Association of Neuro-
Oncology. Neuro-Oncology 16. 
Ahrens, E.T., and Dubowitz, D.J. (2001). Peripheral somatosensory fMRI in mouse at 
11.7 T. NMR in Biomedicine 14, 318-324. 
Baskerville, T.A., Deuchar, G.A., McCabe, C., Robertson, C.A., Holmes, W.M., 
Santosh, C., and Macrae, I.M. (2011). Influence of 100% and 40% oxygen on 
penumbral blood flow, oxygen level, and T2 -weighted MRI in a rat stroke model. 
Journal of Cerebral Blood Flow & Metabolism 31, 1799-1806. 
Bock, C., Schmitz, B., Kerskens, C.M., Gyngell, M.L., Hossmann, K.A., and Hoehn-
Berlage, M. (1998). Functional MRI of somatosensory activation in rat: Effect of 
hypercapnic up-regulation on perfusion- and BOLD-imaging. Magnet Reson Med 39, 
457-461. 
Boonzaier, J., Van Tilborg, G.A.F., Straathof, M., Petrov, P.I., Van Heijningen, C.L., 
Van Vliet, G., Smirnov, N., Van Der Toorn, A., Neggers, S.F., and Dijkhuizen, R.M. 
(2017). Differential outcomes of rTMS and anesthesia effects on functional 
connectivity in the rat brain. Brain Stimulation 10, 418. 
Cash, D., Read, S., Lythgoe, D., Williams, S., Roberts, T., Ireland, M., Smart, S., and 
Hunter, A. (2003). Autoradiographic and functional MRI of rat brain response to 
amphetamine under halothane and alpha-chloralose anaesthesia. Paper presented 
145 
 
at: J Psychopharmacol (SAGE PUBLICATIONS LTD 6 BONHILL STREET, LONDON 
EC2A 4PU, ENGLAND). 
Chen, C.M., Shih, Y.Y.I., Siow, T.Y., Chiang, Y.C., Chang, C., and Jaw, F.S. (2008). 
Antinociceptive effect of morphine in α-chloralose and isoflurane anesthetized rats 
using bold fMRI. Biomedical Engineering - Applications, Basis and Communications 
20, 39-46. 
Ciobanu, L., Reynaud, O., Uhrig, L., Jarraya, B., and Le Bihan, D. (2012). Effects of 
Anesthetic Agents on Brain Blood Oxygenation Level Revealed with Ultra-High Field 
MRI. Plos One 7, 5. 
Ciobanu, L., Solomon, E., Pyatigorskaya, N., Roussel, T., Le Bihan, D., and 
Frydman, L. (2015). FMRI contrast at high and ultrahigh magnetic fields: Insight from 
complementary methods. NeuroImage 113, 37-43. 
Desjardins, M., Berti, R., Pouliot, P., Dubeau, S., and Lesage, F. (2014). Multimodal 
study of the hemodynamic response to hypercapnia in anesthetized aged rats. 
Neurosci Lett 563, 33-37. 
Dunn, J.F., Ding, S., Azzawi, A., Rolett, E.L., and Weaver, J.B. (1996). Hypoxia 
induced heterogeneity in cerebral vascular response measured using functional MRI. 
FASEB Journal 10. 
Easton, N., Marshall, F.H., Marsden, C.A., and Fone, K.C.F. (2009). Mapping the 
central effects of methylphenidate in the rat using pharmacological MRI BOLD 
contrast. Neuropharmacology 57, 653-664. 
Elbel, G.K., Kalisch, R., Schadrack, J., Droese, D.G., Hipp, R.F., and Auer, D.P. 
(2000). Anesthesia and monitoring for FMRI experiments at 7T in rats. Anesth Analg 
90. 
He, X., Zhu, M., and Yablonskiy, D.A. (2008). Validation of oxygen extraction fraction 
measurement by qBOLD technique. Magnet Reson Med 60, 882-888. 
Henninger, N.M.D., Sicard, K.M.P., Li, Z.P.M.D., Kulkarni, P.P., Dutzmann, S.M.D., 
Urbanek, C.M.D., Schwab, S.M.D., and Fisher, M.M.D. (2007). Differential recovery 
of behavioral status and brain function assessed with functional magnetic resonance 
imaging after mild traumatic brain injury in the rat *. Critical Care Medicine 35, 2607-
2614. 
Huang, S., Du, F., Shih, Y.Y.I., Shen, Q., Gonzalez-Lima, F., and Duong, T.Q. 
(2013). Methylene blue potentiates stimulus-evoked fMRI responses and cerebral 
oxygen consumption during normoxia and hypoxia. NeuroImage 72, 237-242. 
146 
 
Jones, R.A., Müller, T.B., Haraldseth, O., Baptista, A.M., and Øksendal, A.N. (1996). 
Cerebrovascular changes in rats during ischemia and reperfusion: A comparison of 
BOLD and first pass bolus tracking techniques. Magnet Reson Med 35, 489-496. 
Kennan, R.P., Suzuka, S.M., Nagel, R.L., and Fabry, M.E. (2004). Decreased 
Cerebral Perfusion Correlates with Increased BOLD Hyperoxia Response in 
Transgenic Mouse Models of Sickle Cell Disease. Magnet Reson Med 51, 525-532. 
Kettunen, M.I., Gröhn, O.H.J., Penttonen, M., and Kauppinen, R.A. (2001). Cerebral 
T1p relaxation time increases immediately upon global ischemia in the rat 
independently of blood glucose and anoxic depolarization. Magnet Reson Med 46, 
565-572. 
Kettunen, M.I., Grohn, O.H.J., Silvennoinen, M.J., Penttonen, M., and Kauppinen, 
R.A. (2002). Effects of intracellular pH, blood, and tissue oxygen tension on T-1 rho 
relaxation in rat brain. Magnet Reson Med 48, 470-477. 
Kim, T., Jennings, J.R., and Kim, S.G. (2014). Regional cerebral blood flow and 
arterial blood volume and their reactivity to hypercapnia in hypertensive and 
normotensive rats. J Cerebr Blood F Met 34, 408-414. 
Kipervaser, Z.G., Pelled, G., and Goelman, G. (2007). Statistical framework and 
noise sensitivity of the amplitude radial correlation contrast method. Magnet Reson 
Med 58, 554-561. 
Lahti, K.M., Ferris, C.F., Sotak, C.H., and King, J.A. (1997). Functional MRI in 
conscious rats using electrical stimulation of a hind paw. Proceedings of the 1997 
23rd Annual Northeast Bioengineering Conference, 61-62. 
Lin, W., Celik, A., Paczynski, R.P., Hsu, C.Y., and Powers, W.J. (1999). Quantitative 
magnetic resonance imaging in experimental hypercapnia: Improvement in the 
relation between changes in brain R2* and the oxygen saturation of venous blood 
after correction for changes in cerebral blood volume. J Cerebr Blood F Met 19, 853-
862. 
Madularu, D., Mathieu, A.P., Kumaragamage, C., Reynolds, L.M., Near, J., Flores, 
C., and Rajah, M.N. (2017). A non-invasive restraining system for awake mouse 
imaging. J Neurosci Meth 287, 53-57. 
Mahmoud, A.D., Lewis, S., Juricic, L., Udoh, U.-A., Hartmann, S., Jansen, M.A., 
Ogunbayo, O.A., Puggioni, P., Holmes, A.P., Kumar, P., et al. (2016). AMP-activated 
Protein Kinase Deficiency Blocks the Hypoxic Ventilatory Response and Thus 
Precipitates Hypoventilation and Apnea. American Journal of Respiratory & Critical 
Care Medicine 193, 1032-1043. 
147 
 
Martin, C., Kennerley, A., Berwick, J., Sibson, N., and Mayhew, J. (2009). Functional 
magnetic resonance imaging in un-anaesthetized rats using a chronically implanted 
surface coil. J Cerebr Blood F Met 29, S606-S607. 
Martin, C.J., Kennerley, A.J., Berwick, J., Port, M., and Mayhew, J.E. (2013). 
Functional MRI in conscious rats using a chronically implanted surface coil. J Magn 
Reson Imaging 38, 739-744. 
Mitschelen, M., Garteiser, P., Carnes, B.A., Farley, J.A., Doblas, S., DeMoe, J.H., 
Warrington, J.P., Yan, H., Nicolle, M.M., Towner, R., et al. (2009). Basal and 
hypercapnia-altered cerebrovascular perfusion predict mild cognitive impairment in 
aging rodents. Neuroscience 164, 918-928. 
Morton, D.W., Maravilla, K.R., Meno, J.R., and Winn, H.R. (2002). Systemic 
theophylline augments the blood oxygen level-dependent response to forepaw 
stimulation in rats. Am J Neuroradiol 23, 588-593. 
Nair, G., and Duong, T.Q. (2004). Echo-planar BOLD-fMRI of mice on a narrow-bore 
9.4 T magnet. Magnet Reson Med 52, 430-434. 
Ogawa, S., Lee, T.-M., Kay, A.R., and Tank, D.W. (1990). Brain magnetic resonance 
imaging with contrast dependent on blood oxygenation. Proceedings of the National 
Academy of Sciences 87, 9868-9872. 
Ogawa, S., Lee, T.M., and Barrere, B. (1993). The sensitivity of magnetic resonance 
image signals of a rat brain to changes in the cerebral venous blood oxygenation. 
Magnet Reson Med 29, 205-210. 
Paley, M., Mayhew, J.E., Martindale, A.J., McGinley, J., Berwick, J., Coffey, P., 
Redgrave, P., Furness, P., Port, M., Ham, A., et al. (2001). Design and initial 
evaluation of a low-cost 3-Tesla research system for combined optical and functional 
MR imaging with interventional capability. Journal of Magnetic Resonance Imaging 
13, 87-92. 
Pan, W.J., Thompson, G., Magnuson, M., Majeed, W., Jaeger, D., and Keilholz, S. 
(2011). Broadband Local Field Potentials Correlate with Spontaneous Fluctuations in 
Functional Magnetic Resonance Imaging Signals in the Rat Somatosensory Cortex 
Under Isoflurane Anesthesia. Brain Connectivity 1, 119-131. 
Plaschke, K., Bardenheuer, H.J., Martin, E., Sartor, K., and Heiland, S. (2006). 
Evolution of apparent diffusion coefficient and transverse relaxation time (T2) in the 
subchronic stage of global cerebral oligemia in different rat models. Experimental 
Brain Research 169, 361-368. 
Pronger, A.M., Korotcov, A., Bosomtwi, A., Jones, S., Selwyn, R.G., and Diaz-
Arrastia, R. (2014). Mulitimodal neuroimaging with hypercapnia to monitor 
148 
 
cerebrovascular function after traumatic brain injury and evaluate treatment. Journal 
of Neurotrauma 31, A26. 
Schmidt, K.F., Febo, M., Shen, Q., Luo, F., Sicard, K.M., Ferris, C.F., Stein, E.A., and 
Duong, T.Q. (2006). Hemodynamic and metabolic changes induced by cocaine in 
anesthetized rat observed with multimodal functional MRI. Psychopharmacology 185, 
479-486. 
Sedlacik, J., Reitz, M., Bolar, D.S., Adalsteinsson, E., Schmidt, N.O., and Fiehler, J. 
(2015). Correlation of oxygenation and perfusion sensitive MRI with invasive micro 
probe measurements in healthy mice brain. Z Med Phys 25, 77-85. 
Shih, Y.Y.I., Wey, H.Y., De La Garza, B.H., and Duong, T.Q. (2011). Striatal and 
cortical BOLD, blood flow, blood volume, oxygen consumption, and glucose 
consumption changes in noxious forepaw electrical stimulation. J Cerebr Blood F Met 
31, 832-841. 
Shu, C.Y., Sanganahalli, B.G., Coman, D., Herman, P., Rothman, D.L., and Hyder, F. 
(2016a). Quantitative β mapping for calibrated fMRI. NeuroImage 126, 219-228. 
Shu, C.Y.a., Herman, P.b., Coman, D.b., Sanganahalli, B.G.b., Wang, H.b., Juchem, 
C.b.c., Rothman, D.L.a.b., de Graaf, R.A.a.b., and Hyder, F.a.b. (2016b). Brain 
region and activity-dependent properties of M for calibrated fMRI. Neuroimage 125 
Supplement, 848-856. 
Thomas, D.L., Lythgoe, M.F., Gadian, D.G., and Ordidge, R.J. (2002). Rapid 
simultaneous mapping of T2 and T2* by Multiple acquisition of spin and gradient 
echoes using interleaved echo planar imaging (MASAGE-IEPI). NeuroImage 15, 992-
1002. 
Uhrig, L., Ciobanu, L., Djemai, B., Le Bihan, D., and Jarraya, B. (2014). Sedation 
agents differentially modulate cortical and subcortical blood oxygenation: evidence 
from ultra-high field MRI at 17.2 T. PLoS ONE [Electronic Resource] 9, e100323. 
Uludağ, K., and Uğurbil, K. (2015). Physiology and Physics of the fMRI Signal. In 
fMRI: From Nuclear Spins to Brain Functions (Springer), pp. 163-213. 
Vanhoutte, G., Verhoye, M., and Van Der Linden, A. (2006). Changing body 
temperature affects the T2* signal in the rat brain and reveals hypothalamic activity. 
Magnet Reson Med 55, 1006-1012. 
Wang, X., Zhu, X.H., Zhang, Y., and Chen, W. (2012). Large enhancement of 
perfusion contribution on fMRI signal. J Cerebr Blood F Met 32, 907-918. 
Wang, X., Zhu, X.H., Zhang, Y., and Chen, W. (2015). Simultaneous imaging of CBF 
change and BOLD with saturation-recovery-T<inf>1</inf> method. PLoS ONE 10. 
149 
 
Williams, S.R., Hodkinson, D., Cash, D., Gigg, J., Williams, S.C., and Deakin, J.W. 
(2013). Minocycline interferes with glutamate neurotransmission in an animal model 
of psychosis and with neurovascular coupling. Journal of Neurochemistry 125, 233-
234. 
Wu, G., Luo, F., Li, Z., Zhao, X., and Li, S.J. (2002). Transient relationships among 
BOLD, CBV, and CBF changes in rat brain as detected by functional MRI. Magnet 
Reson Med 48, 987-993. 
Zhou, J., Payen, J.-F., and van Zijl, P.C.M. (2005). The interaction between 
magnetization transfer and blood-oxygen-level-dependent effects. Magnet Reson 
Med 53, 356-366. 
  
150 
 
6.5 List of definitively included references  
 
Reference 
ID 
Authors Title Year 
13122 Schroeter, 
A.,Grandjean, 
J.,Schlegel, F.,Saab, B. 
J.,Rudin, M. 
Contributions of structural connectivity 
and cerebrovascular parameters to 
functional magnetic resonance 
imaging signals in mice at rest and 
during sensory paw stimulation 
2017 
13123 Smith, J. B.,Liang, 
Z.,Watson, G. D. 
R.,Alloway, K. 
D.,Zhang, N. 
Interhemispheric resting-state 
functional connectivity of the 
claustrum in the awake and 
anesthetized states 
2017 
13136 Grandjean, J.,Preti, M. 
G.,Bolton, T. A. 
W.,Buerge, M.,Seifritz, 
E.,Pryce, C. R.,Van De 
Ville, D.,Rudin, M. 
Dynamic reorganization of intrinsic 
functional networks in the mouse brain 
2017 
13142 Abe, Y.,Tsurugizawa, 
T.,Le Bihan, D. 
Water diffusion closely reveals neural 
activity status in rat brain loci affected 
by anesthesia 
2017 
13145 Wu, T.,Grandjean, 
J.,Bosshard, S. 
C.,Rudin, M.,Reutens, 
D.,Jiang, T. 
Altered regional connectivity reflecting 
effects of different anaesthesia 
protocols in the mouse brain 
2017 
13158 Hamilton, C.,Ma, 
Y.,Zhang, N. 
Global reduction of information 
exchange during anesthetic-induced 
unconsciousness 
2017 
13169 Bukhari, Q.,Schroeter, 
A.,Cole, D. M.,Rudin, 
M. 
Resting state fMRI in mice reveals 
anesthesia specific signatures of brain 
functional networks and their 
interactions 
2017 
13170 Ma, Y.,Hamilton, 
C.,Zhang, N. 
Dynamic Connectivity Patterns in 
Conscious and Unconscious Brain 
2017 
13184 Brynildsen, J. K.,Hsu, L. 
M.,Ross, T. J.,Stein, E. 
A.,Yang, Y.,Lu, H. 
Physiological characterization of a 
robust survival rodent fMRI method 
2017 
13186 Gill, R. S.,Mirsattari, S. 
M.,Leung, L. S. 
Resting state functional network 
disruptions in a kainic acid model of 
temporal lobe epilepsy 
2017 
13198 Tomimatsu, Y.,Cash, 
D.,Suzuki, M.,Suzuki, 
K.,Bernanos, 
M.,Simmons, 
C.,Williams, S. C. 
R.,Kimura, H. 
TAK-063, a phosphodiesterase 10A 
inhibitor, modulates neuronal activity 
in various brain regions in phMRI and 
EEG studies with and without 
ketamine challenge 
2016 
13199 Tsurugizawa, 
T.,Takahashi, Y.,Kato, 
F. 
Distinct effects of isoflurane on basal 
BOLD signals in tissue/vascular 
microstructures in rats 
2016 
151 
 
13203 Yoshida, K.,Mimura, 
Y.,Ishihara, R.,Nishida, 
H.,Komaki, 
Y.,Minakuchi, 
T.,Tsurugizawa, 
T.,Mimura, M.,Okano, 
H.,Tanaka, K. 
F.,Takata, N. 
Physiological effects of a habituation 
procedure for functional MRI in awake 
mice using a cryogenic radiofrequency 
probe 
2016 
13234 Hudetz, A. G.,Liu, 
X.,Pillay, S.,Boly, 
M.,Tononi, G. 
Propofol anesthesia reduces Lempel-
Ziv complexity of spontaneous brain 
activity in rats 
2016 
13242 Chang, P. C.,Procissi, 
D.,Bao, Q.,Centeno, M. 
V.,Baria, A.,Apkarian, 
A. V. 
Novel method for functional brain 
imaging in awake minimally restrained 
rats 
2016 
13247 Shah, D.,Blockx, 
I.,Keliris, G. A.,Kara, 
F.,Jonckers, 
E.,Verhoye, M.,Van der 
Linden, A. 
Cholinergic and serotonergic 
modulations differentially affect large-
scale functional networks in the 
mouse brain 
2016 
13265 Zhurakovskaya, 
E.,Paasonen, 
J.,Shatillo, A.,Lipponen, 
A.,Salo, R.,Aliev, 
R.,Tanila, H.,Gröhn, O. 
Global functional connectivity 
differences between sleep-like states 
in urethane anesthetized rats 
measured by fMRI 
2016 
13282 Paasonen, J.,Salo, R. 
A.,Shatillo, A.,Forsberg, 
M. M.,Närväinen, 
J.,Huttunen, J. 
K.,Gröhn, O. 
Comparison of seven different 
anesthesia protocols for nicotine 
pharmacologic magnetic resonance 
imaging in rat 
2016 
13309 Paasonen, J.,Salo, R. 
A.,Huttunen, J. 
K.,Gröhn, O. 
Resting-state functional MRI as a tool 
for evaluating brain hemodynamic 
responsiveness to external stimuli in 
rats 
2016 
13345 Grimm, O.,Gass, 
N.,Weber-Fahr, 
W.,Sartorius, 
A.,Schenker, 
E.,Spedding, 
M.,Risterucci, 
C.,Schweiger, J. 
I.,Böhringer, A.,Zang, 
Z.,Tost, H.,Schwarz, A. 
J.,Meyer-Lindenberg, A. 
Acute ketamine challenge increases 
resting state prefrontal-hippocampal 
connectivity in both humans and rats 
2015 
13361 Liang, Z.,Watson, G. D. 
R.,Alloway, K. D.,Lee, 
G.,Neuberger, 
T.,Zhang, N. 
Mapping the functional network of 
medial prefrontal cortex by combining 
optogenetics and fMRI in awake rats 
2015 
152 
 
13362 Nasrallah, F. A.,Yeow, 
L. Y.,Biswal, 
B.,Chuang, K. H. 
Dependence of BOLD signal 
fluctuation on arterial blood 
CO<inf>2</inf> and O<inf>2</inf>: 
Implication for resting-state functional 
connectivity 
2015 
13364 Schlegel, F.,Schroeter, 
A.,Rudin, M. 
The hemodynamic response to 
somatosensory stimulation in mice 
depends on the anesthetic used: 
Implications on analysis of mouse 
fMRI data 
2015 
13374 Bettinardi, R. G.,Tort-
Colet, N.,Ruiz-Mejias, 
M.,Sanchez-Vives, M. 
V.,Deco, G. 
Gradual emergence of spontaneous 
correlated brain activity during fading 
of general anesthesia in rats: 
Evidences from fMRI and local field 
potentials 
2015 
13399 Hudetz, A. G.,Liu, 
X.,Pillay, S. 
Dynamic repertoire of intrinsic brain 
states is reduced in propofol-induced 
unconsciousness 
2015 
13403 Lai, H. Y.,Albaugh, D. 
L.,Kao, Y. C. J.,Younce, 
J. R.,Shih, Y. Y. I. 
Robust deep brain stimulation 
functional MRI procedures in rats and 
mice using an MR-compatible 
tungsten microwire electrode 
2015 
13422 Liang, Z.,Liu, X.,Zhang, 
N. 
Dynamic resting state functional 
connectivity in awake and 
anesthetized rodents 
2015 
13464 Nasrallah, F. A.,Low, S. 
M. A.,Lew, S. K.,Chen, 
K.,Chuang, K. H. 
Pharmacological insight into 
neurotransmission origins of resting-
state functional connectivity: α2-
adrenergic agonist vs antagonist 
2014 
13471 Grandjean, 
J.,Schroeter, A.,Batata, 
I.,Rudin, M. 
Optimization of anesthesia protocol for 
resting-state fMRI in mice based on 
differential effects of anesthetics on 
functional connectivity patterns 
2014 
13472 Kundu, P.,Santin, M. 
D.,Bandettini, P. 
A.,Bullmore, E. 
T.,Petiet, A. 
Differentiating BOLD and non-BOLD 
signals in fMRI time series from 
anesthetized rats using multi-echo EPI 
at 11.7T 
2014 
13482 Gong, L.,Li, B.,Wu, 
R.,Li, A.,Xu, F. 
Brain-state dependent uncoupling of 
BOLD and local field potentials in 
laminar olfactory bulb 
2014 
13493 Schroeter, A.,Schlegel, 
F.,Seuwen, 
A.,Grandjean, J.,Rudin, 
M. 
Specificity of stimulus-evoked fMRI 
responses in the mouse: The 
influence of systemic physiological 
changes associated with innocuous 
stimulation under four different 
anesthetics 
2014 
13500 Chao, T. H. H.,Chen, J. 
H.,Yen, C. T. 
Repeated BOLD-fMRI imaging of 
deep brain stimulation responses in 
rats 
2014 
153 
 
13523 Magnuson, M. 
E.,Thompson, G. 
J.,Pan, W. J.,Keilholz, 
S. D. 
Time-dependent effects of isoflurane 
and dexmedetomidine on functional 
connectivity, spectral characteristics, 
and spatial distribution of spontaneous 
BOLD fluctuations 
2014 
13525 Gass, N.,Schwarz, A. 
J.,Sartorius, 
A.,Schenker, 
E.,Risterucci, 
C.,Spedding, M.,Zheng, 
L.,Meyer-Lindenberg, 
A.,Weber-Fahr, W. 
Sub-anesthetic ketamine modulates 
intrinsic BOLD connectivity within the 
hippocampal-prefrontal circuit in the 
rat 
2014 
13533 Nasrallah, F. A.,Tay, H. 
C.,Chuang, K. H. 
Detection of functional connectivity in 
the resting mouse brain 
2014 
13542 Jonckers, E.,Palacios, 
R. D.,Shah, 
D.,Guglielmetti, 
C.,Verhoye, M.,Van Der 
Linden, A. 
Different anesthesia regimes 
modulate the functional connectivity 
outcome in mice 
2014 
13547 Nasrallah, F. A.,Lew, S. 
K.,Low, A. S. 
M.,Chuang, K. H. 
Neural correlate of resting-state 
functional connectivity under α2 
adrenergic receptor agonist, 
medetomidine 
2014 
13634 Liu, X.,Pillay, S.,Li, 
R.,Vizuete, J. 
A.,Pechman, K. 
R.,Schmainda, K. 
M.,Hudetz, A. G. 
Multiphasic modification of intrinsic 
functional connectivity of the rat brain 
during increasing levels of propofol 
2013 
13637 Liang, Z.,Li, T.,King, 
J.,Zhang, N. 
Mapping thalamocortical networks in 
rat brain using resting-state functional 
connectivity 
2013 
13703 Liu, X.,Zhu, X. 
H.,Zhang, Y.,Chen, W. 
The change of functional connectivity 
specificity in rats under various 
anesthesia levels and its neural origin 
2013 
13715 Kalthoff, D.,Po, 
C.,Wiedermann, 
D.,Hoehn, M. 
Reliability and spatial specificity of rat 
brain sensorimotor functional 
connectivity networks are superior 
under sedation compared with general 
anesthesia 
2013 
13729 Huang, S.,Du, F.,Shih, 
Y. Y. I.,Shen, 
Q.,Gonzalez-Lima, 
F.,Duong, T. Q. 
Methylene blue potentiates stimulus-
evoked fMRI responses and cerebral 
oxygen consumption during normoxia 
and hypoxia 
2013 
13841 Liu, X.,Li, R.,Yang, 
Z.,Hudetz, A. G.,Li, S. 
J. 
Differential effect of isoflurane, 
medetomidine, and urethane on 
BOLD responses to acute levo-
tetrahydropalmatine in the rat 
2012 
13843 Liang, Z.,King, 
J.,Zhang, N. 
Intrinsic organization of the 
anesthetized brain 
2012 
154 
 
13849 Airaksinen, A. 
M.,Hekmatyar, S. 
K.,Jerome, 
N.,Niskanen, J. 
P.,Huttunen, J. 
K.,Pitkänen, 
A.,Kauppinen, R. 
A.,Gröhn, O. H. 
Simultaneous BOLD fMRI and local 
field potential measurements during 
kainic acid-induced seizures 
2012 
13890 Nasrallah, F. A.,Tan, 
J.,Chuang, K. H. 
Pharmacological modulation of 
functional connectivity: α 2-adrenergic 
receptor agonist alters synchrony but 
not neural activation 
2012 
13891 Sumiyoshi, A.,Suzuki, 
H.,Ogawa, T.,Riera, J. 
J.,Shimokawa, 
H.,Kawashima, R. 
Coupling between gamma oscillation 
and fMRI signal in the rat 
somatosensory cortex: Its 
dependence on systemic physiological 
parameters 
2012 
13903 Liang, Z.,King, 
J.,Zhang, N. 
Anticorrelated resting-state functional 
connectivity in awake rat brain 
2012 
13911 Tu, Y.,Yu, T.,Fu, X. 
Y.,Xie, P.,Lu, S.,Huang, 
X. Q.,Gong, Q. Y. 
Altered thalamocortical functional 
connectivity by propofol anesthesia in 
rats 
2011 
13930 Herman, 
P.,Sanganahalli, B. 
G.,Hyder, F.,Eke, A. 
Fractal analysis of spontaneous 
fluctuations of the BOLD signal in rat 
brain 
2011 
13948 Pan, W. J.,Thompson, 
G.,Magnuson, 
M.,Majeed, W.,Jaeger, 
D.,Keilholz, S. 
Broadband Local Field Potentials 
Correlate with Spontaneous 
Fluctuations in Functional Magnetic 
Resonance Imaging Signals in the Rat 
Somatosensory Cortex Under 
Isoflurane Anesthesia 
2011 
13959 Wilson, D. A.,Hoptman, 
M. J.,Gerum, S. 
V.,Guilfoyle, D. N. 
State-dependent functional 
connectivity of rat olfactory system 
assessed by fMRI 
2011 
13976 Min, D. K.,Tuor, U. 
I.,Chelikani, P. K. 
Gastric distention induced functional 
magnetic resonance signal changes in 
the rodent brain 
2011 
13988 Desai, M.,Kahn, 
I.,Knoblich, 
U.,Bernstein, J.,Atallah, 
H.,Yang, A.,Kopell, 
N.,Buckner, R. 
L.,Graybiel, A. 
M.,Moore, C. I.,Boyden, 
E. S. 
Mapping brain networks in awake 
mice using combined optical neural 
control and fMRI 
2011 
13995 de Celis Alonso, 
B.,Makarova, T.,Hess, 
A. 
On the use of α-chloralose for 
repeated BOLD fMRI measurements 
in rats 
2011 
155 
 
13996 Kalthoff, D.,Seehafer, J. 
U.,Po, C.,Wiedermann, 
D.,Hoehn, M. 
Functional connectivity in the rat at 
11.7T: Impact of physiological noise in 
resting state fMRI 
2011 
13999 Liu, X.,Zhu, X. 
H.,Zhang, Y.,Chen, W. 
Neural origin of spontaneous 
hemodynamic fluctuations in rats 
under burst-suppression anesthesia 
condition 
2011 
14009 Wang, K.,Van Meer, M. 
P.,Van Der Marel, 
K.,Van Der Toorn, 
A.,Xu, L.,Liu, 
Y.,Viergever, M. 
A.,Jiang, T.,Dijkhuizen, 
R. M. 
Temporal scaling properties and 
spatial synchronization of 
spontaneous blood oxygenation level-
dependent (BOLD) signal fluctuations 
in rat sensorimotor network at different 
levels of isoflurane anesthesia 
2011 
14036 Williams, K. 
A.,Magnuson, 
M.,Majeed, 
W.,LaConte, S. 
M.,Peltier, S. J.,Hu, 
X.,Keilholz, S. D. 
Comparison of α-chloralose, 
medetomidine and isoflurane 
anesthesia for functional connectivity 
mapping in the rat 
2010 
14056 Hutchison, R. 
M.,Mirsattari, S. 
M.,Jones, C. K.,Gati, J. 
S.,Leung, L. S. 
Functional networks in the 
anesthetized rat brain revealed by 
independent component analysis of 
resting-state fMRI 
2010 
14084 Tsurugizawa, 
T.,Uematsu, 
A.,Uneyama, H.,Torii, 
K. 
Effects of isoflurane and alpha-
chloralose anesthesia on BOLD fMRI 
responses to ingested l-glutamate in 
rats 
2010 
14121 Sommers, M. G.,van 
Egmond, J.,Booij, L. H. 
D. J.,Heerschap, A. 
Isoflurane anesthesia is a valuable 
alternative for α-chloralose anesthesia 
in the forepaw stimulation model in 
rats 
2009 
14131 Pawela, C. P.,Biswal, B. 
B.,Hudetz, A. 
G.,Schulte, M. L.,Li, 
R.,Jones, S. R.,Cho, Y. 
R.,Matloub, H. S.,Hyde, 
J. S. 
A protocol for use of medetomidine 
anesthesia in rats for extended 
studies using task-induced BOLD 
contrast and resting-state functional 
connectivity 
2009 
14144 Lu, J.,Dai, G.,Egi, 
Y.,Huang, S.,Kwon, S. 
J.,Lo, E. H.,Kim, Y. R. 
Characterization of cerebrovascular 
responses to hyperoxia and 
hypercapnia using MRI in rat 
2009 
14199 Asanuma, T.,Yasui, 
H.,Sato, M.,Inanami, 
O.,Kuwabara, M. 
A BOLD-fMRI study of cerebral 
activation induced by injection of 
algesic chemical substances into the 
anesthetized rat forepaw 
2008 
14219 Kannurpatti, S. 
S.,Biswal, B. B.,Kim, Y. 
R.,Rosen, B. R. 
Spatio-temporal characteristics of low-
frequency BOLD signal fluctuations in 
isoflurane-anesthetized rat brain 
2008 
156 
 
14234 Chen, C. M.,Shih, Y. Y. 
I.,Siow, T. Y.,Chiang, Y. 
C.,Chang, C.,Jaw, F. S. 
Antinociceptive effect of morphine in 
α-chloralose and isoflurane 
anesthetized rats using bold fMRI 
2008 
14238 Huttunen, J. K.,Gröhn, 
O.,Penttonen, M. 
Coupling between simultaneously 
recorded BOLD response and 
neuronal activity in the rat 
somatosensory cortex 
2008 
14246 Maandag, N. J. 
G.,Coman, 
D.,Sanganahalli, B. 
G.,Herman, P.,Smith, A. 
J.,Blumenfeld, 
H.,Shulman, R. 
G.,Hyder, F. 
Energetics of neuronal signaling and 
fMRI activity 
2007 
14258 Herman, 
P.,Sanganahalli, 
B.,Hyder, F.,Eke, A. 
Non-invasive hypotensive FMRI study 
in rat somatosensory cortex 
2007 
14268 Tuor, U. I.,Wang, 
R.,Zhao, Z.,Foniok, 
T.,Rushforth, 
D.,Wamsteeker, J. 
I.,Qiao, M. 
Transient hypertension concurrent 
with forepaw stimulation enhances 
functional MRI responsiveness in 
infarct and peri-infarct regions 
2007 
14304 Qiao, M.,Rushforth, 
D.,Wang, R.,Shaw, R. 
A.,Tomanek, B.,Dunn, 
J. F.,Tuor, U. I. 
Blood-oxygen-level-dependent 
magnetic resonance signal and 
cerebral oxygenation responses to 
brain activation are enhanced by 
concurrent transient hypertension in 
rats 
2007 
14321 Duong, T. Q. Cerebral blood flow and BOLD fMRI 
responses to hypoxia in awake and 
anesthetized rats 
2007 
14363 Littlewood, C. L.,Cash, 
D.,Dixon, A. L.,Dix, S. 
L.,White, C. T.,O'Neill, 
M. J.,Tricklebank, 
M.,Williams, S. C. R. 
Using the BOLD MR signal to 
differentiate the stereoisomers of 
ketamine in the rat 
2006 
14377 Wang, R.,Foniok, 
T.,Wamsteeker, J. 
I.,Qiao, M.,Tomanek, 
B.,Vivanco, R. A.,Tuor, 
U. I. 
Transient blood pressure changes 
affect the functional magnetic 
resonance imaging detection of 
cerebral activation 
2006 
14378 Schmidt, K. F.,Febo, 
M.,Shen, Q.,Luo, 
F.,Sicard, K. M.,Ferris, 
C. F.,Stein, E. 
A.,Duong, T. Q. 
Hemodynamic and metabolic changes 
induced by cocaine in anesthetized rat 
observed with multimodal functional 
MRI 
2006 
14381 Vanhoutte, G.,Verhoye, 
M.,Van Der Linden, A. 
Changing body temperature affects 
the T2* signal in the rat brain and 
reveals hypothalamic activity 
2006 
157 
 
14382 Littlewood, C. L.,Jones, 
N.,O'Neill, M. 
J.,Mitchell, S. 
N.,Tricklebank, 
M.,Williams, S. C. R. 
Mapping the central effects of 
ketamine in the rat using 
pharmacological MRI 
2006 
14388 Weber, R.,Ramos-
Cabrer, 
P.,Wiedermann, D.,Van 
Camp, N.,Hoehn, M. 
A fully noninvasive and robust 
experimental protocol for longitudinal 
fMRI studies in the rat 
2006 
14401 Kuo, C. C.,Chen, J. 
H.,Tsai, C. Y.,Liang, K. 
C.,Yen, C. T. 
BOLD signals correlate with ensemble 
unit activities in rat's somatosensory 
cortex 
2005 
14409 Ramos-Cabrer, 
P.,Weber, 
R.,Wiedermann, 
D.,Hoehn, M. 
Continuous noninvasive monitoring of 
transcutaneous blood gases for a 
stable and persistent BOLD contrast 
in fMRI studies in the rat 
2005 
14423 Kalisch, R.,Delfino, 
M.,Murer, M. G.,Auer, 
D. P. 
The phenylephrine blood pressure 
clamp in pharmacologic magnetic 
resonance imaging: Reduction of 
systemic confounds and improved 
detectability of drug-induced BOLD 
signal changes 
2005 
14437 Sicard, K. M.,Duong, T. 
Q. 
Effects of hypoxia, hyperoxia, and 
hypercapnia on baseline and stimulus-
evoked BOLD, CBF, and CMRO2 in 
spontaneously breathing animals 
2005 
14445 Dashti, M.,Geso, 
M.,Williams, J. 
The effects of anaesthesia on cortical 
stimulation in rats: A functional MRI 
study 
2005 
14459 Austin, V. C.,Blamire, A. 
M.,Allers, K. A.,Sharp, 
T.,Styles, P.,Matthews, 
P. M.,Sibson, N. R. 
Confounding effects of anesthesia on 
functional activation in rodent brain: A 
study of halothane and α-chloralose 
anesthesia 
2005 
14502 Kannurpatti, S. 
S.,Biswal, B. B. 
Effect of anesthesia on CBF, MAP 
and fMRI-BOLD signal in response to 
apnea 
2004 
14533 Brevard, M. E.,Duong, 
T. Q.,King, J. A.,Ferris, 
C. F. 
Changes in MRI signal intensity during 
hypercapnic challenge under 
conscious and anesthetized 
conditions 
2003 
14539 Tenney, J. R.,Duong, T. 
Q.,King, J. A.,Ludwig, 
R.,Ferris, C. F. 
Corticothalamic modulation during 
absence seizures in rats: A functional 
MRI assessment 
2003 
14544 Kannurpatti, S. 
S.,Biswal, B. B.,Hudetz, 
A. G. 
Baseline physiological state and the 
fMRI-BOLD signal response to apnea 
in anesthetized rats 
2003 
14548 Kannurpatti, S. 
S.,Biswal, B. B.,Hudetz, 
A. G. 
Regional dynamics of the fMRI-BOLD 
signal response to hypoxia-
hypercapnia in the rat brain 
2003 
158 
 
14558 Sicard, K.,Shen, 
Q.,Brevard, M. 
E.,Sullivan, R.,Ferris, C. 
F.,King, J. A.,Duong, T. 
Q. 
Regional cerebral blood flow and 
BOLD responses in conscious and 
anesthetized rats under basal and 
hypercapnic conditions: Implications 
for functional MRI studies 
2003 
14562 Luo, F.,Wu, G.,Li, Z.,Li, 
S. J. 
Characterization of effects of mean 
arterial blood pressure induced by 
cocaine and cocaine methiodide on 
bold signals in rat brain 
2003 
14569 Tuor, U. I.,McKenzie, 
E.,Tomanek, B. 
Functional magnetic resonance 
imaging of tonic pain and vasopressor 
effects in rats 
2002 
14584 Dutka, M. V.,Scanley, 
B. E.,Does, M. D.,Gore, 
J. C. 
Changes in CBF-BOLD coupling 
detected by MRI during and after 
repeated transient hypercapnia in rat 
2002 
14589 Kannurpatti, Erratum: Differential fMRI-BOLD 
signal response to apnea in humans 
and anesthetized rats (Magnetic 
Ressonance in Medicine (2002) 47:5 
(864-870)) 
2002 
14615 Kalisch, R.,Elbel, G. 
K.,Gössl, C.,Czisch, 
M.,Auer, D. P. 
Blood pressure changes induced by 
arterial blood withdrawal influence 
bold signal in anesthesized rats at 7 
Tesla: Implications for pharmacologic 
MRI 
2001 
14617 Peeters, R. 
R.,Tindemans, I.,De 
Schutter, E.,Van der 
Linden, A. 
Comparing BOLD fMRI signal 
changes in the awake and 
anesthetized rat during electrical 
forepaw stimulation 
2001 
14654 Xu, H.,Li, S. J.,Bodurka, 
J.,Zhao, X.,Xi, Z. 
X.,Stein, E. A. 
Heroin-induced neuronal activation in 
rat brain assessed by functional MRI 
2000 
14670 Zaharchuk, 
G.,Mandeville, J. 
B.,Bogdanov Jr, A. 
A.,Weissleder, 
R.,Rosen, B. R.,Marota, 
J. J. A. 
Cerebrovascular dynamics of 
autoregulation and hypoperfusion: An 
MRI study of CBF and changes in 
total and microvascular cerebral blood 
volume during hemorrhagic 
hypotension 
1999 
14678 Dunn, J. F.,Zaim 
Wadghiri, Y.,Meyerand, 
M. E. 
Regional heterogeneity in the brain's 
response to hypoxia measured using 
BOLD MR imaging 
1999 
14685 Hempel, E.,Reith, 
W.,Elste, V.,Heiland, 
S.,Sartor, K. 
Influence of stimulus frequency, 
amplitude and blood pressure on 
signal change in fMRI 
1999 
14688 Lahti, K. M.,Ferris, C. 
F.,Li, F.,Sotak, C. 
H.,King, J. A. 
Comparison of evoked cortical activity 
in conscious and propofol- 
anesthetized rats using functional MRI 
1999 
14696 Lin, W.,Paczynski, R. 
P.,Celik, A.,Hsu, C. 
Effects of acute normovolemic 
hemodilution on T2*-weighted images 
1998 
159 
 
Y.,Powers, W. J. of rat brain 
14702 Hsu, E. W.,Hedlund, L. 
W.,MacFall, J. R. 
Functional MRI of the rat 
somatosensory cortex: Effects of 
hyperventilation 
1998 
14703 Lin, W.,Paczynski, R. 
P.,Celik, A.,Hsu, C. 
Y.,Powers, W. J. 
Experimental hypoxemic hypoxia: 
Effects of variation in hematocrit on 
magnetic resonance T2*-weighted 
brain images 
1998 
14715 Bock, C.,Schmitz, 
B.,Kerskens, C. 
M.,Gyngell, M. 
L.,Hossmann, K. 
A.,Hoehn-Berlage, M. 
Functional MRI of somatosensory 
activation in rat: Effect of hypercapnic 
up-regulation on perfusion- and 
BOLD-imaging 
1998 
14716 Lin, W.,Paczynski, R. 
P.,Celik, 
A.,Kuppusamy, K.,Hsu, 
C. Y.,Powers, W. J. 
Experimental hypoxemic hypoxia: 
Changes in R2* of brain parenchyma 
accurately reflect the combined effects 
of changes in arterial and cerebral 
venous oxygen saturation 
1998 
14721 Dunn, J. F.,Swartz, H. 
M. 
Blood oxygenation: Heterogeneity of 
hypoxic tissues monitored using bold 
MR imaging 
1997 
14734 Kida, I.,Yamamoto, 
T.,Tamura, M. 
Interpretation of BOLD MRI signals in 
rat brain using simultaneously 
measured near-infrared 
spectrophotometric information 
1996 
14746 Graham, G. D.,Zhong, 
J.,Petroff, O. A. 
C.,Constable, R. 
T.,Prichard, J. W.,Gore, 
J. C. 
BOLD MRI monitoring of changes in 
cerebral perfusion induced by 
acetazolamide and hypercarbia in the 
rat 
1994 
15189 Sedlacik, J.,Reitz, 
M.,Bolar, D. 
S.,Adalsteinsson, 
E.,Schmidt, N. 
O.,Fiehler, J. 
Correlation of oxygenation and 
perfusion sensitive MRI with invasive 
micro probe measurements in healthy 
mice brain 
2015 
15316 Mechling, A. E.,Hubner, 
N. S.,Lee, H. L.,Hennig, 
J.,von Elverfeldt, 
D.,Harsan, L. A. 
Fine-grained mapping of mouse brain 
functional connectivity with resting-
state fMRI 
2014 
15923 Lowry, J. P.,Griffin, 
K.,McHugh, S. B.,Lowe, 
A. S.,Tricklebank, 
M.,Sibson, N. R. 
Real-time electrochemical monitoring 
of brain tissue oxygen: A surrogate for 
functional magnetic resonance 
imaging in rodents 
2010 
16784 Houston, G. 
C.,Papadakis, N. 
G.,Carpenter, T. A.,Hall, 
L. D.,Mukherjee, 
B.,James, M. F.,Huang, 
Mapping of the cerebral response to 
hypoxia measured using graded 
asymmetric spin echo EPI 
2000 
160 
 
C. L. H. 
20115 Baskerville, T. 
A.,Deuchar, G. 
A.,McCabe, 
C.,Robertson, C. 
A.,Holmes, W. 
M.,Santosh, C.,Macrae, 
I. M. 
Influence of 100% and 40% oxygen 
on penumbral blood flow, oxygen 
level, and T2 -weighted MRI in a rat 
stroke model 
2011 
22637 Prielmeier, 
F.,Nagatomo, Y.,Frahm, 
J. 
Cerebral blood oxygenation in rat 
brain during hypoxic hypoxia. 
Quantitative MRI of effective 
transverse relaxation rates 
1994 
22791 Prielmeier, F.,Merboldt, 
K. D.,Hanicke, 
W.,Frahm, J. 
Dynamic high-resolution MR imaging 
of brain deoxygenation during 
transient anoxia in the anesthetized 
rat 
1993 
23151 Boonzaier, J.,Van 
Tilborg, G. A. 
F.,Straathof, M.,Petrov, 
P. I.,Van Heijningen, C. 
L.,Van Vliet, 
G.,Smirnov, N.,Van Der 
Toorn, A.,Neggers, S. 
F.,Dijkhuizen, R. M. 
Differential outcomes of rTMS and 
anesthesia effects on functional 
connectivity in the rat brain 
2017 
24362 Sanganahalli, B. 
G.,Herman, 
P.,Blumenfeld, 
H.,Hyder, F. 
FMRI and electrophysiological studies 
with α-chloralose and domitor 
anesthesia 
2009 
29730495 HJ Shim, WB Jung, F 
Schlegel, J Lee, S Kim, 
J Lee, SG Kim 
Mouse fMRI under ketamine and 
xylazine anesthesia: Robust 
contralateral somatosensory cortex 
activation in response to forepaw 
stimulation. 
2018 
29730496 W. Gsell, A. Giarola, T. 
Reese, A. J. Schwarz , 
H. Barjat, S. Smart, A. 
Gozzi, S. Bertani , V. 
Crestan, A. Bifone 
Carry-over effects of gaseous 
anaesthesia on fMRI response and 
tissue oxygen levels in the rat brain 
n.d. 
 
  
161 
 
6.6 The adapted SYRCLE risk of bias tool  
 
Questions can be answered with “yes”, indicating a low risk of bias, “no”, indicating a 
high risk of bias, and “unclear”, meaning that the risk of bias is unclear based on the 
information provided in the respective publication. Guidelines of all journals in which 
the included references are published were checked for specific requirements 
regarding blinding and randomization (list see below). None of those journals claimed 
to publish only randomized or blinded studies. 
To summarize the risk of bias per study as well as across studies, the approach 
proposed in the Cochrane risk of bias tool will be used (Higgins et al., 2011). 
 
6.6.1 Items  
 
1. Selection bias – sequence generation 
 
Describe the methods used, if any, to generate the allocation sequence in 
sufficient detail to allow an assessment whether it should produce comparable 
groups. 
 
Was the allocation sequence adequately generated and applied? 
 
Did the investigators describe a random component in the sequence 
generation process such as:        
Referring to a random number table; 
Using a computer random number generator. 
 
Additional information 
 
Examples of a non-random approach: 
• Allocation by judgment or by investigator’s preference; 
• Allocation based on the results of a laboratory test or a series of tests; 
• Allocation by availability of the intervention; 
• Sequence generated by odd or even date of birth; 
• Sequence generated by some rule based on animal number or cage 
number. 
 
Practical implementation 
• If method described → yes or no depending on method 
• If method not described → unclear 
 
 
2. Selection bias – baseline characteristics 
Describe animal characteristics, if any, that are compared in order to judge 
whether or not intervention and control groups were similar at the start of the 
experiment. 
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Were the groups similar at baseline or were they adjusted for 
confounders in the analysis? 
 
Was the distribution of relevant baseline characteristics balanced for the 
intervention and control groups?        
If relevant, did the investigators adequately adjust for unequal distribution of 
some relevant baseline characteristics in the analysis?    
  
 
Additional information 
 
Relevant baseline characteristics are age, sex and weigth; timepoint of 
baseline image acquisition relative to induction and eventual change of 
anaesthetic; response to stimulation at baseline.  
 
Practical implementation 
• If clearly similar → yes 
• If partially similar, but not all relevant information reported → unclear 
• If clearly different or no information on any of the relevant characteristics 
reported → no 
 
 
3. Selection bias – allocation concealment 
 
Describe the method used to conceal the allocation sequence in sufficient 
detail to determine whether intervention allocations could have been foreseen 
before or during enrolment. 
 
Was the allocation adequately concealed? 
 
Could the investigator allocating the animals to intervention or control group 
not foresee assignment due to one of the following or equivalent methods? 
• Third-party coding of experimental and control group allocation 
• Central randomization by a third party 
• Sequentially numbered opaque, sealed envelopes 
 
Additional information 
 
Examples of investigators allocating the animals being 
possibly able to foresee assignments: 
• Open randomization schedule 
• Envelopes without appropriate safeguard 
• Alternation or rotation 
• Allocation based on date of birth 
• Allocation based on animal number 
• Any other explicitly unconcealed procedure of a non-random approach
  
163 
 
Practical implementation 
• If method described → yes or no according to list of positive and negative 
examples 
• If method not described → unclear 
 
 
4. Performance bias – blinding 
 
Describe all measures used, if any, to blind trial caregivers and researchers 
from knowing which intervention each animal received. Provide any 
information relating to whether the intended blinding was effective. 
 
Were the caregivers and /or investigators blinded from knowledge which 
intervention each animal received during the experiment? Were animals 
selected at random for outcome assessment? 
 
Was blinding of caregivers and investigators ensured, and was it unlikely that 
their blinding could have been broken?      
• ID cards of individual animals, or cage/animal labels are coded and 
identical in appearance. 
• Administration of anaesthetics is performed by a person not involved in 
image processing and outcome assessment; the investigators cannot see 
the procedure and the vaporizer setting. 
• The circumstances during the intervention are specified and similar in both 
groups. 
 
Additional information 
 
Examples of inappropriate blinding: 
• Colored cage labels (red for group A, yellow group B) 
• Expected differences in visible effects between control and experimental 
groups 
• The individual who prepares the experiment is the same as the one who 
conducts and analyses the experiment 
• Circumstances during the intervention are not similar in both groups 
• Examples where circumstances during the intervention were not similar: 
• Timing of administration of the placebo and exp drug was different; timing 
of imaging different between different groups 
• Instruments used to conduct experiment differ between experimental and 
control group (e.g. skinning of skull for optical imaging or electrode 
insertion into the brain in one group, but not the other) 
 
Practical implementation 
As blinding is associated with additional work for the investigators and 
increases the level of evidence ascribed to a study, we expected that any 
effort to blind a study is at least briefly mentioned (e.g. “a blinded 
investigator”). 
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• If blinding described and expected to have been effective → yes 
• If blinding mentioned, but not described how/doubts whether effective → 
unclear 
• If no mention of blinding at all → no 
• If for one aspect of the experiment clear that not blinded → no, because 
very unlikely that rest blinded 
 
 
5. Detection bias – random outcome assessment 
 
Describe whether or not animals were selected at random for outcome 
assessment, and which methods to select the animals, if any, were used. 
 
Were animals selected at random for outcome assessment? 
 
Did the investigators randomly pick an animal during outcome assessment, or 
did they use a random component in the sequence generation for outcome 
assessment?          
• Referring to a random number table; 
• Using a computer random number generator; 
• Etc 
 
Practical implementation 
• If method described → yes or no depending on method 
• If method not described → unclear 
 
 
6. Detection bias – blinding 
 
Describe all measures used, if any, to blind outcome assessors from knowing 
which intervention each animal received. Provide any information relating to 
whether the intended blinding was effective. 
 
Was the outcome assessor blinded? 
 
Was blinding of the outcome assessor ensured, and was it unlikely that 
blinding could have been broken?       
• Outcome assessment methods were the same in 
• both groups. 
• Animals were selected at random during outcome 
• assessment (use signaling questions of entry 6). 
 
Was the outcome assessor not blinded, but do review authors judge that the 
outcome is not likely to be influenced by lack of blinding? (e.g., mortality) 
 
Additional information 
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This item needs to be assessed for each main outcome. 
 
Practical implementation 
As blinding is associated with additional work for the investigators and 
increases the level of evidence ascribed to a study, we expected that any 
effort to blind a study is at least briefly mentioned (e.g. “a blinded 
investigator”). 
• If blinding described and expected to have been effective → yes 
• If blinding mentioned, but not described how/doubts whether effective 
→ unclear 
• If no mention of blinding at all → no 
• If for one aspect of the experiment clear that not blinded → no, because 
very unlikely that rest blinded 
 
 
7. Attrition bias – incomplete outcome data  
 
Describe the completeness of outcome data for each main outcome, including 
attrition and exclusions from the analysis. State whether attritions and 
exclusions were reported, the numbers in each intervention group (compared 
with total randomized animals), reasons for attrition or exclusions, and any re-
inclusions in analyses for the review. 
 
Were incomplete data adequately addressed? 
 
Were all animals included in the analysis?     
 
Were the reasons for missing outcome data unlikely to be related to true 
outcome (e.g., technical failure)?       
Are missing outcome data balanced in numbers across intervention groups, 
with similar reasons for missing data across groups?  
 
Practical implementation 
• If clearly stated that all animals were included → yes  
• If neither stated that all animals included nor exclusions reported or if 
missing outcome data not balanced across groups → unclear 
• If missing suspicion that exclusions related to true outcome or results 
reported for fewer animals than originally included without justification → 
no 
   
  
8. Reporting bias – selective outcome reporting 
 
State how selective outcome reporting was examined and what was found. 
 
Are reports of the study free of selective outcome reporting? 
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Was the study protocol available and were all of the study’s pre-specified 
primary and secondary outcomes reported in the current manuscript? 
  
 
Was the study protocol not available, but was it clear that the published report 
included all expected outcomes (i.e. comparing methods and results section)?
     
 
Additional information 
 
Selective outcome reporting: 
• Not all of the study’ s pre-specified primary outcomes have been reported; 
• One or more primary outcomes have been reported using measurements, 
analysis methods or data subsets (e.g., subscales) that were not pre-
specified in the protocol; 
• One or more reported primary outcomes were not pre-specified (unless 
clear justification for their reporting has been provided, such as an 
unexpected 
• adverse effect); 
• The study report fails to include results for a key outcome that would be 
expected to have been reported for such a study. 
 
Practical implementation 
If no study protocol was available, the second question was decisive for the 
overall assessment of item 8. 
• If no suspicion → yes 
• If not sure → unclear 
• If expected results were not reported → no 
  
9. Other – other source of bias 
 
State any important concerns about bias not covered by other domains in the 
tool. 
 
Was the study apparently free of other problems that could result in a 
high risk of bias? 
 
Was the study free of pooling drugs?     
Additional information 
Experiments in which animals receive – besides the intervention drug – 
additional treatment or drugs which might influence or bias the result. Eg. 
administration of inhalant anaesthetic together with N2O, but injectable 
anaesthetic administered without adding N2O or administration of injectable 
anaesthetic associated with fluid administration, but no fluids administered in 
inhalant anaesthetic group. 
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Were design-specific risks of bias absent?     
Additional information 
Design-specific risks of bias: 
• Crossover design that was not suitable (intervention with no temporary 
effect, or the disease is not stable over time) 
• Crossover design with risk of carry-over effect  
• Crossover design with only first period data being available 
• Crossover design with many animals not receiving 2nd or following 
treatment due to large number of drop-outs probably due to longer duration 
of study 
• Crossover design in which all animals received same order of interventions 
• Multi-arm study in which the same comparisons of groups are not reported 
for all outcomes (selective outcome reporting) 
• Multi-arm study in which results of different arms are combined (all data 
should be presented per group) 
• Cluster randomized trial not taking clustering into account during statistical 
analysis (unit of analysis error) 
• Crossover design in which paired analysis of the results is not taken into 
account 
 
Practical implementation 
• If pooling of drugs explicitly avoided and no concern about design-specific 
risk of bias → yes 
• If pooling of drugs or design-specific risk of bias possible → unclear 
• If pooling of drugs (e.g. if one group inhalants and other group injectables 
and fluid management not described) or clear design-specific risk of bias 
→ no 
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6.6.2 Check of author guidelines  
 
Journals for which author guidelines were checked and no specific requirements 
regarding blinding/randomization standards were found: 
• Australasian Physical and Engineering Sciences in Medicine 
• Biomedical Engineering - Applications, Basis and Communications 
• Brain Connectivity 
• Brain Research 
• Brain Stimulation 
• Brain Structure and Function 
• Brain Topography 
• Cerebral Cortex 
• Chinese Journal of Physiology 
• Epilepsia  
• European Neuropsychopharmacology 
• Frontiers in Neural Circuits 
• Japanese Journal of Veterinary Research 
• Journal of Cerebral Blood Flow & Metabolism 
• Journal of Magnetic Resonance Imaging 
• Journal of Neurophysiology 
• Journal of Neuroscience 
• Journal of Neuroscience Methods 
• Magnetic Resonance Imaging 
• Magnetic Resonance in Medicine 
• NeuroImage. 
• NeuroImage: Clinical  
• Neuropsychopharmacology 
• NeuroReport 
• Neuroscience 
• Neuroscience Letters 
• NMR in Biomedicine 
• Pharmacology 
• PLoS Biology  
• PLOSone  
• Proceedings of the National Academy of Sciences of the United States of 
America 
• Psychopharmacology  
• RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen 
Bildgebenden Verfahren 
• Scientific Reports 
• Stroke 
• Zeitschrift Fur Medizinische Physik 
 
Journals for which author guidelines were not found or not in English 
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• Advances in Experimental Medicine and Biology 
• Chirurgia Italiana  
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6.7 Forms for screening and data extraction 
 
6.7.1 Title abstract screening  
 
Question Text Type Answer Text 
Should reference go on to full 
text screening? 
Radio yes 
  
no   
can't tell 
Reason of exclusion Checkbox other species   
other region of body   
other fMRI modality   
review   
completely different method   
out of age range   
in vitro   
book chapter   
commentary/opinion article   
model description   
data processing   
planned or ongoing study 
Keep a personal copy? Checkbox yes 
 
6.7.2 Full text screening  
 
Question Text Type Answer Text 
Method: Radio BOLD fMRI   
other MRI   
no MRI 
Location: Radio brain   
brain tumor only (e.g. glioma)   
other body region 
Species: Checkbox rat   
mouse   
other 
Age group: Radio adult   
younger   
older 
Type of publication: Radio short form   
full article   
review/opinion piece/talk 
Other reasons for exclusion 
present? 
Checkbox duplicate 
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multiple reporting   
full article available   
baseline study   
one animal per condition   
anesthetic(s) not reported   
no results reported for the 
comparison of interest    
imaging conditions different 
between conditions   
insufficient detail of results   
other   
no 
Comparison of anesthetic 
states? 
Checkbox not relevant (already excluded) 
  
different drugs   
different dosages   
different timepoints   
awake vs anesthetized   
no 
Changes in physiological 
parameters? 
Checkbox not relevant (already excluded) 
  
experimentally induced   
naturally occuring, explicitely 
monitored   
no 
This reference will be: Radio Included   
Excluded 
Keep a personal copy? Checkbox yes 
 
6.7.3 Study characteristics  
 
Question Text Type Answer Text 
rat strain Checkbox Wistar   
Sprague-Dawley   
Long-Evans   
na 
mouse strain Checkbox C57BL/6   
BALB/c   
 I/LnJ   
transgenic ChR2 
sex Checkbox male   
female   
na 
comments strain/sex Text 
 
age (average +/- sd or range in Text 
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weeks) 
weight (average +/- sd or range 
in grams) 
Text 
 
total number of animals Text 
 
number of animals undergoing 
fMRI 
Text 
 
Invasive procedures during prep 
(other than art/ven 
catheterization)? 
Checkbox craniotomy (to expose a certain 
area) 
  
thinning of skull (to create a 
window)   
electrode insertion into the 
brain (with or without small drill 
holes)   
tracheostomy   
-   
na   
Attachment of a head-bar to 
the skull   
exposing skull   
epidural electrode insertion   
gastric tube   
Implanted with intra-gastric (IG) 
balloons or IG catheters   
middle cerebral artery 
occlusion 
Study Design Checkbox comparison between groups 
(one exp.session)   
comparison to baseline (same 
baseline for all animals, same 
experimental session)   
comparison to earlier session 
(same first measurement for all 
animals, multiple sessions))   
crossover - one session   
crossover - multiple sessions   
comparison of time points of 
measurement   
observation   
not clear (na) 
study design - free text Text 
 
experimental paradigm Checkbox peripheral stimulation 
  
central stimulation   
resting state   
PPi as stimulus (i.e. signal pre-
/post-PPi analyzed as with 
other stimuli) 
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calibrated   
other 
peripheral stimulation Checkbox electrical (somatosensory)   
mechanical (somatosensory)   
chemical (somatosensory)   
thermal (somatosensory)   
whisker stimulation   
olfactory   
gustatory   
auditory   
visual   
visceral - mechanical   
visceral - chemical (e.g. 
ingestion of nutrients) 
central stimulation Checkbox electrical   
chemical/pharmacological   
optogenetic 
PPi as stimulus Checkbox change in breathing gas 
mixture   
apnea   
spontanoeus vs. controlled 
ventilation   
blood withdrawal   
fluid supplementation   
pharmacologic (cardiovascular 
parameters)   
change in body temperature 
Comment on stimulation Text 
 
field strength in Tesla Text 
 
time points and duration of 
image acquisition 
Text 
 
ROIs in this study Text 
 
general approach to fMRI data Text 
 
analysis of PP data (if 
applicable, otherwise just â€œ-
â€œ) 
Text 
 
 
6.7.4 Anaesthetic protocol  
 
Question Text Type Answer Text 
AP experimental group name - drug Radio isoflurane   
sevoflurane   
halothane   
iso/medet   
iso/dexmedet 
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medetomidine   
dexmedetomidine   
ketamin/xylazin   
ketamin/medetomidine   
ketamine/dexmedet   
a-choralose   
urethane   
propofol   
Pentobarbital   
plus ketamine   
plus s-ketamine   
plus r-ketamine   
ketamine - xylazine - 
acepromazine   
ketamine/xylazine/acepromazi
ne   
thiobutabarbital   
equithesine   
iso plus ketamine/xylazine   
N2O   
iso plus ketamine   
iso plus medet   
midazolam 
AP experimental group name - dose Radio low dose   
intermediate dose   
high dose   
short iso   
long iso   
spont vent   
contr vent   
after awake   
without awake 
induction Checkbo
x 
inhalation 
  
injection   
na 
inhalant induc Radio isoflurane   
sevoflurane   
halothane   
isoflurane or halothane 
vaporizer setting (%) induc Text 
 
method inhalant induc Radio box   
mask   
na 
total gas flow (l/min) induc Text 
 
gas mixture (in %) induc Checkbo
x 
oxygen  
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air   
nitrogen N2   
nitrous oxide N2O   
na 
injectable 1 induc Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
chloralhydrate   
Pentobarbital   
equithesine   
atropine 
dose/unit/route injectable 1 induc Text 
 
injectable 2 induc Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
- 
dose/unit/route injectable 2 induc Text 
 
Airway management Radio intubation   
nose cone/mask   
na 
 
 
 
 
  
Radio oral 
 
tracheotomy   
na 
Ventilation mode Radio spontaneous   
controlled   
na 
Maintenance during preparation and set-
up 
Checkbo
x 
inhalation 
  
CRI   
top-ups   
induction = maintenance 
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na 
inhalant prep Radio isoflurane   
sevoflurane   
halothane   
isoflurane or halothane 
vaporizer setting (%) prep Text 
 
if stop inhalant after prep: timepoint in 
min after initial bolus/start CRI 
maintenance exp. 
Text 
 
CRI 1 prep Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane 
initial bolus CRI 1 prep (dose/unit/route) Text 
 
rate CRI 1 prep (dose/unit/route) Text 
 
timing CRI 1 prep (start CRI relativ to 
induction/bolus; eventual stop) 
Text 
 
CRI 2 prep Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
- 
initial bolus CRI 2 prep (dose/unit/route) Text 
 
rate CRI 2 prep (dose/unit/route) Text 
 
timing CRI 2 prep (start CRI relativ to 
induction/bolus; eventual stop) 
Text 
 
top-up 1 prep Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
Pentobarbital 
unit/dose/route top-up 1 prep Text 
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interval top-up 1 prep (repeated after x 
min) 
Text 
 
top-up 2 prep Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
- 
unit/dose/route top-up 2 prep Text 
 
interval top-up 2 prep (repeated after x 
min) 
Text 
 
total gas flow (l/min) prep Text 
 
gas mixture (in %) prep Checkbo
x 
oxygen  
  
air   
nitrogen N2   
nitrous oxide N2O   
na 
Maintenance during experiment Checkbo
x 
inhalation 
  
CRI   
top-ups   
induction = maintenance 
inhalant exp Radio isoflurane   
sevoflurane   
halothane   
N2O 
vaporizer setting (%) exp Text 
 
CRI 1 exp Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
midazolam 
initial bolus CRI 1&nbsp;exp 
(dose/unit/route) 
Text 
 
rate CRI 1&nbsp;exp (dose/unit/route) Text 
 
timing CRI 1 exp (start CRI relativ to 
initial bolus/stop inhalant/...) 
Text 
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rate CRI 1 exp after change Text 
 
timing rate change CRI 1 exp and 
additional information 
Text 
 
CRI 2 exp Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
- 
initial bolus CRI 2&nbsp;exp 
(dose/unit/route) 
Text 
 
rate CRI 2&nbsp;exp (dose/unit/route) Text 
 
timing CRI 2&nbsp;exp (start CRI relativ 
to initial bolus/stop inhalant/..) 
Text 
 
rate CRI 2 exp after change Text 
 
timing rate change CRI 2 exp and 
additional information 
Text 
 
top-up 1 exp Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
Pentobarbital   
acepromazine   
thiobutabarbital   
equithesine   
midazolam 
unit/dose/route top-up 1 exp Text 
 
interval top-up 1&nbsp;exp (repeated 
after x min) 
Text 
 
top-up 2 exp Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane 
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- 
unit/dose/route top-up 2 exp Text 
 
interval top-up 2&nbsp;exp (repeated 
after x min) 
Text 
 
total gas flow (l/min) exp Text 
 
gas mixture (in %) exp Checkbo
x 
oxygen  
  
air   
nitrogen N2   
nitrous oxide N2O   
na 
Was an anesthetic drug given on top of 
the maintenance protocol as an 
experimental stimulus? 
Radio yes 
  
no 
on top - drug Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
r-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
heroin 
on top - doses/unit/routes/timing Text 
 
Local anesthesia used? Radio yes   
no 
site of local anesthetic Text 
 
local anesthetic Radio lidocaine   
ropivacaine   
bupivacaine   
mepivacaine 
dose/unit&nbsp; local anesthetic Text 
 
Animals paralyzed? Radio yes   
no 
 
 
 
 
 
NMBA 
Checkbo
x 
pancuronium bromide 
  
gallamine   
mivacurium   
D-tubocurarine chloride  
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na 
dose/unit/route NMBA Text 
 
Other drugs routinely administered 
(name, dose, route, timepoint/interval) 
Text 
 
Comments/explanations anesthetic 
protocol 
Text 
 
 
6.7.5 Awake protocol  
 
Question Text Type Answer Text 
awake group name Radio awake 
Was an acclimatization protocol used prior to 
imaging? 
Radio yes 
  
no 
Describe the acclimatization protocol: Text 
 
Were the animals anesthetized for placement in 
the scanner (in the actual imaging session)? 
Radio yes 
  
no 
induction Checkbox inhalation   
injection 
inhalant induc Radio isoflurane   
sevoflurane   
halothane 
 
 
 
 
 
vaporizer setting (%) induc 
Text 
 
method inhalant induc Radio box   
mask   
na 
total gas flow (l/min) induc Text 
 
gas mixture (in %) induc Checkbox oxygen    
air   
nitrogen N2   
nitrous oxide 
N2O   
na 
injectable 1 induc Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol 
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alfaxalone   
a-chloralose   
urethane   
chloralhydrate 
dose/unit/route injectable 1 induc Text 
 
injectable 2 induc Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
- 
dose/unit/route injectable 2 induc Text 
 
Maintenance during preparation and set-up Checkbox inhalation   
CRI   
top-ups   
induction = 
maintenance 
inhalant prep Radio isoflurane   
sevoflurane   
halothane 
 
 
 
 
 
vaporizer setting (%) prep 
Text 
 
CRI 1 prep Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane 
initial bolus CRI 1 prep (dose/unit/route) Text 
 
rate CRI 1 prep (dose/unit/route) Text 
 
timing CRI 1 prep (start CRI relativ to 
induction/bolus; eventual stop) 
Text 
 
CRI 2 prep Radio medetomidine   
dexmedetomidine   
xylazine 
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ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
- 
initial bolus CRI 2 prep (dose/unit/route) Text 
 
rate CRI 2 prep (dose/unit/route) Text 
 
timing CRI 2 prep (start CRI relativ to 
induction/bolus; eventual stop) 
Text 
 
top-up 1 prep Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane 
unit/dose/route top-up 1 prep Text 
 
interval top-up 1 prep (repeated after x min) Text 
 
top-up 2 prep Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane   
- 
unit/dose/route top-up 2 prep Text 
 
interval top-up 2 prep (repeated after x min) Text 
 
total gas flow (l/min) prep Text 
 
gas mixture (in %) prep Checkbox oxygen    
air   
nitrogen N2   
nitrous oxide 
N2O   
na 
total gas flow (l/min) exp Text 
 
gas mixture (in %) exp Checkbox oxygen    
air   
nitrogen N2   
nitrous oxide 
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N2O   
na 
Was an anesthetic drug given in subanesthetic 
dose as an experimental stimulus? 
Radio yes 
  
no 
on top - drug Radio medetomidine   
dexmedetomidine   
xylazine   
ketamine   
s-ketamine   
propofol   
alfaxalone   
a-chloralose   
urethane 
on top - doses/unit/routes/timing Text 
 
Local anesthesia used? Radio yes   
no 
site of local anesthetic Text 
 
local anesthetic Radio lidocaine   
ropivacaine   
bupivacaine   
mepivacaine 
dose/unit&nbsp; local anesthetic Text 
 
Animals paralyzed? Radio yes   
no 
NMBA Radio pancuronium 
bromide   
mivacurium 
dose/unit/route NMBA Text 
 
Comments/explanations awake protocol Text 
 
 
6.7.6 Monitoring  
 
Question Text Type Answer Text 
Type of experimental groups Radio fMRI anesthetized   
bench-top   
 fMRI awake 
Monitored parameters Checkbox body temperature   
heart rate   
arterial blood pressure   
respiratory rate   
respiratory pattern   
respiratory gases 
(Fi/Fe)   
SpO2/S(a/v)O2 
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pO2    
pCO2    
pH of the blood   
reflexes   
pulse distension (in um)   
hemoglobin 
concentration   
concentration of volatile 
agents (Fi and/or Fe)   
Fi/Fe N2O   
hematocrit   
glucose 
temperature kept at (average +/- sd or range 
in Â°C) 
Text 
 
heart rate - method of measurement Checkbox pulseoxymetry   
arterial line (invasive 
BP)   
ECG   
tail pulse cuff sensor   
not specified 
blood pressure - method of measurement Checkbox invasive   
noninvasive 
respiratory rate - method of measurement Checkbox pressure sensitive 
sensor   
piezo electric force 
transducer   
capnography   
spirometry   
ECG   
visual (observing the 
animal)   
not specified   
controlled ventilation   
artline 
respiratory pattern - definition and method of 
measurement 
Text 
 
respiratory gases Checkbox FiO2   
FeO2   
FiCO2   
FeCO2 
SpO2/S(a/v)O2 - method of measurement Checkbox pulsoxymetry   
arterial blood gas   
venous blood gas   
transcutaneous   
not specified 
pO2 - method of measurement Checkbox arterial blood gas   
venous blood gas 
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transcutaneous   
not specified 
pCO2 method of measurement Checkbox arterial blood gas   
venous blood gas   
transcutaneous   
not specified 
pH - method of measurement Checkbox arterial blood gas   
venous blood gas   
not specified 
reflexes tested Checkbox tail flick   
hind limb withdrawal   
not specified   
whiskering   
â€œblinkâ€œ   
forelimb withdrawal   
tail pinch   
corneal   
palpebral reflex   
righting reflex 
Timepoints of blood gas sampling and/or 
reflex testing 
Text 
 
Comments on the monitoring used (eg 
relevant method for analysis, details 
controlled ventilation) 
Text 
 
 
 
6.7.7 Physiological parameters interventions  
 
Question Text Type Answer Text 
Name of phys.p.i. experimental group Radio hypotension   
hypertension   
hypoxia   
hyperoxia   
hypocapnia   
hypercapnia   
apnoea - room air 
baseline   
apnoea - hypoxic 
baseline   
apnoea - hyperoxic 
baseline   
apnoea - hypocapnic 
baseline   
apnoea - hypercapnic 
baseline 
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apnoea - hyperoxic, 
hypercapnic baseline   
hypothermia   
hyperthermia   
anemia   
tachycardia   
hyperoxia-hypercapnia   
variation of body 
temperature   
Room air with apnoea   
100% O2 with apnoea   
Apnoea with carbogen 
(5% CO2 + 95% O2)   
2% CO2 + 98% air with 
apnea   
5% CO2 + 95% air with 
apnoea   
all gas mixes   
Spontaneous vent. vs 
mechanical vent.   
contr vent   
spont vent   
variable BP   
constant BP 
Name of phys.p.i. experimental group - 
stimulus strength 
Radio strongest 
  
intermediate   
weakest   
urethane   
pentobarbital   
2%, urethane   
2%, pentobarbital   
5%, urethane   
5%, pentobarbital   
awake   
iso   
normal hct   
mild anemia   
moderate anemia 
Type of intervention Checkbox change in breathing gas 
mixture   
apnoea   
blood withdrawal   
fluid supplementation   
pharmacologic    
change in body 
temperature 
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spontaneous vs 
controlled ventilation   
change in controlled 
ventilation settings   
negative lower body 
pressure 
breathing gas mix baseline Checkbox oxygen   
air   
N2   
N2O   
CO2   
na 
breathing gas mix stimulus Checkbox oxygen   
air   
N2   
N2o   
CO2   
na 
breathing gas mix post stimulus Checkbox oxygen   
air   
N2   
N20   
CO2   
na 
apnoea - duration (in s) Text 
 
apnoea - number of cycles Text 
 
apnoea - interval between cycles Text 
 
blood withdrawal - amount in ml (per 
step) 
Text 
 
blood withdrawal - over time (per step) Text 
 
blood withdrawal - number of steps Text 
 
blood withdrawal - total amount Text 
 
blood withdrawal - total time Text 
 
fluid supplementation - fluid type Checkbox cristalloids   
colloids   
blood 
fluid supplmentation - amount in ml per 
bolus 
Text 
 
fluid supplementation - time per bolus Text 
 
fluid supplementation - number of boli Text 
 
fluid supplementation - total amount Text 
 
fluid supplementation - total time Text 
 
pharmacologic - type of drug Checkbox inotrope   
vasopressor   
vasodilator 
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other 
pharmacologic - name of drug Text 
 
pharmacologic - dose/unit/route Text 
 
Parameters under investigation Checkbox body temperature   
heart rate   
arterial blood pressure   
respiratory rate   
respiratory pattern   
respiratory gases - EtCO2   
SpO2 / S(a/v)O2   
pO2   
pCO2   
pH of the blood   
hematocrit   
pulse distension   
other parameters, please 
specify 
heart rate - direction of change Checkbox up   
down   
constant   
other analysis 
heart rate - baseline (average +/- sd in 
bpm) 
Text 
 
heart rate - under stimulation (average +/- 
sd) 
Text 
 
heart rate - post stimulation (average +/- 
sd) 
Text 
 
blood pressure - direction of change Checkbox up   
down   
constant   
other analysis 
blood pressure - baseline (group average 
+/- sd in cmH2O) 
Text 
 
blood pressure - under stimulation 
(average +/- sd) 
Text 
 
blood pressure - post stimulation 
(average +/- sd) 
Text 
 
pCO2 - direction of change Checkbox up   
down   
constant   
other analysis 
pCO2 - baseline (group average +/- sd in 
mmHg) 
Text 
 
pCO2 - under stimulation (average +/- sd) Text 
 
pCO2 - post stimulation (average +/- sd) Text 
 
pO2 - direction of change Checkbox up   
down 
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constant   
other analysis 
pO2 - baseline (group average +/- sd in 
mmHg) 
Text 
 
pO2 - under stimulation (average +/- sd) Text 
 
pO2 - post stimulation (average +/- sd) Text 
 
SpO2 - direction of change Checkbox up   
down   
constant   
other analysis 
SpO2 - baseline (group average +/- sd in 
%) 
Text 
 
SpO2 - under stimulation (average +/- sd) Text 
 
SpO2 - post stimulation (average +/- sd) Text 
 
respiratory rate - direction of change Checkbox up   
down   
constant   
other analysis 
respiratory rate - baseline (group average 
+/- sd in /min) 
Text 
 
respiratory rate - under stimulation 
(average +/- sd) 
Text 
 
respiratory rate - post stimulation 
(average +/- sd) 
Text 
 
hematocrit - direction of change Checkbox up   
down   
constant   
other analysis 
hematocrit - baseline (group average +/- 
sd in %) 
Text 
 
hematocrit - under stimulation (average 
+/- sd) 
Text 
 
hematocrit - post stimulation (average) Text 
 
body temperature - direction of change Checkbox up   
down   
constant   
other analysis 
body temperature - baseline (group 
average in Â°C) 
Text 
 
body temperature - under stimulation 
(average +/- sd) 
Text 
 
body temperature - post stimulation 
(average +/- sd) 
Text 
 
pulse distension - direction of change Checkbox up   
down   
constant   
other analysis 
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pulse distension - baseline (average in 
um +/- sd) 
Text 
 
pulse distension - under stimulation 
(average +/- sd) 
Text 
 
pulse distension - post stimulation 
(average +/- sd) 
Text 
 
respiratory pattern - type of change Text 
 
Comments phys.p. int. anesth Text 
 
ph of blood - direction of change Checkbox up 
  
down   
constant   
other analysis 
ph of blood - baseline (average +/- sd) Text 
 
ph of blood - under stimulation (average 
+/- sd) 
Text 
 
pH of blood - post stimulation (average 
+/- sd) 
Text 
 
EtCO2 - direction of change Checkbox up 
  
down    
constant   
other analysis 
EtCO2 - baseline (average +/- sd) Text 
 
EtCO2 - under stimulation (average +/- 
sd) 
Text 
 
EtCO2 - post stimulation(average +/- sd) Text 
 
 
6.7.8 Physiological parameters observations 
Question Text Type Answer Text 
Name of phys.p.obs. experimental group Radio PP observation   
PPo iso   
PPo medet   
PPo propofol   
PPo urethane   
PPo ac   
PPo ketamin/medet 
Parameters under investigation Checkbox heart rate   
arterial blood pressure   
pH   
pCO2   
pO2    
SpO2 
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hematocrit   
respiratory rate   
body temperature   
pulse distension   
other parameters, please 
specify   
glucose 
heart rate - direction of change Checkbox up   
down   
constant   
other analysis 
heart rate - baseline (average +/- sd in 
bpm) 
Text 
 
heart rate - under stimulation (average +/- 
sd) 
Text 
 
heart rate - post stimulation (average +/- 
sd) 
Text 
 
blood pressure - direction of change Checkbox up   
down   
constant   
other analysis 
blood pressure - baseline (group average 
+/- sd in cmH2O) 
Text 
 
blood pressure - under stimulation 
(average +/- sd) 
Text 
 
blood pressure - post stimulation 
(average +/- sd) 
Text 
 
pH - direction of change Checkbox up 
  
down   
constant   
other analysis 
pH - baseline (group average +/- sd) Text 
 
pH - under stimulation (average +/- sd) Text 
 
pH - post stimulation (average +/- sd) Text 
 
pCO2 - direction of change Checkbox up   
down   
constant   
other analysis 
pCO2 - baseline (group average +/- sd in 
mmHg) 
Text 
 
pCO2 - under stimulation (average +/- sd) Text 
 
pCO2 - post stimulation (average +/- sd) Text 
 
pO2 - direction of change Checkbox up   
down   
constant 
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other analysis 
pO2 - baseline (group average +/- sd in 
mmHg) 
Text 
 
pO2 - under stimulation (average +/- sd) Text 
 
pO2 - post stimulation (average +/- sd) Text 
 
SpO2 - direction of change Checkbox up   
down   
constant   
other analysis 
SpO2 - baseline (group average +/- sd in 
%) 
Text 
 
SpO2 - under stimulation (average +/- sd) Text 
 
SpO2 - post stimulation (average +/- sd) Text 
 
respiratory rate - direction of change Checkbox up   
down   
constant   
other analysis 
respiratory rate - baseline (group average 
+/- sd in /min) 
Text 
 
respiratory rate - under stimulation 
(average +/- sd) 
Text 
 
respiratory rate - post stimulation 
(average +/- sd) 
Text 
 
hematocrit - direction of change Checkbox up   
down   
constant   
other analysis 
hematocrit - baseline (group average +/- 
sd in %) 
Text 
 
hematocrit - under stimulation (average 
+/- sd) 
Text 
 
hematocrit - post stimulation (average) Text 
 
body temperature - direction of change Checkbox up   
down   
constant   
other analysis 
body temperature - baseline (group 
average +/- sd in °C) 
Text 
 
body temperature - under stimulation 
(average +/- sd) 
Text 
 
body temperature - post stimulation 
(average +/- sd) 
Text 
 
pulse distension - direction of change Checkbox up   
down   
constant   
other analysis 
pulse distension - baseline (group Text 
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average +/- sd in um) 
pulse distension - stimulation (group 
average +/- sd in um) 
Text 
 
pulse distension - post stimulation (group 
average +/- sd in um) 
Text 
 
Comments PP obs anesth Text 
 
 
6.7.9 Outcome anaesthetic protocols  
 
Question Text Type Answer Text 
Was a difference observed between different states 
of anesthesia? 
Radio yes 
  
no 
Specify the observed difference(s) Text 
 
In which measures was no difference observed? Text 
 
Personal comments Text 
 
 
6.7.10 Outcome physiological parameters  
 
Question Text Type Answer Text 
Was a difference observed between different 
physiological states? 
Radio yes 
  
no 
Specify the observed difference(s) Text 
 
In which measures was no difference observed? Text 
 
Personal comments Text 
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